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Abstract 
The interaction between antigen presenting cells in the skin with molecules 
secreted by cercariae of Schistosoma mansoni constitutes the first point of 
contact between the host’s immune system and the pathogen. High levels of IL-
10 are produced in infected skin, and macrophages, which readily take up the 
molecules secreted by cercariae, are among the first population recruited to the 
site of infection. 
Macrophages produce high levels of IL-10 when exposed to cercarial 
excreted/secreted (E/S) products, as well as other cytokines and chemokines 
(i.e. IL-1β, IL-6, TNF-α and CCL2), but it is unknown what signalling pathway(s) 
drive the production of IL-10, rather than other pro-inflammatory cytokines such 
as IL-12p40, or how they are linked to innate recognition of E/S antigens. Our 
findings demonstrate that TLRs, particularly TLR4 and TLR2, play a 
fundamental role in the induction of IL-10. Furthermore, MyD88 is essential for 
the activation of multiple MAPK pathways which in turn control E/S product-
induced IL-10. Selective chemical inhibition of specific pathways allowed us to 
determine the contribution of each signalling cascade. We established that the 
activation of MEK/Erk and p38 induced the production of IL-10, whilst it 
negatively affected IL-12p40. Furthermore, the activation of these kinases leads 
to the phosphorylation of CREB, which is responsible for the observed effects 
on IL-10 by being recruited to the promoter of the IL-10 gene. Finally, we show 
that TLR4 and TLR2 are directly implicated in the activation of these pathways 
and that macrophages in the skin produce IL-10 as a result of cercarial 
invasion. 
From these findings we propose a mechanism by which S. mansoni E/S 
products induce a specific MAPK signalling cascade that triggers IL-10 
production in macrophages by binding their TLRs, thus polarizing the immune 
response in the skin. 
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1 Introduction 
1.1 Schistosomiasis 
1.1.1 Overview 
Schistosomiasis, also known as bilharzia, is a parasitic disease caused in 
humans primarily by three species of trematodes: Schistosoma haematobium, 
S. mansoni and S. japonicum, but also by S. intercalatum, and S. mekongi. The 
disease affects 230 million people distributed in tropical and subtropical regions 
of the world (Diagram 1.1) (Colley et al, 2014; Fairfax et al, 2012; Gryseels et al, 
2006). Unlike Central and South America, and East Asia, there is significant 
geographical overlap of different schistosome parasite species in Africa. 
Urogenital schistosomiasis is caused by S. haematobium, whereas S. mansoni 
is responsible for intestinal schistosomiasis (Colley et al, 2014; Gryseels et al, 
2006). 
Diagram 1.1 World distribution of Schistosomiasis. Taken from Colley et 
al, 2014 
 
World distribution of schistosome species is limited by the availability of 
ecological niches for the intermediate hosts of the parasite, which are different 
species of fresh water dwelling snails. S. haematobium and S. mansoni require 
snails from the Bulinus and Biomphalaria genera respectively (Colley et al, 
2014). Infected snails release the free-swimming form of the parasite, called 
cercariae, which are able to locate the mammalian host and start infection 
following percutaneous exposure (Diagram 1.2). Cercariae penetrate the skin 
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Seminar
eosinophilia, fatigue, and abdominal pain lasting 
2–10 weeks. This aspect of schistosomiasis has been 
reviewed in detail.26 The limited presentation of this 
syndrome in residents of endemic regions is probably a 
result of in-utero priming of T-lymphocyte and 
B-lymphocyte responses of babies born to mothers with 
helminthic infections.27,28
Over time, the granulomatous response to eggs is 
downregulated through several mechanisms in most 
individuals, leading to progression to the chronic 
intestinal form of the disease for S mansoni, S japonicum, 
and S mekongi. This form of the disease presents as non-
specifi c intermittent abdominal pain, diarrhoea, and 
rectal bleeding, with the frequency of symptoms often 
related to the intensity of infection.29 Such gastrointestinal 
features are often focal with isolated mucosal hyperplasia, 
pseudopolyposis, and polyposis interspersed with 
normal bowel (appendix).30 Some people with intestinal 
schistosomiasis only poorly immuno regulate their 
response to parasite egg antigens31 and consequently 
develop extensive fi brosis and subsequent hepatosplenic 
disease with periportal fi brosis.32 Patients with periportal 
fi brosis—also called Symmer’s pipe-stem fi brosis—
retain hepatocellular function,33 diﬀ erentiating the 
disease from cirrhosis and other liver diseases. Clinical 
features include upper abdominal discomfort with 
palpable nodular and hard hepato megaly, often with 
splenomegaly. Ascites and haematemesis from 
oesophageal varices as a complication of portal 
hypertension can rapidly lead to death.34 Substantial 
pulmonary hypertension caused by granulomatous 
pulmonary arteritis can also occur in patients with 
advanced hepatic fi brosis disease.35 The time from 
initial infection to advanced fi brosis is usually 
5–15 years.36 However, periportal fi brosis can occur in 
children as young as 6 years,37 showing the need for 
screening and tre tment of preschool children.20
By contrast, the defi ning symptom for urogenital 
schistosomiasis (S haematobium) is haematuria, often 
presenting with urinary frequency, burning micturition, 
and suprapubic discomfort. In endemic regions, 
haematuria is so widespread that it is thought a natural 
sign of puberty for boys, and is confused with menses in 
girls.18 As with severe intestinal schistosomiasis, severe 
urogenital schistosomiasis results from poor 
immunoregulation of antischistosome-egg responses,38 
leading to chronic fi brosis of the urinary tract presenting 
as obstructive uropathy (hydroureter and hydronephrosis39), 
which—along with resulting bacterial superinfection 
and renal dysfunction—can have l thal consequences. 
Squamous-cell carcinoma of the bladder is also strongly 
associated with S haematobium infection.40 This tumour 
is often multifocal, and in regions endemic for 
S haematobium, occurs at a younger age than do 
transitional-cell bladder carcinomas.
Female genital schistosomiasis caused by 
S haematobium strongly aﬀ ects women’s reproductive 
health.41 Eggs in the vesical plexus migrate to the genital 
tract causing infl ammatory lesions in the ovaries, 
fallopian tubes, cervix, vagina, and vulva. Lower genital 
Figure 2: Global distribution of countries where human schistosomiasis is transmitted.
Adapted from Gryseels and colleagues.5
Schistosoma mansoni
Schistosoma haematobium
Schistosoma intercalatum
Schistosoma japonicum
Schistosoma mekongi
Mixed S haematobium or S mansoni
Major rivers and lakes
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and transform into schistosomula, a larval stage of the parasite that is able to 
migrate through the dermis and epidermis, to reach the host’s vasculature. 
Larvae then migrate to the lungs and complete their maturation by pairing and 
lodging in the venous plexus of the bladder, for S. haematobium, or in the portal 
vein system near the intestines, for S. mansoni. Adult worms release several 
hundred eggs per day, which are excreted through urine or faeces allowing 
them to reach fresh water. At this stage the eggs hatch into miricidia that are 
able to infect the snail host, thereby completing their life cycle (Fairfax et al, 
2012; Pearce & MacDonald, 2002).  
Diagram 1.2 Schistosoma mansoni life cycle. Taken from Pearce & 
MacDonald 2002 
 
1.1.2 Pathology, treatment and vaccination 
Schistosome parasites cause pathology as eggs are trapped in tissues or are 
expelled into the gut or bladder lumen. Trapped eggs induce severe local 
inflammatory processes that are characterized by the influx of several types of 
leucocytes and the deposition of collagen, forming immune-mediated 
granulomas (Colley et al, 2014; Girgis et al, 2014; Hotez et al, 2008; Pearce & 
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Box 1 | The biology of schistosomes  
Of the ~2700 genera f Digenian parasites, the 13 that comprise the Schistosomatidae are unusu l in four ways: hey
have two rather than three hosts; they are dioecious (having male and female reproductive organs in separate
individuals), rather than hermaphrodite or asexual; they infect their hosts by directly penetrating the body surface,
rather than as a result of being eaten; and they parasitize the intravascular niche138. As for all sexual Digeneans, there is
an alternation of generations, such that asexual reproduction occurs in the intermediate (snail) host and sexual
reproduction occurs in the definitive (mammalian) host. The life cycle of Schistosoma mansoni is shown in the figure.
S. mansoni lives for long periods, with no evidence of immune-mediated clearance of adult worms139, and it has
evolved to use host factors for developmental signalling. By contrast, there is evidence for the immune-mediated
killing of adult Schistosoma haematobium parasites over time139. Infection is initiated by cercariae, which burrow into
the skin, transform into schistosomula, and then enter the vasculature and migrate to the portal system, where they
mature into adult worms. Eggs, which have tough shells, are released by female parasites within the vasculature; they
cross the endothelium and basement membrane of the vein, and traverse the intervening tissue, basement membrane
and epithelium of the intestine (S. mansoni and Schistosoma japonicum) or bladder (S. haematobium) en route to the
exterior. It is not clear yet how this p ocess occurs, although there se ms to be an immunological component, because
egg excretion is minimal in immunocompromised mice, but can be increased by the transfer of sera or lymphocytes
from infected animals140. Moreover, in a comparison of S. mansoni-infected HIV+ and HIV− patients, a correlation
between diminished egg excretion and decreased CD4+ T-cell counts was apparent141. It is unclear how eggs initially
attach to the endothelium and initiate penetration during extravasation, although factors that are released from
platelets in response to the eggs seem to be involved140,142.
So far, it has proved to be impossible to culture schistosomes through their complete life cycle in vitro, and there are no
published reports of techniques for routinely expressing transgenes in schistosomes or for targeted gene silencing. Also,
there are no schistosome cell lines. So, analyses of schistosome–host interactions rely on host-focused interventions and
traditional parasitological techniques.
Snail
Intermediate host
Eggs
(~140 µm)
Fresh water
Cercariae
(~800 µm)
Host-derived mediators
(TGF-β, IL-7, TNF ?)
CD4+
T cells
Receptors for host-
derived mediators
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Miracidia
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IL-7, interleukin-7; TGF-β, transforming growth factor-β; TNF, tumour-necrosis factor.
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MacDonald, 2002). These granulomas limit the movement of eggs, which 
eventually die, leaving behind a fibrotic plaque in the tissue (Pearce & 
MacDonald, 2002). As these processes continually occur in the liver and the 
gut, in the case of S. mansoni, host organ functionality is severely compromised 
leading to complications and in some cases death of the infected host (Richter 
et al, 1998). Additionally, in urogenital schistosomiasis the extent of tissue 
damage in the bladder is positively correlated with bladder cancer (Schwartz, 
1981). 
Adult worms ingest erythrocytes, causing anemia, and their location in the 
portal vein can lead to periportal fibrosis and hypertension, as well as portal 
shunting (Colley et al, 2014; Wilson, 1990). Moreover, larval migration trough 
the lungs can severely impact the aerobic capacity of infected individuals, even 
several decades post infection (Bustinduy et al, 2011). Long lasting effects of 
early chronic infection have an important impact on physical performance and 
educational attainment (Colley et al, 2014). 
Current therapy for schistosomiasis is restricted to one isoquinolinone drug 
called praziquantel (Gryseels et al, 2006; Mutapi et al, 2011; Wilson et al, 
2011). The drug allows efficient clearance of adult worms, but it requires intact 
antibody responses (Colley et al, 2014; Gryseels et al, 2006). The drug has no 
proven effect on developing larvae or eggs (Hotez, 2009), consequently it has 
limited efficacy for long term control of the disease in endemic areas. 
Vaccine development efforts are still ongoing, but there have not been any 
successful clinical trials in humans (Colley et al, 2014). Historically, there has 
been significant focus on vaccines using irradiated cercariae (Hewitson et al, 
2007; Mountford & Harrop, 1998). Only recently the full genome of the parasite 
was sequenced (Berriman et al, 2009; Protasio et al, 2012), and there is hope 
that its characterization will aid the development of a prophylactic vaccine. 
1.1.3 Immune response 
As with other helminthic infections, schistosomiasis is characterized by a strong 
Th2 response, marked by elevated levels of interleukin (IL-) 4, eosinophilia in 
the blood and increased levels of Immunoglobulin (Ig) E (Fairfax et al, 2012; 
Hotez et al, 2008; Pulendran & Artis, 2012).  
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As S. mansoni is patent in mice, this host species provides an important 
infection model, and consequently the immune response to S. mansoni is 
relatively well characterized. Soluble S. mansoni egg antigen (SEA) obtained 
from mature eggs is a potent driver of T helper (Th) 2 responses by CD4+ T 
cells (MacDonald et al, 2002; Perona-Wright et al, 2006). Eggs trapped in the 
liver release antigens that are picked up by dendritic cells (DCs), which are then 
able to polarize CD4+ T cells towards a Th2 phenotype (de Jong et al, 2002; 
Everts et al, 2010; Phythian-Adams et al, 2010). Molecular characterization of 
SEA has highlighted the role of some proteins (e.g. Omega-1) that might be 
responsible for the induction of Th2 responses (Everts et al, 2009). C-type lectin 
receptors and Toll like receptors have also been implicated in the recognition of 
SEA by DCs (Everts et al, 2012; Everts et al, 2010; Meevissen et al, 2011; van 
Liempt et al, 2007). 
Leucocytes involved in granuloma formation around eggs following chronic S. 
mansoni infection in the mouse include DCs and CD4 T cells, but also 
eosinophils and macrophages (Pearce & MacDonald, 2002). As this 
environment is strongly biased towards a Th2 phenotype, IL-4 is able to drive 
DCs and macrophages into an alternatively activated state (Barron & Wynn, 
2011; Cook et al, 2012; Girgis et al, 2014). In macrophages, this is represented 
by an increase in the expression of Arginase 1 (Arg-1), Resistin like molecule α 
(Relmα) and chitinase like 3 (Ym1) (Gordon & Martinez, 2010; Martinez et al, 
2009). Granuloma structures are also present in the gut, where eggs utilize 
Peyer’s patches to escape into the intestinal lumen (Turner et al, 2012). 
The consequences of the immune processes against S. mansoni in later stages 
of the disease, which collectively fall under what is being termed type 2 
immunity (Allen & Maizels, 2011; Pulendran & Artis, 2012), are neither 
protective for the host, nor entirely beneficial for the pathogen. Adult worms are 
able to live in infected hosts for years in the case of humans (Colley et al, 
2014), yet immune responses are necessary for the worms to fully mature. 
However, lack of IL-4 receptor alpha (IL-4Rα) or alternatively activated 
macrophages, have been shown in mice to significantly increase the egg output 
(Herbert et al, 2004; Ramalingam et al, 2008). Effectively, S. mansoni chronic 
infection is a balance between host fitness and tolerance of the parasite, limiting 
the amount of damage caused in tissues. 
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This description of immune responses to S. mansoni in the chronic phase is by 
no mean exhaustive, yet the main focus of this thesis is on the early stages of 
the infection, as cercariae penetrate the skin, which will be discussed in greater 
detail. 
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1.2 S. mansoni cercarial skin infection 
Most immunological studies have focused on the chronic phase of S. mansoni 
infection, leaving the larval (prior to worm maturation and egg deposition) phase 
of disease largely uncharacterized, and often broadly referred to as Th1 (Fairfax 
et al, 2012; Hotez et al, 2008). However, the process of cercarial penetration of 
the skin has been investigated in the context of radiation-attenuated larvae as 
putative vaccines. 
1.2.1 Immune responses in the skin 
The skin is a complex stratified tissue that modulates the interplay between the 
immune system and the environment. As such, it plays host to a plethora of 
non-pathogenic microorganism (Belkaid & Naik, 2013; Naik et al, 2012) and 
immune cells that are in constant interaction, both of which have the potential to 
shape the immune responses to invading parasites (Pasparakis et al, 2014).  
The skin is divided into two layers. The outer superficial epidermis is primarily 
comprised of keratinocytes, langerhans cells (LCs) and certain types of T cells 
(like Dendritic epidermal T cells (DETC) or CD8+ T cells). The underlying dermis 
is composed of stromal cells, like fibroblasts, and several types of immune cells 
such as macrophages, DCs, T cells, mast cells and innate lymphoid cells (ILCs) 
(Diagram 1.3) (Nestle et al, 2009; Pasparakis et al, 2014). 
In the epidermis, LCs are seeded from the Yolk sac and fetal liver (Ghigo et al, 
2013) and whilst they are normally thought to be a type of DC, can be thought 
of as tissue resident macrophages (Davies et al, 2013). These cells are actively 
monitoring the skin to find pathogens and can act as antigen presenting cells 
(Kumkate et al, 2007; Pasparakis et al, 2014).  
The source of DCs and macrophages in the dermis is contentious, with a 
significant input from the bone marrow (Jakubzick et al, 2013; Malissen et al, 
2014). Both groups of cells are similarly poised to respond to infections, and 
pro-inflammatory macrophages in particular have been implicated in several 
pathogenic settings both as driving inflammation, or having a host protective 
role (Fuentes-Duculan et al, 2010; Meng et al, 2009). Keratinocytes, in the 
epidermis, and ILCs in the dermis, are a source of cytokines for other immune 
cells (Pasparakis et al, 2014), and act as early warning systems against 
infection. Neutrophils can be recruited to the dermis by keratinocytes (Albanesi 
 25 
et al, 2005), and are associated with severe inflammatory processes in the skin 
(Abram et al, 2013). Mast cells on the other hand, are always in the dermis, and 
are quick to respond to any infection by de-granulating and facilitating pathogen 
clearance (Nestle et al, 2009; Pasparakis et al, 2014). 
Diagram 1.3 Immune cells in the skin. Adapted from Pasparakis et al, 2014 
 
T cells in the skin are varied in composition and can be found both in the dermis 
and epidermis. An important proportion are memory antigen specific T cells, 
both CD8+ and CD4+ (Mackay et al, 2013; Sanchez Rodriguez et al, 2014) 
which are generally found in the epidermis. CD4+ T cells in the dermis can be 
regulatory T cells (Belkaid et al, 2002; Campanelli et al, 2006) or memory T 
cells.  
Dendritic epidermal T cells
(DETCs). A population of T cells 
present in mouse skin. DETCs 
express CD3 and a T cell 
receptor, and they derive from 
the fetal thymus. Following 
activation, DETCs can secrete 
large amounts of 
pro-inflammatory mediators, 
which participate in the 
communication between 
DETCs, neighbouring 
keratinocytes and Langerhans 
cells.
Fibrocytes
A population of mesenchymal 
cells that reside in connective 
tissues. Fibrocytes have 
minimal cytoplasm and lack 
biochemical evidence of 
protein synthesis. Fibrocytes 
can migrate from the blood 
into connective tissues and 
have roles in wound healing 
and fibrotic tissue repair.
skin but are absent from human skin. It is important to 
take these differences into account when interpreting 
the inflammatory skin phenotypes observed in mouse 
models in relation to the mechanisms that drive the 
pathogenesis of human inflammatory skin diseases.
The dermis is rich in extracellular matrix and con-
tains stromal cells such as fibroblasts, fibrocytes and 
structural cells of the blood and lymph vessels. In addi-
tion, many different populations of myeloid and lym-
phoid immune cells either reside in or traffic through the 
dermis (FIG. 1). These cell populations are dynamic and 
undergo marked changes during an immune response.
Myeloid cells in skin immunity and inflammation
Surprisingly little is known about the development and 
dynamics of the myeloid cell network in the skin. The 
denomination ‘myeloid cells’ is not entirely accurate, 
as some of the cells in this population do not originate 
from the bone marrow. On the basis of their location 
and origin, it is possible to distinguish these populations 
as either skin-resident myeloid cells or circulating bone 
marrow-derived myeloid cells that enter the skin from 
the blood. However, these populations are not mutually 
exclusive as there is evidence that tissue-resident cells 
can be replenished by their circulating counterparts. 
In this Review, we discuss recent studies that have pro-
vided new insights into the role of skin epidermal and 
dermal myeloid cell populations in skin immunity 
and inflammation in mice and humans.
Dendritic cell subsets and functions in mouse skin. It 
was previously thought that Langerhans cells — the 
dendritic cell (DC) population that seeds the epidermis 
before birth — are exclusively of bone marrow origin3. 
However, protein expression analysis and lineage- 
tracing experiments have revealed that mouse 
Langerhans cells derive from two different embryonic 
sources under conditions of tissue homeostasis: the fetal 
liver and, to a minor extent, the yolk sac4. Langerhans 
cell maintenance in the epidermis depends on signalling 
through colony-stimulating factor 1 receptor (CSF1R)3. 
Macrophage colony-stimulating factor (M-CSF) con-
tributes to the repopulation of the epidermis with 
Langerhans cells under inflammatory conditions but 
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Figure 1 | Structure and cellular components of the skin in mice and humans. Mouse skin (panel a) has densely packed 
hair follicles, whereas human skin (panel b) has larger areas of interfollicular skin with sparse hair follicles. Human skin  
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An additional important component of the skin is the bacterial flora covering it. 
The role of commensal microbiota on immune response in the skin is not fully 
understood. Unlike the gut, defects in innate signaling have no effect on the 
composition of skin flora (Belkaid & Naik, 2013), but the numbers of regulatory 
T cells and the fate of infections are severely affected by commensal bacteria 
(Naik et al, 2012). 
1.2.2 Cercarial structure and E/S products 
S. mansoni cercariae are macroparasites with several specialized tissues that 
are designed to facilitate invasion of the host (Diagram 1.4) (Dorsey et al, 
2002). 
Diagram 1.4 Schematic of S. mansoni cercaria. Adapted from Dorsey et al, 
2002 
 
The tail (Diagram 1.5, i), which permits the movement of the cercariae in fresh 
water, is lost upon penetration of the skin, leaving the body (Diagram 1.5, ii) to 
burrow through the tissue (Paveley et al, 2009). This body is covered in a 
carbohydrate rich coating, called the glycocalyx that could protect larvae from 
immune attack (McKerrow et al, 2006). 
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Diagram 1.5 Fluorescent labeling of S. mansoni cercariae revealing pre- 
and post-acetabular glands. Taken from Paveley et al, 2009 
 
The contents of the post and pre-acetabular glands (Diagram 1.5, iii & iv 
respectively) of the parasite are released though the acetabular ducts (Diagram 
1.5, v) into the skin and are called Excretory/Secretory (E/S) products (aka 0-
3hRP) (Paveley et al, 2009). Cercariae penetrate the skin by releasing these 
molecules to remodel the extracellular matrix (Curwen et al, 2006; Paveley et 
al, 2009; Wilson, 2012) and aid migration of larvae through the skin to reach 
blood vessels thereby facilitating onward migration (McKerrow & Salter, 2002; 
Salter et al, 2000).  
S. mansoni cercarial E/S products have been shown to contain more than 50 
different proteins (Curwen et al, 2006; Knudsen et al, 2005), that are expressed 
in different proportions and released in the first three hours after mechanical 
transformation. 
Of the identified proteins in 0-3hRP the most often mentioned are the enzymes 
in the mixture, which allow remodeling of extracellular matrix necessary for 
parasite penetration of the skin. Of this group, the best studied is cercarial 
elastase, which has chymotrypsin activity enabling it to break skin elastin (Salter 
et al, 2000). Nonetheless, at least seven other elastases are secreted into the 
skin, alongside five metalloproteases one of which is Invadolysin (Wilson, 
2012). The specificity of these enzymes is unknown. In addition to aiding 
penetration, they could be responsible for degradation of antibodies directed at 
cercariae (McKerrow et al, 2006). 
Several of the proteins present in 0-3hRP are heavily glycosylated (Jang-Lee et 
al, 2007), and glycans could play an important role in the immunomodulatory 
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properties of 0-3hRP (Hokke & Deelder, 2001; Jenkins et al, 2005). Consensus 
in the scientific community is that glycans in cercarial secretions are responsible 
for their immunomodulatory effects. However, the only protein in 0-3hRP with a 
defined immunomodulatory role, Sm16, is not glycosylated (Jang-Lee et al, 
2007). Sm16 is able to induce apoptosis if it reaches the cytosol of cells 
(Holmfeldt et al, 2007), and effectively blocks signaling downstream of TLR4 
and TLR3 (Brännström et al, 2009). 
1.2.3 Immune responses in the skin to invading cercariae 
S. mansoni cercariae are not fast in penetrating human skin. They first crawl on 
the surface for ~40s before starting penetrating movements, which they only 
achieve after several minutes (Haas & Haeberlein, 2009). As stated before, 
most studies of immune processes in the skin to invading cercariae have 
concentrated on responses after vaccination with irradiated parasites. The 
exceptions are studies where the tools employed were limited (i.e. before flow 
cytometry or fluorescent microscopy were available). From these early studies, 
it is possible to ascertain that an influx of primarily neutrophils, but also 
macrophages and DCs is apparent at the site of infection (Incani & McLaren, 
1984). Evidence from more recent studies using irradiated parasites, shows that 
LCs are able to migrate to the skin-draining lymph node and present antigen 
(Kumkate et al, 2007). Indeed, the skin exposed to radiation-attenuated 
parasites appears to develop a Th1-type immune response, with IL-12p40 
playing an important role (Hewitson et al, 2007). These findings were supported 
by two more recent studies, which confirmed the appearance of neutrophils, 
DCs and macrophages at this early stage (Paveley et al, 2009), accompanied 
by the recruitment of a substantial population of eosinophils following repeated 
infection (Cook et al, 2011). Neutrophils, DCs and macrophages all appear to 
take up cercarial E/S products released by the invading larvae, and the latter 
two cell types then migrate to the skin draining lymph nodes (Paveley et al, 
2009). 
The data on cytokine and chemokine production from the skin is again originally 
available from earlier studies with irradiated cercariae. Cytokines are produced 
in the skin as a cascade including MIP1α, eotaxin, IL-6, IL-1, IL-18 and IL-
12p40 and IL-10, several of which reached their peak production 4 days after 
parasite exposure (Hogg et al, 2003a). The crosstalk between IL-12p40 and IL-
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10 in particular was investigated showing that IL-10 in the skin was able to limit 
IL-12p40 production, thus preventing efficacy of Th1 vaccine-induced immune 
responses (Hogg et al, 2003a; Hogg et al, 2003b). In studies using normal 
parasites, modest increases in the production of IL-10, IL-4 and IL-13 were 
shown in the first few days after infection compared to naïve skin, whilst 
markedly elevated levels were detected for IL-12p40, tumor necrosis factor 
alpha (TNF-α) and thymic stromal lymphopoietin (TSLP) (Cook et al, 2011). 
CD4+ T cells in the skin draining lymph nodes proliferate in response to S. 
mansoni cercarial antigen and produce interferon gamma (IFN-γ), IL-10 and IL-
4 (Cook et al, 2011; Pemberton et al, 1991). The antigen-specific proliferative 
response can be supported by DCs from the skin after S. mansoni infection, 
adding evidence to the hypothesis that these cells prime CD4+ T cells by 
migrating from the skin (Cook et al, 2011).  
In summary, the immune response in the skin to invading S. mansoni cercariae 
exhibits features from a classical inflammatory setting with neutrophil and 
monocyte influx, but also has characteristics of type 2 immunity with recruitment 
of eosinophils and production of IL-4. This mixed Th1/Th2 response after a 
primary infection in the skin is further supported by the proliferative responses in 
the skin draining lymph nodes, where both IFN-γ and IL-4 are being produced.  
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1.3 Macrophages  
Macrophages are phagocytic cells that reside in different organs, or circulate in 
the blood (Wynn et al, 2013). Macrophages exhibit different phenotypes in 
between tissues and within a tissue, as is the case for the spleen (Davies et al, 
2013; Murray & Wynn, 2011). Tissue resident macrophages are seeded in most 
tissues from an embryonic stage, and maintain their numbers through local 
proliferation (Jenkins et al, 2013; Schulz et al, 2012). Alternatively, these cells 
can differentiate from circulating monocytes that are recruited to the sites of 
infection during inflammatory processes (Girgis et al, 2014; Jenkins et al, 2011).  
Unlike DCs, macrophages are unable to prime naïve CD4+ T cells, but they 
present antigen in the tissues and are an important source of cytokines at the 
sites of infection (Benoit et al, 2008; Chow et al, 2011; Davies et al, 2013; 
Gordon & Martinez, 2010). Consequently, these cells have the ability to 
condition the adaptive immune response, so study of their biology has been 
closely examined in recent decades (Davies et al, 2013; Gordon, 2003; Gordon 
& Martinez, 2010; Wynn et al, 2013). Moreover, macrophages are also the 
target of cytokines released by effector T cells. They can become activated in 
an IFN-γ-dependent manner, or an IL-4-dependent manner, and in both 
instances become important effector cells of the adaptive immune response 
(Barron & Wynn, 2011). 
1.3.1 Macrophage activation 
IFN-γ activation of macrophages, or classical activation, occurs following 
bacterial infections leading to a strong Th1 phenotype in CD4+ T cells (Barron & 
Wynn, 2011). Classically activated macrophages (CAMϕs) have increased 
bactericidal capacity as they have enhanced expression of inducible nitric oxide 
synthase (iNOS), which leads to higher levels of nitric oxide (NO) production. 
These cells are able to mediate pathogen clearance and produce increased 
levels of IL-12p70, further supporting the Th1 environment (Benoit et al, 2008). 
IL-4 activation of macrophages, or alternative activation, occurs in helminth 
infections, but also when there is extensive tissue damage, or during allergy. 
Alternatively activated macrophages (AAMϕs) have increased expression of 
Arg-1, Relmα and Ym1. These cells also proliferate in situ, have increased 
phagocytic capacity and elevated levels of major histocompatibility complex 
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class II (MHC-II) expression (Balce et al, 2011; Davies et al, 2013; Gordon & 
Martinez, 2010; Jenkins & Allen, 2010; Jenkins et al, 2013; Loke et al, 2007; 
Rojas López & Duque Correa, 2007). 
Macrophages are able to recognize many different stimuli using pattern 
recognition receptors (PRR) to discern the most appropriate route of activation 
they should undergo. Three clearly defined families of PRRs have been 
described, including toll-like receptors (TLRs), C-type lectin receptors (CLRs) 
and nucleotide oligomerization domain (NOD)-like receptors (NLRs) (Akira & 
Takeda, 2004; Davicino et al, 2011; Kufer & Sansonetti, 2011).  
Stimulation with PRRs ligands results in the production of cytokines such as IL-
1β, IL-6, TNFα, IL-10 and IL-12 (Benoit et al, 2008; Gordon, 2003; Martinez et 
al, 2009) and the expression of several markers of activation, such as MHC-II, 
CD80 and CD86 (Wynn et al, 2013). Nonetheless, changes in the levels of 
these molecules are only a subset of the activation that macrophages undergo 
upon ligand binding, which have only now been partly characterized though the 
analysis of the proteome and secretome of activated macrophages (Li et al, 
2011; Meissner et al, 2013).  
1.3.2 Endocytosis 
Macrophages constantly sample their environment by actively internalizing 
molecules and particles via endocytosis. That process can be energy costly 
(Watts, 2011), and severely impact signaling pathways (Kagan & Iwasaki, 2012; 
Shilo & Schejter, 2011). Endocytosis and endosomal trafficking depend on actin 
polymerization and Ca+ signaling (Huotari & Helenius, 2011; Watts, 2011). 
Thus, endocytosis involves the remodeling of the cytoskeleton and the 
rearrangement of membranes, which necessitates a series or organized 
signaling events (Traub, 2011; Watts, 2011). The phosphatidylinositol-4,5-
bisphosphate 3-kinase (PI3K) family of kinases participate in the rearrangement 
of membrane structures and trafficking in cells by phosphorylating lipids on the 
cell membrane and endosomes (Stephens et al, 2002; Vanhaesebroeck et al, 
2012). As such, this family of kinases contributes to triggering signaling 
pathways leading to phagocytosis and other processes. 
Several families of phagocytic receptors are available to macrophages to initiate 
endocytosis (Baranova et al, 2012; Goodridge et al, 2011; Joshi et al, 2006; 
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Kagan & Iwasaki, 2012). Some of these receptor families require opsonization 
of the material before they can be engaged, which is usually achieved via 
complement or antibodies, and is typically directed at extracellular bacteria and 
dying cells (Joshi et al, 2006). In addition to their role in activating 
macrophages, CLRs, such as DC-specific intercellular adhesion molecule-3-
grabbing non-integrin (DC-SIGN) on dendritic cells or the macrophage mannose 
receptor (MR) in macrophages and dendritic cells, directly bind carbohydrates 
on the surface of proteins on pathogens (Gringhuis et al, 2007; Martinez-
Pomares et al, 2001; Svajger et al, 2011). Scavenger receptors can also bind to 
foreign or modified lipids and mediate their internalization (Baranova et al, 
2012; Oury, 2014). 
1.3.3 Macrophages in S. mansoni infection 
Macrophages play a fundamental role in S. mansoni infection at all stages of 
the disease. They are able to partly mediate protective immunity induced by 
irradiated cercariae by increased production of nitric oxide (Caulada-Benedetti 
et al, 1991; James et al, 1998), although this has been contested (Coulson et 
al, 1998). Furthermore, if LCs are regarded as tissue resident macrophages 
(Davies et al, 2013), they have also been shown to migrate to the skin-draining 
lymph nodes where they can to present antigen after exposure to vaccinating 
parasites (Kumkate et al, 2007). F4/80+ cells in the skin after infection, which 
include LCs as well as macrophages, take up cercarial E/S products and 
migrate to the lymph node (Paveley et al, 2009). Moreover, after multiple 
exposure to invading cercariae, F4/80+ macrophages become alternatively 
activated in the skin (Cook et al, 2011), most likely to control the excessive 
tissue damage caused by the migrating parasite and in the process conditioning 
the overall immune response in the skin. In addition, during the pre-patent 
phase of the adult worm infection prior to egg deposition, these mononuclear 
cells have significantly impaired function as APCs, leading to hypo-
responsiveness from T cells in the mesenteric lymph nodes, in a mechanism 
dependent on IL-12p40 production (Ferragine et al, 2013). 
AAMϕs are essential for host survival during S. mansoni infection, by 
maintaining barrier function in the gut during the acute phase and limiting Th1 
responses and pathology during the chronic phase of the disease (Herbert et al, 
2004). Furthermore, they are involved in limiting fibrosis through the expression 
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of Arg-1, as enhanced liver fibrosis as well as granulomatous inflammation was 
evident in infected mice when macrophages were unable to produce this protein 
(Pesce et al, 2009). These cells are partly recruited from the blood to establish 
granulomas around the eggs (Girgis et al, 2014), although AAMϕs are not 
required for these structures to be maintained (Herbert et al, 2004). 
Nonetheless, their increased production of Arg-1 and IL-10 limits the extent of 
Th2 responses, thus limiting inflammation and limiting scarring potentially by 
acting on fibroblasts (Barron & Wynn, 2011). 
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1.4 Innate immune signaling 
1.4.1 TLRs 
Toll was initially discovered in Drosophila melanogaster, when it was found that 
the lack of this protein made that organism susceptible to fungal infection 
(Valanne et al, 2011). Since, TLRs have been found in several organisms and 
are now recognized as a well-conserved system of receptors that control innate 
immune responses in many cells of the immune system. Several ligands have 
been identified for the existing 13 TLRs in mice, 10 of which have human 
homologues (Adachi et al, 1998; Akira & Takeda, 2004; Dillon et al, 2004; 
Downes & Marshall-Clarke, 2010; Hoshino et al, 1999; Ioannou & Voulgarelis, 
2010; Shi et al, 2011; Takeuchi et al, 1999).  
TLRs can be localized in the cell surface (e.g. TLR1, 2, 4 & 6) or in endosomes 
(e.g. TLR3, 7, 9, 10 & 11), which is related to the ligands they are associated 
with. TLR2 and TLR4 recognize products of the outer walls of extracellular 
bacteria and fungi (Sato et al, 2003; Takeuchi et al, 1999), whereas endosomal 
TLRs usually recognize nucleic acids or products of intracellular pathogens (like 
flagellin from Toxoplasma gondii) (de Jong et al, 2002; Yarovinsky et al, 2005). 
Upon recognition of their ligand, TLRs can form homodimers (e.g. TLR4) or 
heterodimers with more than one TLR (e.g. TLR2/1 or TLR2/6) (Akira & Takeda, 
2004; Kagan & Iwasaki, 2012). Upon dimerisation several adaptor proteins can 
be recruited to the intracellular domains of TLRs to activate multiple signaling 
pathways (Diagram 1.6) (Bonham et al, 2014).  
Most TLRs utilize MyD88 as their main adaptor molecule, which is recruited to 
the plasma membrane by toll-interleukin 1 receptor (TIR) domain containing 
adaptor protein (TIRAP), however TLR4 and TLR3 can also use TIR-domain-
containing adapter-inducing interferon β (TRIF), which is a recruited alongside 
TRIF related adaptor molecule (TRAM) (Adachi et al, 1998; Bonham et al, 2014; 
Donnelly et al, 2010; Kagan & Iwasaki, 2012; Laird et al, 2009; Liu et al, 2012; 
Muzio et al, 1997; Shi et al, 2011; Warner & Nunez, 2013; Wesche et al, 1997). 
TLR-ligand binding triggers a cascade of kinases which involves the activation 
of interleukin-1 receptor-associated kinase 1 (IRAK1), and then mitogen 
activated protein kinase (MAPK) kinase kinase 7 (MAP3K7) (or TAK1), 
alongside several scaffolding proteins like TNF-receptor associated factor 6 
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(TRAF6) (Diagram 1.6). MAP3K7 phosphorylates of inhibitor of nuclear factor 
kappa B Kinase β (IKKβ) leading to the activation of the nuclear factor kappa B 
(NF-κB) system, which is made out of several different proteins (such as p65, 
p105 and its degradation product p50). These subunits, which remain in the 
cytoplasm when inactive, form homodimers or heterodimers upon release and 
direct transcription of pro-inflammatory cytokines (such as IL-12, IL-6 and IL-1), 
chemokines, as well as other transcription factors (Adachi et al, 1998; Hinz & 
Scheidereit, 2014; Hoesel & Schmid, 2013; Iwasaki et al, 2011; Muzio et al, 
1997; Oeckinghaus et al, 2011; Ruland, 2011; van Berlo et al, 2010; Warner & 
Nunez, 2013; Wesche et al, 1997; Yu et al, 2011). 
Diagram 1.6 Toll like receptor signaling pathway. Taken from Akira et al, 
2004 
 
TLRs also employ several different accessory receptors that either facilitate 
ligand binding or modulate the activation of TLRs and recruitment of adaptor 
molecules. These co-receptors include membrane bound proteins like CD14 
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-independent pathways are involved in TLR4-mediated
production of inflammatory cytokines50,51. Therefore,
the expression of the genes that encode inflammatory
cytokines and co-stimulatory molecules is differentially
regulated during TLR signalling.
Although MyD88 has been reported to be involved
in TLR3 signalling52, TLR3 seems to transduce its 
signals mainly through the MyD88-independent 
pathway, because stimulation with the TLR3 ligand
polyinosinic–polycytidylic acid (poly I:C) does not
result in impaired production of inflammatory cytokines
and co-stimulatory molecules in MyD88-deficient mice
(S.A and K.T., unpublished observations).
Adaptor family
The discovery of the MyD88-independent pathway led
researchers to characterize the signalling pathways of
the various TLRs, the activation of which leads to dif-
ferent patterns of gene expression. As a result, the mol-
ecular mechanisms underlying such differences can
now be explained, at least in part, by the existence of
several adaptors, which are used by different TLRs.
These adaptors, which all have TIR domains, include
the following (in order of identification): MyD88;
TIRAP (TIR-domain-containing adaptor protein; also
known as MyD88-adaptor-like protein, MAL); TRIF
(TIR-domain-containing adaptor protein inducing
IFN-β; also known as TIR-domain-containing mole-
cule 1, TICAM1); and TRAM (TRIF-related adaptor
molecule; also known as TIR-domain-containing
molecule 2, TICAM2) (FIG. 3).
TIRAP. Identification of the MyD88-independent
pathway of TLR4 signalling led to the discovery of the
second TIR-domain-containing adaptor, which is
known as TIRAP53,54. Unlike MyD88, TIRAP does not
have a DD and was initially thought to mediate the
MyD88-independent pathway of TLR4 signalling.
However, the physiological role of TIRAP was revealed
by generating knockout mice: the production of
inflammatory cytokines in response to LPS was found
to be defective in TIRAP-deficient mice, but the
expression of IFN-inducible genes and the delayed
activation of NF-κB was still observed54,55. This phe-
notype was similar to that of MyD88-deficient mice,
and it indicated that TIRAP is essential for the TLR4-
mediated, MyD88-dependent signalling pathway but
not the MyD88-independent pathway. The possibility
that MyD88 and TIRAP might function redundantly in
the MyD88-independent pathway was excluded by gen-
erating mice deficient in both MyD88 and TIRAP.
Enforced overexpression of MyD88 in TIRAP-deficient
embryonic fibroblasts, but not vice versa, activates the
NF-κB-dependent promoter, indicating that TIRAP
probably acts upstream of MyD88 (S.A. and K.T., unpub-
lished observations). Interestingly, TIRAP-deficient
mice also show impaired cytokine production in
response to TLR2 ligands, despite having normal
responses to TLR3, TLR7 and TLR9 ligands55,56.
Therefore, TIRAP is essential for MyD88-dependent
signalling through TLR2 and TLR4.
pathway is sufficient for the induction of co-stimulatory
molecules. For TLR4, the MyD88-independent pro-
duction of co-stimulatory molecules is mainly sec-
ondary to the production of IFN-β47. By contrast, the
TLR-mediated expression of genes that encode inflam-
matory cytokines is controlled by the MyD88-dependent
pathway, although both the MyD88-dependent and 
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Figure 3 | Involvement of TIR-domain-containing adaptors in TLR-signalling pathways.
The Toll/interleukin-1 (IL-1)-receptor (TIR)-domain-containing adaptor molecule MyD88 (myeloid
differentiation primary-response protein 88) mediates the Toll-like receptor (TLR)-signalling pathway
that activates IRAKs (IL-1-receptor-associated kinases) and TRAF6 (tumour-necrosis-factor-
receptor-associated factor 6), and leads to the activation of the IKK complex (inhibitor of nuclear
factor-κB (IκB)- kinase complex), which consists of IKK-α, IKK-β and IKK-γ (also known as IKK1,
IKK2 and nuclear factor-κB (NF-κB) essential modulator, NEMO, respectively). This pathway is
used by TLR1, TLR2, TLR4, TLR5, TLR6, TLR7 and TLR9 and releases NF-κB from its inhibitor so
that it translocates to the nucleus and induces expression of inflammatory cytokines. TIRAP (TIR-
domain-containing adaptor protein), a second TIR-domain-containing adaptor protein, is involved
in the MyD88-dependent signalling pathway through TLR2 and TLR4. By contrast, TLR3- and
TLR4-mediated activation of interferon (IFN)-regulatory factor 3 (IRF3) and the induction of IFN-β
are observed in a MyD88-independent manner. A third TIR-domain-containing adaptor, TRIF (TIR-
domain-containing adaptor protein inducing IFN-β), is essential for the MyD88-independent
pathway. The non-typical IKKs IKK-ε and TBK1 (TRAF-family-member-associated NF-κB activator
(TANK)-binding kinase 1) mediate activation of IRF3 downstream of TRIF. A fourth TIR-domain-
containing adaptor, TRAM (TRIF-related adaptor molecule), is specific to the TLR4-mediated,
MyD88-independent/TRIF-dependent pathway. 
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and CD36, or soluble factors such as lymphocyte antigen 96 (MD2) and 
lipopolysaccharide (LPS) binding protein (LBP) (Lee et al, 2012). 
1.4.2 Mitogen activated protein kinases 
Mitogen activated protein kinases (MAPKs) are a diverse family of proteins that 
transport signals received from the environment by becoming phosphorylated, 
and phosphorylating others kinases in turn. These proteins are involved in 
growth, development, cell cycle, metabolism and immune signaling and can be 
activated downstream of several receptors including TLRs (Arthur & Ley, 2013). 
These signaling cascades lead to the phosphorylation of transcription factors 
that trigger gene expression. MAPKs are incredibly versatile because they are 
an interwoven network of signaling pathways that feed into each other (Arthur & 
Ley, 2013; Bandyopadhyay et al, 2010; Deak et al, 1998; Farhan et al, 2010; 
Gehart et al, 2010). These proteins are highly stratified: MAPK kinase kinases 
(MAP3K) phosphorylate MAPK kinases (MAP2K), which in turn phosphorylate 
MAPKs that further phosphorylate MAPK activate-protein kinases (MAPKAP) 
(i.e. Proto-oncogene serine/threonine-protein kinase (RAF) activates Mitogen 
activated protein kinase kinase 1/2 (MEK1/2), which activates Extracellular 
signal-regulated kinase (Erk1/2), which phosphorylates Ribosomal s6 kinase 
(RSK1/2)) (Arthur & Ley, 2013; Bain et al, 2007). Multiple MAPKs have more 
than one isoform, and it is often difficult to study the role, if any, of each one 
(Beardmore et al, 2005; Braem et al, 2011; Deak et al, 1998). 
MAPKs can be directly activated downstream of TLRs by MAP3K7 (Diagram 
1.7), which phosphorylates the kinases upstream of p38 and JNK. MAP3K7 
(TAK1) also mediates the phosphorylation of p105, which is then degraded, 
releasing Tumor progression locus 2 (Tpl2) or MAP3K8 to phosphorylate 
MEK1/2, which then phosphorylates Erk1/2 (Arthur & Ley, 2013; Braem et al, 
2011; Elcombe et al, 2013; Laird et al, 2009; Lawrenz et al, 2012; Mayer et al, 
2013; Medina et al, 2010; Pinto et al, 2011; Rommel et al, 1999; Salmeron et al, 
1996; Yan et al, 2010; Yang et al, 2010). 
MAPKs regulate transcription through the phosphorylation of several 
transcription factors, such as cAMP response element binding protein (CREB), 
Activator protein 1 (AP-1) and c-Jun (Elcombe et al, 2013; MacKenzie et al, 
2013; Mayer et al, 2013; Strippoli et al, 2012; van Vliet et al, 2013; Wen et al, 
2010). 
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Diagram 1.7 TLR activation of MAPKs. Taken from Arthur et al, 2013 
 
1.4.3 Innate immune signaling in S. mansoni infection 
Only a few differences have been described in S. mansoni infection of TLR-
deficient mice compared to wild type animals. TLR2-deficient mice have 
significantly fewer eosinophils in granulomas measured after 5 weeks, but 
survival of the infected hosts is largely unaffected (Magalhães et al, 2010). 
Nonetheless, SEA has a well-documented potent effect on TLR signaling in 
DCs. Thus, SEA is able to block LPS induced IL-12p40 production in an IL-10 
independent manner (Kane et al, 2004). Despite being a “silent” antigen in 
terms of cytokine expression and overall gene expression changes, SEA is able 
to modulate DC and macrophage cytokine responses and gene expression, 
when these cells are exposed to SEA in conjunction with various TLR ligands, 
including LPS (Correale & Farez, 2009; Kane et al, 2004; van Riet et al, 2009) 
and Pam3CSK4 (Agrawal et al, 2003). The modulation of those responses was 
often attributed to being mediated by TLR2. Indeed, lipids in SEA bind directly 
to TLR2 and are able to condition DCs and consequently affect T-cell 
responses (Magalhães et al, 2010; van der Kleij et al, 2002). 
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between the two myeloid cell-specific mutations of 
TAK1 might relate to the analysis of different types of 
macrophage (peritoneal macrophages versus BMDMs). 
Alternatively, another MAP3K might compensate for 
the complete absence of the TAK1 protein8, which might 
not occur when cells express a truncated TAK1 mutant14.
Other MAP3Ks. The MAP3K apoptosis signal- 
regulating kinase 1 (ASK1; also known as MAP3K5) 
is required for LPS activation of p38α in DCs and 
for optimal LPS induction of the pro-inflammatory 
cytokines TNF, IL-1 and IL-6 (REF. 17). Consistent with 
this, Ask1−/− mice are protected from both LPS-induced 
septic shock and arthritis induced by the transfer of 
serum from K/BxN transgenic mice18. In the steady state, 
ASK1 forms an inactive complex with thioredoxin. 
TLR4 stimulation induces the production of ROS, 
which triggers the dissociation of thioredoxin from the 
complex, promoting ASK1 autophosphorylation and 
activation19. After ROS stimulation, ASK1 forms a high 
molecular mass complex with other proteins, including 
TRAF2 and TRAF6, which promote ASK1 oligomeriza-
tion and activation20. Recent studies have shown that 
ASK1 signalling is also regulated by glycogen synthase 
kinase 3β (GSK3β), through the capacity of GSK3β to 
promote ASK1 stability21.
The MAP3K MAPK/ERK kinase kinase 3 (MEKK3; 
also known as MAP3K3) can be recruited to TRAF6 
via its association with sequestosome 1 (also known 
as p62)22. ln accordance with this, it has been reported 
that the IL-1β-induced activation of p38α and JNKs, but 
not ERK1 and ERK2, is abolished in MEKK3-deficient 
MEFs23. However, a second study showed normal 
MAPK activation following IL-1β stimulation of 
MEKK3-deficient MEFs, so the role of MEKK3 in 
MAPK activation remains unclear11. The contribu-
tion of MEKK3 to p38α and JNK activation in primary 
myeloid cells has not been studied, but small interfering 
RNA (siRNA)-mediated knockdown of Mekk3 partially 
reduces LPS-mediated activation of p38α, ERK1 and 
ERK2 in RAW264.7 cells24.
The activation of ERK1 and ERK2 by all TLRs in 
primary macrophages is mediated by the MAP3K 
TPL2 (REF. 25). In unstimulated cells, TPL2 is in a com-
plex with the NF-κB subunit precursor protein p105 
(also known as NF-κB1), which inhibits the kinase 
activity of TPL2 (REFS 26,27). TLR stimulation acti-
vates the IκB kinase (IKK) complex, which phospho-
rylates p105, inducing its K48-linked ubiquitylation 
and proteasome-mediated proteolysis28. After it has 
been released from p105-mediated inhibition, TPL2 
can then phosphorylate MAPK kinase 1 (MKK1) 
and MKK2 upstream of ERK1 and ERK2. IKK2 also 
directly phosphorylates TPL2 on Ser400, which is 
 crucial regulatory residue in its carboxyl terminus 
that is required for LPS to induce ERK activation in 
macrophages29,30. In fibroblasts, TAK1 is required for 
the IL-1β-mediated activation of IKK and, conse-
quently, the TPL2-mediated activation of ERK1 and 
ERK2. However, TAK1 expression is not needed for 
LPS-mediated activation of IKK or ERK1 and ERK2 
in macrophages8, which suggests that another MAP3K 
is involved.
An important area of future work is determining 
which MAP3Ks regulate each of the MAPK pathways 
following TLR stimulation of myeloid cells, and a key 
question is whether a MAP3K substitutes for TAK1 in 
TLR activation of MAPKs in macrophages.
Figure 2 | Activation of MAPKs. Following Toll-like receptor (TLR) or interleukin-1 receptor 
(IL-1R) ligation (not shown), myeloid differentiation primary-response protein 88 (MYD88) is 
recruited to the Toll and IL-1 receptor (TIR) dom i  of the receptor. For TLR2 and TLR4, this 
recruitment requires MYD88 adaptor-like protein (MAL; also known as TIRAP). MYD88 and 
the serine/threonine kinase IL-1 r ceptor-as ociated kinase 4 (IRAK4) then interact via their 
death domains. IRAK4 catalytic activity subsequently induces a complex with IRAK1 and 
+4#-CPFVJG'WDKSWKVKPNKICUG60(TGEGRVQTCUUQEKCVGFHCEVQT|
64#(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conjugating enzyme 13 (UBC13), together with either TRAF6 or an as yet unidentified 
'|NKICUGECVCN[UGUVJGHQTOCVKQPQH-NKPMGFRQN[WDKSWKVKPEJCKPUQP64#(CPF+4#-
TAK1-binding protein 2 (TAB2) and TAB3 recruit TGFβ-activated kinase 1 (TAK1) to K63-linked 
polyubiquitylated TRAF6, which triggers TAK1 activation of the p38α and Jun N-terminal 
kinase (JNK) mitogen-activated protein kinase (MAPK) pathways. The regulatory subunit  
of the IκB kinase (IKK) complex, NF-κB essential modulator (NEMO), binds to K63-linked 
polyubiquitin and is also recruited to the IRAK4 complex together with the associated 
catalytic subunits IKK1 and IKK2. This facilitates the TAK1-mediated phosphorylation of 
IKK2, which induces the nuclear translocation of nuclear factor-κB (NF-κB) subunits. NEMO 
can also bind to linear ubiquitin chains synthesized by the linear ubiquitin assembly complex 
(LUBAC)141 (not shown). LUBAC is required for optimal TLR activation of IKK, but is not 
essential for MAPK activation142,143. IKK2-induced proteolysis of the NF-κB subunit precursor 
protein p105 is also an essential step in the activation of the tumour progression locus 2 
(TPL2) and the downstream extracellular signal-regulated kinase 1 (ERK1) and ERK2 pathway, 
which releases TPL2 from p105-mediated inhibition. TPL2 signalling is also controlled by 
the associated ubiquitin-binding protein, A20-binding inhibitor of NF-κB activation 2 
(ABIN2), which is required to maintain TPL2 protein stability. Apoptosis signal-regulating 
kinase 1 (ASK1) forms an inhibited complex with thioredoxin (TRX) in unstimulated cells. 
TLR-induced reactive oxygen species (ROS) promote the dissociation of TRX from ASK1, 
which then phosphorylates MAPK kinase 3 (MKK3) and/or MKK6. Active ASK1 is a 
component of a large complex, which includes TRAF2 and TRAF6. IFNβ, interferon-β; IL, 
interleukin; iNOS, inducible nitric oxide synthase; TNF, tumour necrosis factor; Ub, ubiquitin.
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The effects of SEA on these cells are at least partly mediated by Erk1/2 and 
p38 (Agrawal et al, 2003; Correale & Farez, 2009; Goh et al, 2009; van Riet et 
al, 2009), and the ratio between the phosphorylation of these two MAPKs in the 
context of stimulation with LPS, could be indicative of the ability of DCs to 
polarize T cells towards a Th2 phenotype (van Riet et al, 2009). In particular, 
p38 has been implicated in coordinating SEA processing in DCs (Marshall & 
Pearce, 2008). 
Other than TLRs, receptors involved in the recognition of SEA by macrophages 
include several CLRs, particularly macrophage galactose-type lectin (MGL) and 
MR (van Liempt et al, 2007). However, the role of these receptors is mostly 
associated with the uptake of the antigens (Meevissen et al, 2012; Meevissen 
et al, 2011). 
The role of TLRs and CLRs in the recognition or uptake of cercarial E/S 
products is much more limited, and there is no knowledge of the involvement of 
MAPKs. The MR is partly responsible for the uptake of cercarial E/S in vitro and 
in vivo, with a modest effect on the cytokine production by macrophages 
deficient for this CLR (Paveley et al, 2011). Moreover, IL-6 and IL-12p40 
production by macrophages exposed to 0-3hRP is entirely dependent on 
MyD88, but only partly dependent on TLR4 (Jenkins et al, 2005). 
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1.5 IL-10 
IL-10 has a very well defined role in the immune system. It acts as a master 
regulator of inflammatory processes, by limiting the extent of the immune 
response and encouraging resolution of inflammation (Saraiva & O'Garra, 
2010). It has a fundamental role in maintaining tolerance at barrier sites and its 
absence leads to chronic pathological inflammatory conditions that severely 
affect the fitness of affected individuals (Kuhn et al, 1993).  
IL-10 can be expressed by all T-cells subsets and is a primary effector 
mechanism employed by regulatory or suppressive T cells, particularly Type 1 
regulatory cells (Tr1) (Sabat et al, 2010). IL-10 expression in all Th subsets is 
governed by the transcription factor c-MAF (Saraiva et al, 2009; Saraiva & 
O'Garra, 2010; Xu et al, 2009). GATA3 has also been implicated in the initiation 
of IL-10 transcription in Th2 cells, particularly by inducing chromatin remodeling 
(Chang et al, 2007; Shoemaker et al, 2006). 
IL-10 can also be expressed by macrophages and DCs, although the signaling 
pathways that allow this have been less well defined, with different kinases, 
such as Erk, p38, Mitogen! and stress!activated protein kinases (MSK) 
(Ananieva et al, 2008; Elcombe et al, 2013) and transcription factors, like 
CREB, c-MAF, NF-κB p50 homodimers and CCAAT/enhancer binding protein β 
(C/EBPβ) implicated (Ananieva et al, 2008; Cao et al, 2005; Cao et al, 2006; 
MacKenzie et al, 2013; Nandan et al, 2012). IL-10 production in macrophages 
and DCs has been described in response to TLR and CLR ligands, particularly 
ligands for DC SIGN and MGL in combination with LPS, or LPS alone (Cao et 
al, 2006; Elcombe et al, 2013; van Vliet et al, 2013). Extensive chromatin 
remodeling also occurs in the IL-10 promoter of macrophages, including hyper-
phosphorylation, with this last feature being Erk dependent (Lucas et al, 2005; 
Saraiva et al, 2005; Zhang et al, 2006). 
The IL-10 receptor signals in cells using Janus kinase 1 (JAK1), tyrosine kinase 
2 (TYK2) and Signal transducer and activator of transcription 3 (STAT3) (Sabat 
et al, 2010). It also activates Dual specificity phosphatases (DUSPs) and Src 
homology region 2 domain-containing phosphatase-1 (SHP1), which are well 
known inhibitors of TLR signaling (Hammer et al, 2006; Okazawa et al, 2005; 
Yuk et al, 2011). IL-10 blocks the production of pro-inflammatory cytokines, the 
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proliferation of T cells and the expression of MHC-II. However, IL-10 also 
promotes the uptake of dead/apoptotic cells through the up-regulation of 
scavenger receptors (de Waal Malefyt et al, 1991; Sabat et al, 2010). 
1.5.1 IL-10 in S. mansoni infection 
The role of IL-10 in parasitic infections has been well studied. In S. mansoni 
mouse models, IL-10 has been shown to modulate the immune response in the 
liver and in the mesenteric lymph nodes, primarily by preventing excessive 
pathology (Redpath et al, 2014). Indeed, animals deficient for IL-10 presented 
excessive liver fibrosis, succumbed to infection faster (week 10) than wild type 
controls, and had significantly enlarged liver granulomas at later stages of the 
disease (week 15) (Mentink-Kane et al, 2011; Sadler et al, 2003; Wynn et al, 
1998). Further more, T cell derived IL-10 and non-T cell derived IL-10 were 
important limiting pathology (Hesse et al, 2004). IL-10 has also been found to 
prevent mice from becoming resistant to the parasite after praziquantel 
treatment, as second challenge of mice treated with the drug and an anti-IL-10 
receptor antibody were able to clear 50% more worms than praziquantel only 
treated controls (Wilson et al, 2011). Moreover, IL-10 is able to partly drive 
macrophages in the granulomas towards an incomplete alternative activated 
phenotype (Dewals et al, 2010). Evidence for a potential role of IL-10 in humans 
is also available from a recent study that showed that blood cultures from 
infected individuals produced more IL-10 in response to S. mansoni antigens 
than cultures from healthy controls (Turner et al, 2013). Interestingly, lower 
levels of IL-10 positively correlated with higher periportal fibrosis in infected 
individuals (Booth et al, 2004). Moreover, IL-10 significantly limits IL-12p40-
mediated Th1 responses in the skin after vaccination with irradiated cercariae 
(Hogg et al, 2003b), and can block IFN-γ-induced nitric oxide killing of 
schistosomula in vitro (Gazzinelli et al, 1992).  
Finally, the cellular source of IL-10 is known only in later stages (after 4 weeks) 
of the disease, where primarily CD4+ T cells (often CD25+) produce it in the liver 
or mesenteric lymph nodes (Redpath et al, 2014; Scheer et al, 2014).  
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1.6 Setting the scene 
S. mansoni cercarial E/S products have been shown to be internalized in vitro 
by bone marrow derived DCs and macrophages, as well as in vivo by some cell 
populations in the skin, including F4/80+ macrophage-like cells (Paveley et al, 
2009). It has also been shown that the uptake of cercarial E/S products by 
macrophages is partly mediated by the mannose receptor (Paveley et al, 2011). 
S. mansoni cercarial E/S products elicit a strong cytokine response from in vitro 
stimulated macrophages and DCs, and the production of these cytokines is 
dependent on MyD88, which implies a significant role for TLRs in the detection 
of cercarial E/S products (Jenkins et al, 2005). 
Skin immune responses to S. mansoni cercariae warrant further examination, 
with particular attention placed on the role of E/S products and macrophages, 
which become alternatively activated after multiple infections, with a 
concomitant increase in the production of IL-10 by whole skin explants (Cook et 
al, 2011). 
This project aims to demonstrate that an in vitro model of macrophages allows 
investigation of the ability of S. mansoni cercarial E/S products to induce the 
production of IL-10 in preference to IL-12p40. This model will be used to 
interrogate the intracellular signaling events that occur in macrophages leading 
to the production of IL-10, and implicate the role of TLRs in the recognition of 
helminth antigens. Finally, the in vivo cellular sources of IL-10 will be 
determined in a single skin infection with S. mansoni cercariae. 
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2 Materials and Methods 
2.1 Animals and bone marrow 
All animals were bred and maintained in the Biological Services Facility at the 
Department of Biology, University of York, according to the standards laid out in 
the Animal’s Scientific Procedures Act 1986. All strains were housed in filter-
topped cages and under specific pathogen free conditions. The University of 
York Ethics committee approved all experimental work carried out. Age 
matched female C57BL/6 strain mice between 6-10 weeks old were used for all 
experimental procedures. The outbred strain of mouse, NMR-I, which was used 
to maintain the parasite life cycle, was routinely bought from Harlan 
Laboratories, UK. 
All transgenic strains were on a B6 genetic background. Transgenic mice with 
the IL-10 protein tagged with green fluorescent protein (GFP) (IL-10+/gfp) 
(Kamanaka et al, 2006) and TLR2 deficient (TLR2-/-) (Takeuchi et al, 1999) 
mice were initially purchased from the Jackson Laboratory, USA, and then 
maintained in the Biological Services Facility. IL-10+/gfp mice were kept as a 
heterozygote line to avoid reported deficiencies in IL-10 production (Kamanaka 
et al, 2006). IL-10 deficient (IL-10-/-) mice (Kuhn et al, 1993) were obtained from 
Dr Marika Kullberg (University of York), whilst Prof Paul Kaye (University of 
York) provided Rag deficient (Rag-/-) mice, which lack T and B cells.  
Bones from TLR4 deficient (TLR4-/-) (Hoshino et al, 1999) and MyD88 deficient 
(MyD88-/-) (Adachi et al, 1998) mice were obtained from Prof Andrew 
MacDonald, from mice housed in University of Edinburgh, UK. Tpl-2 deficient 
(Tpl2-/-) (Dumitru et al, 2000) mice were obtained from Dr Mark Wilson from 
mice housed in the National Institute of Medical Research, Mill Hill, London, UK. 
2.2 Parasites and parasite derived material  
A Puerto Rican strain of Schistosoma mansoni (S. mansoni) was maintained in 
the laboratory by routinely infecting NMR-I mice and Biomphalaria glabrata 
snails. 
To obtain infective cercariae, latent snails were placed in the dark for a 
minimum of 24h and then exposed to incandescent light for 2h to induce the 
release of the parasites. For the purposes of mouse infection cercariae were 
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collected, counted and diluted to a concentration of approximately 150 parasites 
per milliliter (ml). 
Alternatively, cercariae were used to prepare two types of antigen preparations 
used for in vitro stimulation. 
2.2.1 Generation of cercarial E/S products (0-3hRP) 
Cercarial E/S products were produced as described previously (Curwen et al, 
2006; Jang-Lee et al, 2007; Jenkins et al, 2005; Paveley et al, 2009). Briefly, 
cercariae were chilled for 1 hour in a large volume of water (~500ml) in order to 
allow them to sediment. Excess liquid (parasite-free) was removed and the 
concentrated parasites washed with chilled filter-sterilized water 3 times. After 
the third wash, cercariae were mechanically transformed by vortexing for 90s 
and then cultured in RPMI® (Gibco) containing 50U/ml penicillin and 50µg/ml 
streptomycin for 3 hours at 37°C 5% CO2. Culture supernatants were collected, 
further removing transformed cercariae (schistosomula) and parasite tails from 
the preparation by centrifugation (800g for 8min at 4°C). Supernatants were 
stored at -20°C until needed. Up to 80ml of pooled supernatants from parasites 
shed on different dates were concentrated to 1ml using a filter spin column with 
a molecular weight cut off of 3kDa (GE Life Sciences). This concentrated 
preparation, retaining all molecules above 3kDa, was subsequently referred to 
as cercarial Excretory/Secretory (E/S) products (a.k.a. 0-3hRP). The protein 
concentration of 0-3hRP was measured using a BCA® protein assay (Thermo 
Scientific) according to the manufacturer’s instructions.  
2.3 In vitro culture and stimulation of Bone marrow derived 
macrophages 
Femurs and tibias were obtained from animals described in 2.1; muscle was 
scraped from bones and the bone marrow was flushed out with PBS using a 
25G needle. Cell suspensions were filtered to remove bone and tissue debris 
and then enumerated using a hemocytometer. Aliquots of 5x106 cells were re-
suspended in 10ml of DMEM® medium (Gibco) containing 10% FCS, 2mM L-
Glutamine (Gibco), 50U/ml penicillin, 50µg/ml streptomycin and 50µM 2-
mercaptoethanol (Complete DMEM). This was supplemented (1:5) with 
Macrophage colony stimulating factor (M-CSF) obtained from culture 
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supernatants of L929 murine fibroblast cell line. Bone marrow cell suspensions 
were subsequently cultured at 37°C and 5%CO2 in 10cm culture dishes. 
After 7 days, media was discarded and adherent cells washed with cold PBS 
before being left for 10min in warm PBS in order to let the cells detach. Cultured 
cells were then collected by scraping the plastic surface to further detach cells 
and prepared for subsequent applications by spinning them down at 1000g at 
4°C and re-suspending them in complete DMEM. Cells obtained in this manner 
were subsequently used as bone marrow derived macrophages (BMMϕ). 
2.4 Flow cytometric analysis of antibody-labeled cells 
Cells obtained from tissues, or in vitro cultures, were incubated in round bottom 
96 well plates with goat serum and anti CD16/CD32 monoclonal antibody (mAb) 
(eBiosciense), for 10min at 4°C to prevent non-specific mAb binding to Fc-
receptors. Cells were then labeled with the appropriate mAb dilution in 10µl of 
1% FCS in PBS (FACS buffer) for 30-45min at 4°C (see Table 2.1). Cells were 
washed with FACS buffer at 1000g for 7min at 4°C and then re-suspended in 
350µl of FACS buffer for immediate acquisition by flow cytometry, or fixed in 
100µl 2% paraformaldehyde (PFA) in PBS prior to flow cytometry acquisition at 
a later point. 
2.4.1 Labeling of cells for intracellular molecules  
Cells already labeled for surface markers were subsequently stained for 
intracellular proteins using Foxp3 Fixation/Permeabilization (Fix/Perm) 
Concentrate and Diluent (eBioscience) adapting the manufacturer’s protocol. 
Briefly, cells were placed in Fix/Perm solution for 1 hour (or ON) at 4°C. Cells 
were then washed once (as described above) with 1X Permeabilization (Perm) 
buffer (eBioscience) and stained in 50µl of Perm buffer with appropriate 
antibody dilution (see Table 2.1) for 1 hour at 4°C. Finally, cells were washed 
once with Perm buffer and re-suspended in PBS for subsequent analysis. 
2.4.2 Labeling of cells for intracellular phosphorylated proteins 
Stimulated BMMϕ were washed with cold PBS and then fixed in 2% PFA in 
PBS for 10min at 37°C. Fixed cells were then recovered by scrapping and left 
ON at 4°C in round bottom 96 well plates. 
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After ON incubation, cells were spun as described above, then incubated in 
50µl fresh Fix/Perm buffer for 1 hour before being spun again and incubated 
with relevant anti-phospho Ab diluted 1:200 in 100µl of Perm buffer for 1 hour at 
room temperature. Cells were washed again with Perm buffer and then 
incubated for 1 hour at room temperature with goat anti-rabbit Alexa Fluor 488 
diluted 1:200 in Perm buffer. Finally, cells were washed and re-suspended in 
300µl of PBS for later analysis by flow cytometry. 
2.5 Enzyme linked immune absorbent assays 
Culture supernatants were analyzed for the amount of cytokines present using 
commercially available enzyme linked immune absorbent assays (ELISA). IL-10 
and IL-12p40 ELISA kits were purchased from R&D Systems and performed 
according to their specifications. 
Briefly, flat bottom 96 well plates were incubated with capture mAb ON and then 
washed with 0.1% Tween PBS (PBST) 3 times. Plates were blocked for 2 hours 
with 1% Bovine Serum Albumin (BSA) prior to the addition of culture 
supernatants and/or recombinant cytokine standards for a further 2 hours. After 
3 more washes with PBST, biotinylated detection mAb was added to the wells 
and incubated for 2 hours. Plates were washed again, and incubated for 20min 
with streptavidin conjugated to horseradish peroxidase. Three final washes 
were performed and 50µl of TMB® substrate (KPL) added to each well. 
Reactions were stopped with 2N NaH2SO4 and the optical density measured 
using a Dynex 5000 microplate reader. Cytokine concentrations were 
established based on a standard curve within each assay. Limits of detection 
for each cytokine were at 32pg/ml. 
2.6 RNA extraction and gene expression analysis by 
Polymerase Chain Reaction 
Ribonucleic acid (RNA) from 2x106 stimulated BMMϕ was obtained using the 
High Pure RNA isolation kit (Roche) following the manufacturer’s instructions. 
Purified RNA was quantified using a Nanodrop (Thermo Scientific), and based 
upon these readings the same amount of RNA (typically 1 µg) from each 
sample was made into cDNA (complementary deoxyribonucleic acid) using 
SuperScript® (Life Technologies). 
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cDNA was diluted 1:5 and used for gene expression analysis via quantitative 
real time polymerase chain reaction (qPCR) using primers listed in Table 2.2  
and Fast Sybr Green® master mix (Life Technologies) with three technical 
replicates per sample. Melting temperatures were always 60°C and primers 
were used at 0.8µM in the reaction. qPCR was carried out using a StepOnePlus 
PCR system. 
Changes in gene expression were calculated using the delta-delta Ct method 
(Livak & Schmittgen, 2001) with glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH) as a housekeeping gene. 
2.7 Statistical analysis 
Two tailed t-tests (for experiments with only two experimental groups) or 
analysis of variance (ANOVA) and then multiple comparisons tests 
(Bonferroni’s, Tukey’s, Sidak’s and Dunnett’s) (when experiment included more 
than 2 groups) were performed to establish significant differences between the 
groups (* = p<0.05, ** = p<0.01; *** = p<0.001, **** = p<0.0001) using the 
software package GraphPad Prism®. Error bars represent the standard error of 
the mean (SEM), based on technical replicates for in vitro experiments, or 
biological replicates for in vivo experiments. 
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Table 2.1 Flow cytometry antibodies 
Bone marrow derived macrophages - Surface markers 
Antigen Fluorochrome Clone Isotype Supplier 
F4/80 eF-450 BM8 IgG2a,k eBioscience 
APC BM8 IgG2a,k eBioscience 
CD11b PE-Cy7 M1/70 IgG2b,k eBioscience 
MHC-II PE M5/114 IgG2b,k eBioscience 
CD11c FITC HL3 IgG1 BD Pharmigen 
CD80 APC 16-10A1 Ham. IgG eBioscience 
CD86 PE GL1 IgG2a,k eBioscience 
CD40 FITC 3/23 IgG2a,k Pharmigen 
CD14 PerCP-eF710 Sa2-8 IgG2a,k eBioscience 
SR-AI/MSR1 PE 268318 IgG2b,k R&D Systems 
CD36 αIgA-PE* JC63.1 IgA Cayman  
Egr1 GαRb AF488** 44D5 Rabbit IgG CST*** 
Bone marrow derived macrophages - Intracellular signaling Proteins 
Antigen Secondary Clone Isotype Supplier 
Erk 1/2 
GαRb AF488 
Rabbit 
Rabbit IgG 
CST 
P-Erk 1/2 Rabbit CST 
P-p38 Rabbit CST 
P-RSK D5D8 CST 
P-CREB 87G3 CST 
P-p105 18E6 CST 
P-p65 93H1 CST 
P-Akt Rabbit CST 
Dermal Exudate Cells 
Antigen Fluorochrome Clone Isotype Supplier 
CD11b BV711 M1/70 IgG2b,k BD Horizon 
MHC-II APC M5/114 IgG2b,k eBioscience FITC 269 IgG2a,k BD biosciences 
CD4 APC GK1.5 IgG2b,k eBioscience PerCP Cy5.5 RM4-5 IgG2a,k eBioscience 
CD3 BV785 17A2 IgG2b,k BioLegend 
*Anti-mouse IgA – PE (eBiocience) 
**Goat anti Rabbit AlexaFluor 488 (Life Technologies) 
***Cell Signaling Technology 
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Table 2.2 PCR Primers 
Bone marrow derived macrophages - Gene expression 
Gene Forward Primer (5’- 3’) Reverse Primer (5’- 3’) 
IL10 GGTCTTGGGAAGAGAAACCAG GCCACAGTTTTCAGGGATGA 
IL12b ATCAAGAGCAGTAGCAGTTC TACTTCTCATAGTCCCTTTG 
GAPDH CCATGTTTGTGATGGGTGTG CCTTCCACAATGCCAAAGTT 
IL10 promoter 1 AGAGGAGAGTTCTGGTGCCT GGTGACTTCCGAGTCAGCAA 
IL10 promoter 2 AGAGGCCCTCATCTGTGGAT GCAGAAGTTCATTCCGACCA 
IL10 promoter 3 TGTGGCTTTGGTAGTGCAAG TGCTGCCTGCTCTTACTGAC 
IL10 promoter 4 CTAGGAGCATGTGGCTCTGG GTCTACCCGACAGCACAGAG 
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3 Global changes in the expression of genes and 
proteins in BMMϕs stimulated with cercarial E/S 
products 
3.1 Introduction 
Macrophages are an important source of cytokines at the site of infection and 
are among the main initial responders to parasite invasion. These cells have the 
ability to condition the innate immune response and are also activated by the 
adaptive immune response. Consequently, the study of their biology has been 
closely scrutinized in recent decades (Davies et al, 2013; Gordon, 2003; 
Gordon & Martinez, 2010; Wynn et al, 2013).  
Macrophages are able to recognize many different stimuli and their response is 
tailored to the situation they encounter. Macrophages use pattern recognition 
receptors (PRR) to discern the most appropriate route of activation they should 
undergo. Of the known families of PRRs, by far the best characterized is the 
TLR family. Several ligands have been identified for the existing 13 TLRs in 
mice, 10 of which have human homologues (Adachi et al, 1998; Akira & 
Takeda, 2004; Dillon et al, 2004; Downes & Marshall-Clarke, 2010; Hoshino et 
al, 1999; Ioannou & Voulgarelis, 2010; Shi et al, 2011; Takeuchi et al, 1999).  
Upon stimulation with TLR ligands, macrophages will produce cytokines, such 
as IL-1, IL-6, TNFα, IL-10 and IL-12 (Benoit et al, 2008; Gordon, 2003; Martinez 
et al, 2009). These cells also modify the expression of several markers of 
activation (Wynn et al, 2013). In order to characterize possible changes that 
result from TLR stimulation, unbiased approaches that offer a broad coverage 
of changes need to be employed. Several of those studies have centered on 
gene expression analysis using microarrays (Pena et al, 2011; Thomas et al, 
2006). Nonetheless, analysis of the proteome and secretome of macrophages 
have also been performed mainly through the use of mass spectrometry (Li et 
al, 2011; Meissner et al, 2013). However, these instruments are not inherently 
quantitative and so different methods have been employed to utilize their 
potential to identify novel activation markers in combination with accurate 
estimation of protein level changes (Mallick & Kuster, 2010). In recent years, 
two approaches have been gaining ground: iTRAQ labeling and label-free 
quantitative proteomics. Of the two approaches, label-free proteomics offers a 
similarly accurate but significantly cheaper alternative (Aebersold & Mann, 
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2003; Bodenmiller & Aebersold, 2010; Domon & Aebersold, 2006; Ferret-
Bernard et al, 2012; Mallick & Kuster, 2010; Patel et al, 2009; Robitaille et al, 
2013). Label-free quantitative proteomics works by generating an average 
chromatogram of all the peaks identified across all MS runs, which is then used 
to asses the relative abundance of each peptide based on a control sample. 
This method can be used to detect modest changes in protein expression, 
down to a 20% fold change (Mallick & Kuster, 2010).  
Analysis of the results produced by either of these proteomic techniques 
requires the use of bioinformatic tools. These tools allow exploration of links 
between the identified hits that are not immediately apparent. Gene ontology 
(GO) term enrichment has been a preferred method for large protein lists, as it 
reveals functional protein clusters and cellular localization of the identities 
(Ferret-Bernard et al, 2012; Li et al, 2011; Meissner et al, 2013). 
Bioinformatic analyses offer a window into the balance between the expression 
patterns of several proteins produced as a consequence of the signals triggered 
in macrophages upon exposure to TLR ligands. The transduction of these 
signals is made through several families of kinases, such as MAPKs, which 
transport signals received from the environment by becoming phosphorylated 
and phosphorylating others in turn. Eventually, signaling cascades lead to the 
activation of several transcription factors that trigger gene expression. MAPKs 
are incredibly versatile because they are an interwoven network of signaling 
pathways that feed into each other (Arthur & Ley, 2013; Bandyopadhyay et al, 
2010; Deak et al, 1998; Farhan et al, 2010; Gehart et al, 2010). Therefore, an 
understanding of their activation can only be achieved if several of them are 
measured dynamically. Consequently, proteomic approaches are best 
accompanied by a study of posttranslational modification of proteins and also 
changes in gene expression. With this information, activation of macrophages 
upon stimulation with TLR ligands can be presented as a clearer picture. 
In the following chapter, the response of macrophages to S. mansoni cercarial 
E/S products is explored by using several unbiased large-scale techniques. 
After characterizing macrophages obtained by differentiating bone marrow 
precursors, BMMΦs were exposed to the excretory/secretory (E/S) products 
released by schistosome cercariae and changes in the membrane proteome, 
the activation of several MAPKs and the expression of an array of genes is 
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measured. In the end, a holistic view of the events that occur in macrophages 
exposed to cercarial E/S products is presented. 
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3.2 Chapter specific materials and methods 
3.2.1 Label free quantitative proteomics of membrane proteins 
3.2.1.1 Membrane protein extraction 
BMMΦs were cultured in 10cm culture dishes in complete DMEM as described 
in 2.3 with 5x106 cells per dish, and then stimulated with 50µg/ml 0-3hRP 
supplemented with 2µg/ml Polymixin B (PMB; Sigma), 1ng/ml of LPS (Sigma), 
or left un-stimulated (Media). After overnight culture, media was discarded and 
cells washed with cold PBS before being left in 10ml of warm PBS for 10min at 
37°C. Cells were then scraped from the dish, pooled together as duplicates and 
finally centrifuged at 1000g for 7min at 4°C to concentrate them and remove the 
PBS. The cells were washed again before use.  
BMMΦs were finally re-suspended in 1ml of sonication buffer containing 
250mM sucrose, 10mM Tris, 0.5mM KCl, pH 7.2, supplemented with a protease 
inhibition cocktail (Thermo Scientific) and then sonicated (Sonopuls® Bandelin) 
on ice at 40-50% power with continuous 1s pulses for 1min. 
Cell lysates were centrifuged at 800g for 10min to remove larger membrane 
structures (i.e. nuclei) and any intact cells.  The supernatant was recovered and 
spun again under the same conditions before being transferred to new tubes 
and centrifuged at 14000g at 4°C for 20min. Supernatants (containing crude 
cytosolic fraction) were removed and remaining pellets (enriched for membrane 
proteins) prepared for mass spectrometry by filtered aided sample preparation 
(FASP).  
3.2.1.2 Label free quantitative proteomics 
Membrane protein samples were prepared for proteomic analysis using FASP 
by the staff in the Centre for Excellence in Mass Spectrometry (Department of 
Biology, University of York). During FASP, all cellular components other than 
proteins are removed using a filter unit in which proteins are kept throughout 
processing. In the filter, proteins are denatured, disulfide bonds are broken and 
peptides are generated using trypsin. Peptides are then eluted in an appropriate 
solvent. 
Samples were analyzed using a liquid chromatography – mass spectrometry 
(LC-MS) system, comprised of a Waters nanoAcquity ultra pressure liquid 
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chromatography (UPLC) and a Bruker maXis high-performance quadrupole – 
time of flight (Q-TOF) mass spectrometer. For data analysis using the label-free 
quantitative (expression) proteomics approach, the Nonlinear Dynamics 
Progenesis software was used (Patel et al, 2009). Protein searches were made 
against the International Protein Index (IPI) mouse database to identify any 
hits/identities. 
3.2.1.3 Gene ontology (GO) term enrichment and subcellular localization 
analysis of regulated proteins 
Subcellular classifications were performed with Gene Ontology classification 
(http://www.ebi.ac.uk/GOA/) according to the accession number of protein 
identities in Uniprot. If no classification was found, the Mouse Genome 
Informatics website (http:// www.informatics.jax.org/) was used. Proteins were 
analyzed according to Gene Ontology (GO) classification using Visual 
Annotation Display (VLAD; proto.informatics.jax.org/prototypes/vlad-1.0.3/). 
Significant hits were selected on the basis of the number of proteins (k) found 
within each category. 
3.2.2 Kinase proteome profiler array 
BMMΦs were stimulated in a 6 well plate (2x106 cells per well) with 50µg/ml 0-
3hRP supplemented with 2µg/ml PMB for 5, 30 and 60 minutes. After 
stimulation, samples were prepared for analysis with the Proteome Profiler 
Array according to the manufacturer’s instructions (R&D Systems).  
Briefly, cells were lysed with the lysis buffer supplied by the manufacturer for 
30min on ice before cell debris was removed by centrifugation at 800g for 
10min. The final lysate was mixed with a biotinylated mAb cocktail and 
incubated for 1 hour at room temperature. Lysate/mAb mixtures were then 
incubated with pre-blocked Proteome Profiler membranes overnight at 4°C. The 
membranes were then washed several times with the manufacturer’s wash 
buffer and finally incubated with streptavidin conjugated with horseradish 
peroxidase (HRP). SuperSignal® West Pico (Thermo Scientific) 
chemiluminescence reagent was used to reveal the antibody labelling of 
proteins on the membranes using X-ray film imaging (GE Healthcare). Equal 
volumes of Luminol/Enhancer Solution and Stable Peroxidase solution were 
mixed and incubated with labelled/probed membranes for 5min. 
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Chemiluminescence reagent was removed by washing and X-ray film finally 
exposed for different lengths of time prior to development. 
Densitometry analysis of the blots was performed using a BIO-RAD Gel Doc™ 
EZ system with the Image Lab® software package (Bio-Rad Laboratories). 
Pixel intensity was measured over a fixed area for each mAb in the array (i.e. 
same number of pixels were analyzed) and adjusted based on a global 
background subtraction. Different membranes were normalized based on the 
positive controls in the array. 
3.2.3 qPCR array for MAPK and Toll-like receptor signaling 
BMMΦs were stimulated with 50µg/ml of 0-3hRP supplemented with 2µg/ml of 
PMB, 1ng/mL of LPS, or simply cultured in media for 30min in 24 well plates 
(1x106 cells per well). Each treatment was performed in triplicate. Replicates 
were pooled and RNA extracted as described before (2.6) for analysis using 
RT2 Profiler PCR Array (QIAGEN) following the manufacturer’s instructions.  
Briefly, 0.6µg of RNA from each sample was reverse-transcribed into cDNA 
using the RT2 first strand kit. The cDNA was mixed with the RT2 SYBR Green 
Master Mix and distributed to a 96 well plate pre-coated with primer pairs for 
target genes. ABI Prism 7300 was used to perform qPCR, and the resulting Ct 
values were obtained using Applied Biosystems SDS Software (Life 
Technologies) with the same threshold for all genes and samples. Ct values 
were used to calculate the differences in gene expression and perform relevant 
quality control checks (genomic DNA contamination, retro-transcription controls 
and negative PCR controls) using the PCR Array Data Analysis Template Excel 
provided by the manufacturer.  
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3.3 Results 
3.3.1 In vitro differentiation of bone marrow cells into macrophages 
Bone marrow (routinely) obtained from femurs and tibias of 6 week old female 
C57BL/6 mice was cultured as described in 2.3 to obtain BMMϕs used 
throughout the project. The culture conditions described in 2.3 rely heavily on 
the quality of the M-CSF used, which in this case was sourced from 
supernatants of L929 (L-Sup) fibroblast cultures (Deryugina et al, 1995). Stable 
and reproducible results for BMMϕs were obtained by supplementing complete 
DMEM with 20% L-Sup from a single stock. Bone marrow cells successfully 
differentiated into viable F4/80+CD11b+MHC-IIlowCD11clow cells (Figure 3.1). 
Cell yields averaged 20x106 BMMΦs per mouse. The expression of the surface 
markers F4/80, CD11b, and CD11c was consistent in all experiments, however, 
MHC-II levels were the most variable. 
The general gating strategy (Figure 3.1A) used thought out the project included 
selecting for events on the basis of size and granularity using the forward 
scattering (FSC), and side scattering (SSC) of light, respectively. Single cells 
were selected by analyzing the quadratic distribution of events using the FSC. 
Finally, viable cells were gated using a viability dye as described in 2.4.  
A typical phenotype of differentiated bone marrow cells (Figure 3.1B) is 
presented alongside a bar graph showing the percentage of positive cells for 
each marker from 7 independent experiments (Figure 3.1C). CD11b was 
expressed in all BMMϕs, as this protein is found in all myeloid cells. F4/80, also 
expressed in all BMMϕs, is a well-established marker of macrophages in 
tissues, but is present in other immune cells (i.e. DCs and eosinophils). MHC-II 
expression was low and variable, and as this marker can be up regulated upon 
activation and stress, its low levels confirmed the naïve nature of BMMϕs 
(Benoit et al, 2008; Galli et al, 2011; Gordon, 2003; Gordon & Martinez, 2010; 
Jenkins & Allen, 2010). Percentage of CD11c positive BMMϕs was low (~10%), 
so contamination from DCs was ruled out, as all bone marrow derived DCs are 
positive for this marker (data not shown) (Downes & Marshall-Clarke, 2010; 
Jenkins & Mountford, 2005). 
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3.3.2 Cytokine production by BMMΦs in response to overnight 
stimulation with 0-3hRP and other PAMPs 
3.3.2.1 Endotoxin contamination present in 0-3hRP is neutralized by 
Polymixin B 
S. mansoni cercarial E/S products (aka 0-3hRP) obtained as described in 2.2.1 
come from a non-sterile environment. Although cercariae are extensively 
washed and cultured in sterile media containing antibiotics, low levels of 
endotoxin contamination are still detectable (Jenkins & Mountford, 2005) and 
have been neutralized using PMB (Cardoso et al, 2007; Cooperstock, 1974; 
Jenkins et al, 2005). To investigate the effect of 0-3hRP in the absence of 
endotoxin LPS was neutralized using PMB. 
BMMϕs (1x105 cells per well in 96 well plates) were stimulated overnight with 
50µg/ml of 0-3hRP or 1ng/ml of LPS, with or without 2µg/ml of PMB, or left un-
stimulated (Media). Supernatants were collected and analyzed for the presence 
of IL-10 and IL-12p40 by ELISA (see 2.5).  
Addition of PMB resulted in a significant but partial decrease in the production 
of both IL-12p40 and IL-10 by BMMϕs in response to 0-3hRP (Figure 3.2) whilst 
the same quantity of PMB totally neutralized LPS-induced cytokine production 
in the cells. Since in the presence of PMB, 0-3hRP was still able to induce 
significantly elevated levels of both cytokines, it is clear that BMMΦs respond to 
components of 0-3hRP and not exclusively to any potential endotoxin 
contamination present in the antigen preparation. Consequently, to ensure that 
the immune responses measured were specific to components of 0-3hRP of 
helminthic origin, PMB was included in all subsequent experiments. 
3.3.2.2 0-3hRP induces a distinct cytokine response in BMMΦs 
Macrophages respond to many innate stimuli that allow them to condition the 
immune response. Several TLR antagonists have been described (Akira & 
Takeda, 2004; Hoshino et al, 1999; Takeuchi et al, 1999) and each induces a 
distinct response from these cells. To investigate how S. mansoni cercarial E/S 
products compare to other innate stimuli, BMMϕs were exposed to 0-3hRP 
alongside several different TLR ligands (Figure 3.3). 
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BMMΦs (1x105) were exposed overnight to 0-3hRP (50µg/ml), LPS (1ng/ml), 
Zymosan A (50µg/ml), Poly I:C (25µg/ml), Pam3CSK4 (5µg/ml), or left un-
stimulated (Media).  
0-3hRP induced a distinct response in BMMΦ cytokine production, with 
relatively low levels of IL-12p40 and high levels of IL-10 (Figure 3.3). Classically 
pro-inflammatory stimuli like LPS or Pam3CSK4 induced higher levels of IL-
12p40 than any other ligand. Likewise, they induced a significantly smaller 
production of IL-10. Poly I:C induced modest levels of IL-12p40 (similar to those 
induced by 0-3hRP) and low levels of IL-10. BMMΦs exposed to Zymosan A, a 
complex mixture of proteins and glycans from yeast, exhibited the greatest 
amounts of anti-inflammatory IL-10. In summary, the increased levels of IL-10 
secreted by BMMΦs in response to 0-3hRP, without a correspondingly high IL-
12p40 production, show this antigenic preparation is different from other 
PAMPs. 
3.3.3 Changes to the membrane proteome of BMMΦs after stimulation 
with 0-3hRP and LPS 
Proteins on the cell surface of macrophages mediate communication with other 
cells. Investigations into changes in the levels of MHC-II, CD80, CD86 and 
CD40 using flow cytometry in BMMΦs exposed to 0-3hRP yielded no significant 
results (data not shown). As IL-10, but not IL-12p40, production by these 
stimulated cells has the potential of modulating the immune response, the 
regulation of receptors in the membrane of these 0-3hRP stimulated cells 
warranted investigation. Consequently, an unbiased approach was pursued to 
investigate the changes in membrane protein expression in macrophages 
exposed to cercarial E/S products. LPS, a pro-inflammatory stimulus, was used 
alongside 0-3hRP to compare how these two stimuli affected the membrane 
proteome of stimulated BMMϕs. 
3.3.3.1 Membrane protein extraction and LC-MS/MS pre-run 
BMMΦs were stimulated overnight with 0-3hRP (50µg/ml), LPS (1ng/ml) or left 
un-stimulated (Media) as described in 3.2.1. After membrane protein 
enrichment, samples were pooled and prepared for label free quantitative 
proteomics. 
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To assess the quality of protein samples, and the result of membrane 
enrichment protocol, the preparations were analyzed using LC-MS/MS. In total 
416 proteins were identified across the three different samples using the IPI 
mouse database (Table 8.1). Of the 416 proteins identified, 39 (9.4%) were only 
present in BMMϕs stimulated with 0-3hRP, whereas LPS and Media had 51 
(12.3%) and 52 (12.5%) unique proteins, respectively (Figure 3.4). Importantly, 
60% of all proteins identified were present in two or more samples, which 
enables comparisons between levels of expression using the label free 
proteomics approach, especially as 190 (45.7%) hits were present in all 
samples, which the analysis will focus on. 
To evaluate the success of membrane protein enrichment in the samples, 
protein hits were analyzed for GO term enrichment using VLAD, as described in 
3.2.1.3. The number of proteins associated with a GO term (k) and the 
percentage of proteins in the sample that mapped to each term were used to 
choose relevant cellular localizations. 
Of 416 identified hits, only 404 proteins had associated GO terms, which is the 
value to which reported percentages refer to from here on. From that total, 71% 
of identified hits were associated with membranes (Table 3.1), and 39% 
mapped to the plasma membrane. This result suggests that the strategy 
employed to achieve enrichment of membrane proteins from the cell lysates 
was successful, especially as only 12.9% of proteins associated with the 
cytosol. 
Proteins from membrane-bound organelles were abundant, with 35% of 
proteins associated with the mitochondrion and 25% with the nucleus. Of the 
detected proteins, 49.3% can be associated with membrane-bounded vesicles, 
while small structures such as lysosomes were also represented with 13.9% of 
proteins mapping to this GO term. 
As for molecular processes in which detected proteins were involved with, 39% 
(152) of hits were associated with “responses to stimulus” (GO:0050896), with 
21.3% (83) associated with “signaling” (GO:0023052) and 7.4% (39) with 
“immune response” (GO:0006955). 
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3.3.3.2 Label-free quantitative proteomics of membrane enriched protein 
samples 
The samples described above were used for quantitation of protein changes 
using a novel, label-free, mass spectrometry approach (Li et al, 2011; Meissner 
et al, 2013; Patel et al, 2009). As the method requires further repetition of MS 
runs, coverage was increased and 436 proteins were identified by MS/MS 
across the samples, of which quantitation data were obtained for 254. Hits were 
ranked based on Mascot Score and filtered for significance (p<0.05; i.e. a 
Mascot Score greater than 67) guaranteeing that mass spectra was accurately 
matched to identified proteins and reducing the chances of false discovery. 
Only hits that met that criteria and had at least two peptides from each protein 
used for quantitation are reported. Coefficients of variation (CV%) of the peptide 
quantitation for each protein are also given. Hits with a 30% or lower variation 
are included in the GO term enrichment analysis. Regulated proteins reported 
are those with more than a 1.5 fold up or down regulation, with a median ratio 
greater than 1.5 or lower than 0.67. Detailed lists of the association of regulated 
proteins in both treatments with each GO term for biological processes (Table 
8.2) or cellular localization (Table 8.3) are presented in the appendix.  
Thirty four proteins were up-regulated in BMMϕs exposed to 0-3hRP and only 3 
were down-regulated compared to Media (Table 3.2). Conversely, LPS 
stimulated 7 proteins to be up-regulated with the same number being down-
regulated compared to Media (Table 3.3). These results are summarized in 
Figure 3.5, where quantified proteins in BMMϕs stimulated with 0-3hRP and 
LPS are directly compared to one another. Missing bars correspond to proteins 
for which good quality data was not available. No error bar is presented when 
only 1 peptide was used for quantitation.  
Similarities between samples obtained using the two different stimulation 
regimes are evident. Immune response proteins, such as the Macrophage 
scavenger receptor 1 (MSR1), CD14 and H2-Q2 were up-regulated in both 
samples. However, LPS treated BMMϕs had several down-regulated proteins, 
more than for 0-3hRP treated cells (Figure 3.5). Only ATP synthase subunit 
beta (Atp5b) was down-regulated in LPS and up-regulated in 0-3hRP. 
These changes are revealed as a pattern when regulated proteins in each 
sample are analyzed for GO term enrichment. Both treatments had similar 
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proportions of up-regulated proteins associated with “biological regulation” 
(70.4% in 0-3hRP vs. 71.4% in LPS), “response to stimulus” (51.9% in 0-3hRP 
vs. 57.1% in LPS) and “response to stress” (40.7% in 0-3hRP vs. 42.9% in 
LPS). However, 0-3hRP treated macrophages had a greater number of up-
regulated proteins mapping to “metabolic process” with 48.1% compared to 
28.6% in LPS (Table 3.4). As a consequence, proteins related to “immune 
system process” were enriched in LPS treated macrophages with 57.1% 
compared to 25.9% in 0-3hRP. However, 0-3hRP treated BMMϕs up-regulated 
proteins associated with “regulation of MAPK” (11.1%), a category that was 
absent in LPS treated cells. In contrast with the observations reported above, 
LPS treated macrophages down-regulated several proteins mapping to 
metabolic process (66.7%) compared to none in 0-3hRP treated cells (Table 
3.4).  
Finally, in accordance with the earlier GO term enrichment analysis (see Table 
3.1), several proteins up and down regulated in both treatments were 
associated with membranes or membrane structures (Table 3.5). Proteins 
associated with organelles were up and down-regulated to a greater extent in 0-
3hRP treated BMMϕs than in LPS stimulated cells. Notably, an association with 
the mitochondrion (66.7%) was only recorded in down-regulated proteins after 
LPS treatment. This corroborates the down-regulation of metabolic processes 
associated proteins in LPS treated cells but not in 0-3hRP treated BMMϕs. 
3.3.3.3 Validation of protein expression using flow cytometric analysis of 
antibody-labelled 0-3hRP treated BMMϕs 
From the results obtained above, three proteins were selected to partially 
validate the observations made. CD36 (Baranova et al, 2012; Fonager et al, 
2012; Leelahavanichkul et al, 2012) and CD14 (Baumann et al, 2010) were 
both regulated on BMMϕs and have well-established associations with innate 
immune responses in macrophages, particularly with the Toll-like receptor 
system (Lee et al, 2012). MSR1 on the other hand, has been reported to have 
various roles in responses to pathogens (Blanchet et al, 2014; Mukhopadhyay 
et al, 2011). All three proteins are expressed on the surface of macrophages 
and specific antibodies were commercially available. 
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BMMϕs were exposed to 0-3hRP (50µg/mL) for 18 hours, or left untreated 
(Media) in three independent experiments. Cells were labeled as described in 
2.4 for surface expression of CD36, MSR1 and CD14. 
All three markers corroborated the results obtained by mass spectrometry 
(Figure 3.6). Expressed as the percentage of positive cells (Figure 3.6A & C) 
and as the median fluorescence intensity (MFI) (Figure 3.6B & D), both 
approaches identified the differential expression of CD36, MSR1 and CD14 in 
accordance with the calculations made using the label-free proteomics 
approach. CD14 and MSR1 were significantly up-regulated on BMMϕs 
stimulated with 0-3hRP compared to Media, whilst the expression of CD36 was 
significantly down-regulated (Figure 3.6A & C). The MFI values further confirm 
the modest nature of the changes in the expression of these markers (as seen 
in Figure 3.5), with changes not exceeding 2 fold up or down regulation. 
3.3.4 Phosphorylation of MAPKs in BMMΦs after stimulation with 0-3hRP 
Investigation into phenotypic changes in BMMϕs exposed to S. mansoni 
cercarial E/S products has thus far emphasized that these cells only subtly 
change the expression of different molecules, despite the marked differences in 
cytokine production. The differences detected by proteomics indicated a strong 
association with metabolic processes in BMMϕs, and importantly with regulation 
of MAPKs, which are a well characterized signaling family of proteins. 
Therefore, the activation status of MAPKs was evaluated using a commercially 
available kinase proteome profiler array. 
3.3.4.1 Kinase proteome profiler array of BMMϕs treated with 0-3hRP 
BMMϕs were stimulated with 0-3hRP (50µg/ml) for 5, 30 and 60min and 
proteins then extracted from lysed cells and tested for the activation of MAPKs 
as described in 3.2.2. To avoid overexposure or arrays, X-ray films were 
exposed to membranes for various lengths of time, with 1min being selected 
based on signal quality (i.e. avoiding overexposure of positive controls and 
maximizing detection of phosphorylated proteins). Images of x-ray film of 
membranes are presented in Figure 3.7. Positive and negative controls (PBS) 
were consistent across all membranes. Due to limited number of membranes, 0 
time point was not included. 
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Several MAPKs were active, as seen by phosphorylation, at 5min (e.g. JNK 
pan), however stronger signals were apparent after 30 and 60min of stimulation 
with 0-3hRP (such as CREB, ERK or TOR) (Figure 3.7). Intriguingly, not all 
detected signals remained strong after 60min of exposure to cercarial E/S 
products (e.g. JNK 2 and p38α). 
3.3.4.2 Densitometry analysis of kinase proteome profiler array 
To more accurately measure the levels of phosphorylation of the detected 
signals in the membranes, a densitometry analysis was performed on the 
exposed X-ray films. Pixel density was quantified on each coordinate of the 
array using identical circular areas followed by global background subtraction 
(which led to some negative values). Values were normalized based on the 
positive controls on each blot to account for inter-membrane variation, as 
recommended by the manufacturer. Finally, technical replicates (n=2) in each 
membrane were used to calculate the mean and standard deviation for each of 
the 26 proteins in the array. 
The strongest signal detected corresponded to ERK2 (Figure 3.8), followed by 
CREB, JNK pan, JNK2, p38α, RSK1 and TOR. After exposure to 0-3hRP, the 
strongest signals for individual kinases corresponded to the 5min time point in 7 
cases (p70 S6K, p38δ, p38β, MKK3, HSP27, JNK pan and JNK 3), to the 30min 
time point in 3 cases (p38α, JNK 2 and CREB) and to the 60min time point also 
in 3 cases (RSK2, MKK6, ERK2). Sustained activation was clear in TOR, GSK-
3α/β, GSK-3β and MSK2 where signal strength at 30 and 60min were equally 
high. Other kinases had a dip in the signal after 30min of exposure (RSK1 and 
p53) with levels returning to the initial time point after 60min. Notably, no 
changes between time points were detected in the Akt family, or for ERK1, p38γ 
and JNK1. 
3.3.4.3 Fold changes in kinase activation after stimulation with 0-3hRP 
The segregation of kinases into different dynamics of activation implied a 
temporal regulation as part of different signaling cascades. To further explore 
this feature of the response to 0-3hRP, densitometry data was analyzed as fold 
changes in phosphorylation compared to the earliest available time point 
(5min). Normalized densitometry data was used to calculate fold changes in 
protein phosphorylation using 5min (arbitrarily set to 1) as a reference point. 
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MAPKs were segregated into 4 groups according to peaks of activation, as 
described above. Mean fold changes and SD for activated proteins at each time 
point are presented (Figure 3.9). 
Proteins that were phosphorylated at 5min (Figure 3.9A) showed a pronounced 
reduction in activation at both 30 and 60min, with levels at 60min being lowest 
for 4 out of 7 proteins in this group. Conversely, MAPKs that had a dip in the 
signal at 30min (Figure 3.9B) recovered initial levels of phosphorylation after 
60min of stimulation. 
The remaining three groups were remarkably similar. All proteins had 
consistently similar fold changes in activation between 30min and 60min (Figure 
3.9D), excluding p38α (Figure 3.9C) and RSK2 (Figure 3.9D), which differed 
between this two time points. Thus, these 8 proteins (p38α, CREB, RSK2, 
ERK2, MSK1, TOR, GSK-3α/β and GSK-3β) appeared dynamically linked 
(JNK2 excluded as it did not exceeded the 2 fold change threshold of 
activation).  
3.3.5 Rapid gene expression changes in BMMΦs after stimulation with 0-
3hRP; analysis by qPCR array 
BMMϕs exposed to 0-3hRP activated several kinases through phosphorylation 
with a very tight temporal regulation. This activation was most apparent after 
30min. Furthermore, 0-3hRP modulated various proteins that regulate signal 
transduction and are involved with the TLR system (3.3.3.2). Therefore, the 
expression of genes related to MAPK activation and TLR stimuli was tested 
after 30min of exposure to 0-3hRP using a qPCR array with 156 genes (see 
3.2.3). 
BMMϕs were stimulated with 0-3hRP (50µg/ml), LPS (1ng/ml) or left un-
stimulated (Media) for 30min. RNA was extracted from these cells and prepared 
for analysis as described in 3.2.3. RNA transcripts for 156 test genes, plus 5 
house-keeping genes (HKGs), were tested using a qPCR array (for full list of 
genes see Table 3.6). Samples met all relevant quality controls, which included 
testing for genomic DNA contamination, retro-transcription controls and 
negative PCR controls. Changes in gene expression were calculated based on 
Ct values as specified in 2.6 using all 5 HKGs (Hprt, Gapdh, Gusb, Actb and 
Hsp90ab1) by using their average Ct values for each sample. 
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3.3.5.1 BMMϕs treated with 0-3hRP alter the expression of several genes 
Using un-stimulated macrophages (Media) to calculate fold differences in 
transcript levels (Figure 3.10), 55 genes were found to be regulated in 0-3hRP 
and LPS stimulated BMMϕs using a 2-fold change threshold. Unlike LPS, which 
mainly caused up-regulation of various genes (such as Il12a, Mapk13, Lta), 0-
3hRP had a powerful effect on the expression of multiple transcripts both by 
inducing (Figure 3.10A) or repressing (Figure 3.10B) expression. Notably, LPS 
stimulated BMMϕs up-regulated the expression of several proteins of the MAPK 
family, whereas cells stimulated with 0-3hRP down-regulated their transcription 
or did not affect their expression at all (e.g. Map3k7, Mapk8ip2, Mapk13).  
Differences in IL-10 and IL-12p40 protein production reported earlier (3.3.2.2) 
were consistent with expression of their genes at the transcript level, with 0-
3hRP stimulated BMMϕs producing more Il10 and less Il12a transcript than LPS 
treated cells (Figure 3.10A). 0-3hRP powerfully induced the expression of 
several cytokines (e.g. Il1a, Il1b, Il10, Il6), although LPS also activated their 
transcription.  
Ct value differences between target transcripts and HKGs within each sample 
were calculated (2-ΔCt) for BMMϕs exposed to 0-3hRP and LPS. A direct 
comparison of the value for each gene between the two treatments was made  
(Figure 3.11). Genes with a greater than 2-fold change in either direction fall 
outside the dotted lines which represent the 2-fold threshold. HKGs were 
constant between the samples (Figure 3.11 in red), however several target 
genes were differentially regulated between the two samples. For example, the 
differences in Il10 and Il12a mentioned above remained apparent in this new 
analysis (Figure 3.11 in blue). CD14, which was found to have similar protein 
levels in LPS and 0-3hRP stimulated BMMϕs (Figure 3.5), also had similar 
levels of transcript (Figure 3.11 in orange). 
3.3.5.2 qPCR for specific gene transcripts corroborate PCR array 
To verify the results obtained using the qPCR array for genes related to MAPKs 
and TLRs, RNA was obtained from 0-3hRP stimulated BMMϕs and tested 
specifically for 4 of the regulated transcripts. 
BMMϕs were stimulated with 0-3hRP (50µg/ml), LPS (1ng/ml) or left un-
stimulated (Media). RNA was extracted and used for gene expression analysis 
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as described in 2.6 using primers for Il10 and Il12b (see Table 2.2) or with 
primers purchased from QIAGEN (equal to the primers in the array) for mitogen 
activated protein kinase kinase kinase 7 (Map3k7) and early growth response 
protein 1 (Egr1), which were selected for being the most down or up-regulated 
transcripts in 0-3hRP stimulated BMMϕs, respectively (Figure 3.10). Changes in 
gene expression were quantified relative to un-stimulated (Media) BMMϕs using 
Gapdh as a HKG. 
Initial experiments were performed to examine the expression of Egr1 (Figure 
3.12A) and Map3k7 (Figure 3.12B) in BMMϕs after 30min exposure to 0-3hRP 
or LPS. The results for Egr1 confirmed earlier observations (Figure 3.10), with a 
pronounced expression of this transcription factor in response to 0-3hRP but 
not LPS (Figure 3.12A). However, the expression of Map3k7 by qPCR did not 
agree with the qPCR array data as no changes of expression were detected 
although by array this kinase was reduced after stimulation with 0-3hRP(Figure 
3.12B). 
Due to the dynamic temporal nature of MAPK activation (see 3.3.4.3), changes 
in the timing of expression for Egr1 and Map3k7 transcripts, as well as Il10 and 
Il12b, were investigated (Figure 3.13). The expression of Il10 after 30min of 
exposure to 0-3hRP was significantly higher than response to Media (Figure 
3.13A), thus confirming the array results. Moreover, this transcript continued to 
increase at 100min of exposure. However, Il12b was only marginally increased 
compared to Media after 30min exposure to 0-3hRP (Figure 3.13B; averaging 
1.6 fold increase) and the increase was only significant after 100min exposure. 
The dramatic induction of Egr1 by 30min was evident, however its expression 
decreased back to levels for cells cultured with Media only after 100min (Figure 
3.13C). The expression of Map3k7 was not statistically different in BMMϕs 
treated with 0-3hRP and their un-stimulated counterparts at any of the time 
points tested (Figure 3.13D).  
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3.4 Discussion 
BMMϕs stimulated with 0-3hRP exhibit a strikingly unique activation state. 
These cells produced high levels of anti-inflammatory cytokine IL-10 and low 
levels of pro-Th1 cytokine IL-12p40. They also changed the way in which they 
regulated their metabolism, potentially to fuel immune processes differently. 
Furthermore, BMMϕs exposed to 0-3hRP activated and regulated several 
MAPKs whose activation profile matches that of the transcription of Il10 and 
Egr1. Finally, they appear to regulate these features using components of the 
TLR system, such as CD14 and CD36, which have altered expression levels in 
stimulated cells compared to resting cells. 
3.4.1 0-3hRP elicits a unique response in BMMϕs 
The number of studies addressing the effects of 0-3hRP on immune cells is 
limited. S. mansoni cercarial secretions are a complex mixture of proteins that 
can be obtained for in vitro studies in more than way, which has led to some 
discrepancies in findings by different groups around the world. The focus of this 
work was the effect of 0-3hRP, prepared by mechanical disruption of cercariae, 
on murine macrophages. 0-3hRP obtained in that manner has been shown to 
contain at least one bacterial product (LPS) (Jenkins et al, 2005), which was 
successfully neutralized using PMB throughout this study. Nonetheless, other 
PAMPs of microbial origin are undoubtedly present in 0-3hRP, however 
completely controlling experimentally for their effect is not currently possible. 
This issue is partly addressed by washing cercariae extensively and by 
incubating the parasite with antibiotics. However, in a natural environment, 
individuals will be exposed to cercariae in an unsterile environment, which could 
support the idea of a “dirty” 0-3hRP having more physiological relevance. 
Determining the exact nature and levels of “contaminants” in 0-3hRP would 
require complex mass spectrometric analysis of the preparation, targeting a 
broad range of molecules of different biochemical nature. Those experiments 
are beyond the scope of the current work. 
This study employed BMMϕs to study the effects of 0-3hRP. Several methods 
exist for the isolation and production of other macrophage for in vitro studies 
(Bailey et al, 2011; Jenkins et al, 2005; John et al, 2013; Mukhopadhyay et al, 
2011). All methods available should be judged on the basis of physiological 
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relevance, cell yield, homogeneity of the results, being of naive phenotype, and 
having plasticity upon maturation with specific ligands. Conditioning bone 
marrow cells with CSF-1, which drives the differentiation and proliferation of 
macrophages in vivo (Jenkins et al, 2011; Jenkins et al, 2013) and has been 
used for the same purpose in vitro, produces cells that have the required 
plasticity to respond differentially to a plethora of stimuli that mature 
macrophages may encounter in vivo in the tissues and blood (Bailey et al, 
2011; Deryugina et al, 1995). BMMϕs prepared in this manner were found to 
have a homogeneous and high expression of CD11b (myeloid cell marker) and 
F4/80, which is expressed by macrophages in tissues and by other immune 
cells like eosinophils and dendritic cells. A small percentage of BMMϕs 
expressed CD11c compared to bone marrow derived DCs (data not shown) and 
expression of MHC-II was similarly low. Furthermore, these cells were readily 
available, as yields were high in every culture, and were able to produce 
cytokines when challenged with 0-3hRP and a range of PAMPs. Thus, this 
system provided a physiologically relevant, homogeneous, naïve and plentiful 
experimental platform to assess the effect of stimulation with S. mansoni 
cercarial E/S products. 
0-3hRP elicited cytokine production in BMMϕs that was significantly different 
from other PAMPs, and was independent of possible endotoxin contamination. 
The low levels of IL-12p40 and high levels of IL-10 detected in culture 
supernatants after overnight exposure to the antigenic preparation, suggest that 
0-3hRP is driving a mixed response. IL-12p40 is essential to induce Th1 
responses from the adaptive immune system (Cook et al, 2011; de Jong et al, 
2002; Yang et al, 2010). However, IL-10 is a master regulator of the immune 
response that dampens inflammation, limits T cell activation and induces tissue 
repair (Antoniv & Ivashkiv, 2011; Belkaid et al, 2001; Kamanaka et al, 2006; 
Kuhn et al, 1993; Sabat et al, 2010; Saraiva & O'Garra, 2010; Specht et al, 
2012). This duality in the response from BMMϕs exposed to 0-3hRP matches 
the mixed responses often encountered at infection sites of schistosome 
infections, in which both cytokines are present (Cook et al, 2011; Hewitson et al, 
2007; Pearce & MacDonald, 2002; Perona-Wright et al, 2006). Cells from the 
immune system in the skin will encounter 0-3hRP as larvae migrate though this 
tissue. Therefore, immune cells in the skin could be driven to this mixed 
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cytokine response by exposure to the secretions of invasive larvae. Evidence 
for the presence in S. mansoni infected skin of IL-10 and IL-12p40, but also IL-
1β and IL-6 that were also induced (at transcript level) by 0-3hRP, is already 
available (Hogg et al, 2003b), and 0-3hRP could be partly responsible for the 
induction of all these cytokines in vivo.  
3.4.2 Changes in membrane proteins in BMMϕs stimulated with 0-3hRP 
Label-free quantitative proteomics was used to investigate membrane proteins 
from stimulated BMMϕs in an effort to further elucidate changes in response to 
0-3hRP. This method provided sufficient coverage and accuracy to measure 
changes in hundreds of membrane proteins simultaneously in BMMϕs 
stimulated with 0-3hRP or LPS. The effectiveness of the membrane enrichment 
was evidenced by the over-representation of these proteins in the samples 
(71%). However, the association of some proteins with the GO term 
“membrane” is not limited to integral membrane proteins, but rather to proteins 
that interact or are part of the membrane. Moreover, no input sample (i.e. pre-
membrane enrichment) was analyzed, and that would be required to rigorously 
assess the success of the process. 
Relative changes (with respect to resting cells) revealed that BMMϕs stimulated 
with 0-3hRP up-regulated the expression of proteins involved in metabolic 
processes, which was not the case in cells stimulated with LPS. BMMϕs 
exposed to 0-3hRP increase the expression of proteins linked with the GO term 
“metabolism of organic substances”, which could mean that processing and 
responding to 0-3hRP is costly from an energy point of view, to a greater extent 
than responding to LPS. However, due to the limited number of protein hits that 
mapped to metabolism, it is not possible to determine exactly how 0-3hRP is 
affecting these processes. Further experiments measuring the uptake of 
carbohydrates and lipids, as well as the consumption of oxygen and production 
of lactate would commence to address this feature of 0-3hRP stimulated 
macrophages. Indeed, understanding the energy requirement of 0-3hRP 
activated macrophages would shed light on potential differences and similarities 
with cells activated by other ligands. Others have explored the interplay and 
intimate linkage between metabolism and the immune response (Arnoult et al, 
2011; Everts et al, 2014; Ferret-Bernard et al, 2012; Gehart et al, 2010; 
Pulendran & Artis, 2012; Vanhaesebroeck et al, 2012; West et al, 2011). 
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Hypoxic conditions are often associated with inflammation (Bartels et al, 2013), 
consequently immune cells will need to fundamentally change the way they 
obtain energy. The possibility these finding raise with respect to the regulation 
of metabolism of macrophages by 0-3hRP is in line with previous reports of the 
effect of other S. mansoni antigenic preparations (i.e. SEA) on DCs (Ferret-
Bernard et al, 2012).  
0-3hRP stimulated macrophages up-regulated surface proteins with known 
immunological functions. Changes in MSR1, CD36 and CD14 were validated 
using flow cytometry. These three proteins have been reported to mediate 
macrophage responses to different stimuli. MSR1 and CD36 are both 
scavenger receptors that could be implicated in uptake of 0-3hRP, as is the 
case with other ligands (Baranova et al, 2012; Blanchet et al, 2014; Fonager et 
al, 2012; Mukhopadhyay et al, 2011; Oury, 2014; Sulahian et al, 2008). 
However, as CD36 expression is reduced, 0-3hRP might be exerting its anti-
inflammatory properties by reducing the availability of this receptor on the 
surface of macrophages. CD14 is perhaps the best characterized co-receptor 
for the TLR system (Akira & Takeda, 2004; Ambarus et al, 2012; Baumann et 
al, 2010; Ioannou & Voulgarelis, 2010; Valanne et al, 2011). CD14 up-
regulation in 0-3hRP treated BMMϕs provides a starting point for the implication 
of TLRs in the recognition of parasite secretions. 
Finally, the GO term enrichment analysis revealed that BMMϕs stimulated with 
0-3hRP up-regulated proteins that modulate MAPK responses, a category 
absent from LPS treated cells. In conjunction with the up-regulation of elements 
of the TLR system and the distinct cytokine production elicited by the parasite 
secretions, MAPKs appeared to be a likely link between the exposure to 0-
3hRP and the downstream immune response. 
3.4.3 Activation of MAPKs in BMMϕs stimulated with 0-3hRP is tightly 
regulated 
Activation of MAPKs in BMMϕs exposed to 0-3hRP was diverse. Although un-
stimulated BMMϕs were not included in this analysis (i.e. no time point 0 was 
performed), a clear temporal regulation of activation of MAPKs was evidenced 
across the tree time points measured. The most interesting feature of these 
findings was the dynamic link observed between p38α, MSK2, ERK2, RSK2 
and CREB, suggesting that these proteins might be part of the same signaling 
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pathway. Others have reported links (see Diagram 3.1) between p38α and 
MSK2 (Yang et al, 2010) or ERK2 and RSK2 (Bain et al, 2007; Mayer et al, 
2013; van Vliet et al, 2013). Moreover, CREB has been reported to be 
downstream of both p38 and Erk1/2 (Deak et al, 1998; Elcombe et al, 2013; 
Mayer et al, 2013; van Vliet et al, 2013; Wen et al, 2010). However, the 
association made in the present study between all these molecules, with a 
common activator and similar dynamics of phosphorylation, is novel. The 
implications of these associations and how they relate to the production of 
cytokines in response to 0-3hRP in vivo and in vitro will be explored fully in 
subsequent chapters. The relative contribution of these kinases to the 
phenotype observed in stimulated macrophages will be obtained through a 
combination of genetically deficient animals and chemical inhibitors. 
Diagram 3.1 Previously reported links between MAPKs 
 
Demonstrated associations (solid lines) and proposed links (dashed lines) by 
previous studies between MAPKs. 
Other kinases were also active in macrophages exposed to 0-3hRP. The strong 
and prolonged activation of TOR, which started after 30min of stimulation with 
0-3hRP, is unclear as other members of the TOR signaling pathway were not 
active (such as the Akt family) or had very low levels of activation (p70 S6K) 
(Gwinn et al, 2008). Furthermore, GSK-3 was also active, as discussed further 
down, but reports suggest TOR blocks this kinase (Alessandrini et al, 2011; 
Cremer et al, 2011; Wang et al, 2011). Consequently, the role of the activation 
of TOR in the context of 0-3hRP-stimulation would require further exploration. 
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Chemical inhibition of stimulated macrophages through rapamycin would 
provide a starting point for these experiments. 
GSK-3α/β is a well-known regulator of signaling events in macrophages. It 
functions mainly as an inhibitor of the transcription of numerous genes and has 
been described to act in concert with IL-10 to suppress the activation of certain 
transcripts in favor of others (Antoniv & Ivashkiv, 2011; Park et al, 2011; Wang 
et al, 2011). GSK3-α/β is activated in response to 0-3hRP in BMMϕs after 
30min and remains highly active after 60min. In that way, it could be 
cooperating with the other triggered signals to favor an anti-inflammatory 
response, similar to the known ability of p38α to maintain low levels of IL-12 
(Yang et al, 2010). 
Overall, 0-3hRP stimulated BMMϕs activate several MAPKs that are regulated 
differently, resulting in different temporal dynamics. A group of these kinases 
appears to act in concert, peaking at 30min of activation and then maintaining 
those high levels of activity for at least 30 more minutes. This group contains 
several kinases that have been linked to TLRs and cytokine production, 
particularly that of IL-10. Therefore, the gene expression of macrophages after 
30min exposure to 0-3hRP was investigated, targeting genes that are linked 
with MAPKs and the TLR system. 
3.4.4 Gene expression in BMMϕs exposed to cercarial E/S products 
The gene expression profile of macrophages exposed to 0-3hRP was 
dramatically different from that elicited by LPS after 30min of exposure. 0-3hRP 
induced a stronger cytokine response from macrophages, which had higher 
levels of TNFα, IL-1 and IL-6 transcript than LPS stimulated cells. These 
cytokines have been conventionally associated with the innate immune system 
(Benoit et al, 2008; Hertzog et al, 2011; Ioannou & Voulgarelis, 2010; Rathinam 
et al, 2012; Ruland, 2011). They are produced faster than other cytokines and 
often their levels drop as the inflammatory process evolves.  
The increase in cytokine transcript levels was also true for IL-10, which unlike 
TNFα, IL-1 and IL-6, dampens the immune response and is associated with the 
resolution of inflammation, not its commencement (Belkaid et al, 2001; Kuhn et 
al, 1993; Sabat et al, 2010; Saraiva & O'Garra, 2010). Unlike all other cytokines, 
IL-12 was higher in LPS stimulated macrophages than in 0-3hRP stimulated 
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ones. These results confirm the observations made when the levels of these 
cytokines were measured in culture supernatants. 0-3hRP consistently induced 
higher levels of IL-10 and lower levels of IL-12 than LPS. This contrast 
underpins the difference between 0-3hRP and LPS as innate stimuli. Cercarial 
E/S products are a potent immune stimulus, however they deviate from classic 
pro-inflammatory PAMPs. 
The most highly expressed transcript in 0-3hRP stimulated BMMϕs was Egr1. 
This transcription factor is known to be induced by several signaling cascades 
in response to growth factors, sheer stress and oxygen deprivation (Pagel & 
Deindl, 2011), and both Erk and CREB are upstream from it (Pagel & Deindl, 
2011; Shen et al, 2011). Egr1 targets several hundred genes, some of which 
are related to inflammation, however, its role in this process is not clear and is 
more often associated with tissue damage (Fu et al, 2003). The production of 
this transcript was validated using qPCR and tested at different times after 
stimulation with 0-3hRP, alongside Il10 and Il12b. 
The transcription of Il10 and Egr1 was reminiscent of the phosphorylation of 
MAPKs, which peaked at 30min. Egr1 activation was transient, and after 
100min not different from Media, unlike Il10 transcription that continued to 
increase. Il12b, on the other hand, was only significantly elevated after 100min. 
This evidence links IL-10 and Egr1 to the phosphorylation of the MAPKs 
described earlier, as their dynamic of activation matches each other.
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3.5 Summary 
BMMϕs exposed to 0-3hRP dramatically altered the expression and synthesis 
of a varied array of proteins that differ from the activation elicited by LPS 
(Diagram 3.2). Those differences included the potent induction by 0-3hRP of an 
array of cytokines (at the transcript level), including IL-10. However, this was not 
the case for IL-12. LPS on the other hand induced the expression of MAPK that 
were not up-regulated by 0-3hRP. Moreover, 0-3hRP up-regulated proteins 
associated with the regulation of signaling and MAPK cascades, a category 
absent from LPS.  
Diagram 3.2 Summary of global changes in stimulated BMMϕs 
 
Summary of up and down regulated transcripts (italics), protein and processes 
(boxes) in 0-3hRP (orange) and LPS (red) stimulated BMMϕs. Bold text 
identifies transcripts/proteins where levels were higher in either treatment.  
LPS and 0-3hRP also differentially regulated proteins associated with metabolic 
processes. Finally, receptors like CD14 and MSR1 were up-regulated by both, 
yet only 0-3hRP down-regulated the expression of CD36, a TLR co-receptor. 
Together these findings highlight the distinctiveness of 0-3hRP as an innate 
stimulus and suggest that both MAPKs and TLRs play a role in the response to 
0-3hRP by macrophages, a feature that will be explored in the next chapter. 
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Figure 3.1 Production of macrophages by differentiation of bone marrow 
cells from femurs and tibia of C57BL/6 mice 
Bone marrow cells cultured for 7 days were stained with (A) a viability dye and 
(B) labeled with antibodies against F4/80, CD11b, MHC-II and CD11c or 
relevant isotype controls. Representative flow plots (A, B) with percentages for 
numbers of cells within each gate and (C) bar graph showing mean values 
(+SD) of percentage of positive cells from 7 independent experiments are 
presented.  
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Figure 3.2 Cytokine production by BMMΦs in response to 0-3hRP is not 
due to endotoxin contamination 
Supernatants from BMMΦs stimulated overnight with 0-3hRP (50µg/ml) or LPS 
(1ng/mL) with or without PMB (2µg/ml) were analyzed for IL-12p40 and IL-10 by 
cytokine specific ELISA. Means +SEM of three technical replicates are 
presented. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between mean of 0-3hRP alone or with the 
addition of PMB (*** = p<0.01). The result is representative of three 
independent experiments. 
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Figure 3.3 Cytokine production by BMMΦs exposed to different PAMPs 
Culture supernatants from BMMΦs exposed overnight to 0-3hRP (50µg/ml), 
LPS (1ng/ml), Zymosan A (50µg/ml), Poly I:C (25µg/ml), Pam3CSK4 (5µg/ml) or 
left un-stimulated (Media) were tested for IL-12p40 and IL-10. Means +SEM of 
three technical replicates are presented. ANOVA and then Dunnett’s multiple 
comparisons test were performed to examine differences between the means 
compared to 0-3hRP (* = p<0.05; ** = p<0.01; *** = p<0.001; **** = p<0.0001; 
ns = p>0.05). The result is representative of three independent experiments. 
IL-12p40
0-3
hR
P
LP
S
Zy
m
Po
ly 
I:C
PA
M 3
CS
K 4
Me
dia
0
5000
10000
15000
20000
IL
-1
2p
40
 p
g/
m
L ***
ns
ns
****
**
IL-10
0-3
hR
P
LP
S
Zy
m
Po
ly 
I:C
PA
M 3
CS
K 4
Me
dia
0
50
100
150
1000
1500
IL
-1
0 
pg
/m
L
** * ***
****
****
 77 
 
Figure 3.4 Venn diagram depicting the protein hits for the membrane 
proteome of BMMϕs after stimulation with 0-3hRP, LPS, or Media 
Membrane protein enriched samples from BMMϕs stimulated overnight with 0-
3hRP (50µg/ml), LPS (1ng/ml) or left un-stimulated (Media) were analyzed with 
LC-MS/MS to identify changes in expressed proteins. In total, 416 different 
proteins were identified. BMMϕs for each treatment regime presented unique 
proteins, whilst others were shared by more than one treatment regime 
. 
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Figure 3.5 Comparison of regulated proteins in BMMϕs stimulated with 0-
3hRP or LPS 
BMMϕs were stimulated for 18 hours with 0-3hRP (50µg/ml), LPS (1ng/ml) or 
left un-stimulated. Cells were lysed, three independent samples from for 
treatment were pooled, and after membrane protein enrichment, the proteome 
quantified using a label-free approach. Results were filtered for significance 
(p<0.05) and low variation (CV%<30%) with at least 2 peptides used for 
quantitation (except when no error bar is given). Median fold changes 
calculated based on samples from un-stimulated BMMϕs for each protein and 
SD are presented. Missing bars correspond to poor data quality. 
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Figure 3.6 Expression of CD14, CD36, and MSR1 in BMMϕs exposed to 0-
3hRP (Continued in the next page) 
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Figure 3.6 (continued) Expression of CD14, CD36, and MSR1 in BMMϕs 
exposed to 0-3hRP 
BMMΦs were exposed for 18 hours to 0-3hRP (50µg/ml) or left un-stimulated 
(Media) and then labeled with antibodies for CD36, CD14 and MSR1. 
Representative flow plots for cells expressing CD14, CD36 and MSR1 (A & C), 
and bar charts depicting their mean MFI values (B & D). Means +SEM of three 
technical replicates for each protein are given. Unpaired two tailed t-tests were 
performed to examine differences between means of 0-3hRP and Media (** = 
p<0.01; *** = p<0.001). The result is representative of three independent 
experiments. 
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Figure 3.7 Kinase proteome profiler array of BMMϕs exposed to 0-3hRP 
BMMΦs were exposed to 0-3hRP (50µg/ml) for 5, 30 or 60 minutes before 
being lysed and MAPK phosphorylation measured using a kinase proteome 
profiler array (R&D). Membranes from each time point and the coordinates for 
the proteins are presented; each protein is in duplicate in the array. Positive 
controls for the assay are in the corners. 
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Figure 3.8 Densitometry analysis of kinase proteome profiler array 
Densitometry analysis of MAPK phosphorylation measured using a kinase 
proteome profiler array. Positive controls in each membrane were used to 
normalize the results and a global background subtraction was performed. 
Means between technical replicates (duplicates) and SD are presented. 
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Figure 3.9 Fold changes in MAPK phosphorylation 
Fold changes in phosphorylation of MAPKs were calculated using the 5-minute 
time point as a reference (arbitrarily set to one). Mean fold changes and SD are 
presented for each protein. Proteins with peak activation after 5min (A), 30min 
(C), 60min (D), a dip in activation (B) or sustained activation (E) are segregated 
to different graphs. Dotted lines correspond to a 2-fold change threshold.
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Figure 3.10 Regulated genes in treated BMMϕs 
Fold changes in the expression of genes related to MAPKs or TLRs were 
calculated on BMMϕs after treatment for 30min with 0-3hRP (50µg/ml) or LPS 
(1ng/ml) using the un-stimulated BMMϕs as a reference, and the average Ct 
value of 5 HKG (Hprt, Gapdh, Gusb, Actb and Hsp90ab1) to normalize. Fold 
changes for up-regulated transcripts (A) or down-regulated transcripts (B) 
according to 0-3hRP stimulation, are presented. Dotted line represents the 2 
fold change threshold. 
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Figure 3.11 Gene expression differences in stimulated BMMϕs 
BMMϕs were exposed for 30min to 0-3hRP (50µg/ml) or LPS (1ng/ml). RNA 
was extracted and used in a qPCR array to find changes in expression of 161 
genes. Differences between Ct values for genes related to MAPKs or TLRs to 
Ct values for HKGs (Hprt, GAPDH, Gusb, Actb and Hsp90ab1; in red) were 
calculated (2-ΔCt) for each treatment. 2-ΔCt values for LPS and 0-3hRP are 
presented against each other for all genes. Transcripts within the dotted lines 
were not different between the two treatments. 
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Figure 3.12 Validation of transcript levels in stimulated BMMϕs 
BMMϕs were exposed for 30min to 0-3hRP (50µg/ml), LPS (1ng/ml) or left un-
stimulated (Media). RNA was extracted and transcript levels of Egr1 (A) and 
Map3k7 (B) calculated using the delta delta Ct method with Media as reference 
and Gapdh as a HKG. Mean fold changes +SEM are presented from three 
technical replicates. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between the means of stimulated cells 
compared to Media (**** = p<0.0001; ns = p>0.05). The result is representative 
of three independent experiments. 
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Figure 3.13 Time course of transcription of regulated genes in BMMϕs 
treated with 0-3hRP 
BMMϕs were exposed for 10, 30 or 100min to 0-3hRP (50µg/ml) or left un-
stimulated (Media). RNA was extracted and transcript levels of Il10 (A), Il12b 
(B), Egr1 (C) and Map3k7 (D) calculated using the delta delta Ct method with 
Media as reference and Gapdh as a HKG. Means ±SEM are presented from 
three technical replicates. ANOVA and then Sidak’s multiple comparisons test 
were performed to examine differences between the means of 0-3hRP treated 
cells compared to Media at each time point (**** = p<0.0001; ns = p>0.05). The 
result is representative of three independent experiments. 
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Table 3.1 Cellular localization of protein hits (k) and percentages (out 404 
hits) 
Cellular localization 
GO term % k 
GO:0016020: membrane 71.0 287 
Plasma Membrane 
GO:0005886: plasma membrane 34.9 141 
GO:0009986: cell surface 10.4 42 
GO:0042995: cell projection 17.3 70 
Endosomes 
GO:0000323: lytic vacuole 13.9 56 
GO:0005764: lysosome 13.9 56 
GO:0031988: membrane-bounded vesicle 49.3 199 
GO:0005765: lysosomal membrane 7.2 29 
Organelles 
GO:0005739: mitochondrion 35.6 144 
GO:0005634: nucleus 25.0 101 
GO:0005783: endoplasmic reticulum 15.1 61 
GO:0005794: Golgi apparatus 9.4 38 
GO:0005829: cytosol 12.9 52 
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Table 3.2 Regulated proteins in 0-3hRP stimulated BMMϕs compared to Media 
Accession Protein Peptides Fold change 
Number of 
Peptides 
used for 
quantitation 
CV 
[%] 
Up-regulated 
MGI:98352 Sod2 Superoxide dismutase [Mn] 3 3.45 2 17.49 
MGI:98257 Msr1 macrophage scavenger receptor 1 isoform a 3 3.13 2 6.65 
MGI:1333743 Mpeg1 macrophage expressed gene 1 3 2.86 2 7.06 
MGI:1913391 Ifitm3 Interferon-inducible protein homolog 4 2.78 4 20.5 
MGI:2445284 Lrrc25 Leucine-rich repeat-containing protein 25 precursor 2 2.22 2 2.85 
MGI:88318 Cd14 Monocyte differentiation antigen CD14 precursor 9 2.17 4 16.18 
MGI:1350931 Tcirg1 T-cell, immune regulator 1 11 2.13 2 28.01 
MGI:3649467 Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) isoform 1 2 2.08 2 2.08 
MGI:97783 Psap Sulfated glycoprotein 1 precursor 9 2.08 2 1.34 
MGI:87906 Actg1 Actin, cytoplasmic 2 2 2.00 2 12.85 
MGI:106504 Efhd2 Swiprosin 1 11 1.96 4 20.95 
MGI:99523 Prdx1 Peroxiredoxin-1 14 1.92 7 13.78 
MGI:88574 Cybb Cytochrome b-245 heavy chain 5 1.85 2 15.67 
MGI:107460 Cox6b1 Cytochrome c oxidase subunit VIb isoform 1 4 1.85 2 4.19 
MGI:1312985 Tagln2 Transgelin-2 4 1.82 2 1.76 
MGI:107341 Ctss cathepsin S 8 1.82 3 24.84 
MGI:95834 Pdia3 Protein disulfide-isomerase A3 precursor 16 1.79 4 10.82 
MGI:95896 H2-Q2; H2-L; H2-Q1; H-2D cell surface glycoprotein (Fragment) 7 1.79 3 12.02 
MGI:106222 Capza2 F-actin-capping protein subunit alpha-2 10 1.72 4 9.03 
MGI:109618 Atp6v1b2 Vacuolar ATP synthase subunit B 13 1.72 6 19.73 
MGI:96749 Anpep Aminopeptidase N 18 1.72 4 18.49 
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MGI:1099832 Tln1 Talin-1 25 1.72 2 12.54 
MGI:98817 Hsp90b1 Endoplasmin precursor 9 1.69 2 3.01 
MGI:96897 Lyz2 Lysozyme C 6 1.67 2 2.52 
MGI:104808 Lcp1 Plastin-2 26 1.64 8 13.46 
MGI:97591 Pkm2 Isoform M2 of Pyruvate kinase isozymes M1/M2 10 1.64 2 8.14 
MGI:104652 Capzb Isoform 2 of F-actin-capping protein subunit beta 10 1.61 3 9.52 
MGI:894315 Rap1b Ras-related protein Rap-1b precursor 9 1.61 3 13.29 
MGI:97167 Msn Moesin 26 1.59 5 7.17 
MGI:3644836 Slc25a5 ADP/ATP translocase 2 19 1.59 3 10.36 
MGI:3648808 Eef1a1 Elongation factor 1-alpha 1 7 1.59 2 13.57 
MGI:105384 Hspa8 Heat shock cognate 71 kDa protein 14 1.59 3 8.28 
MGI:106915 Vdac2 Voltage-dependent anion-selective channel protein 2 8 1.54 3 16.01 
MGI:2138133 Lrrc59 Leucine-rich repeat-containing protein 59 5 1.52 2 9.11 
Down-regulated 
MGI:96794 Lmna Isoform A of Lamin-A/C 34 -1.56 2 11.39 
MGI:96414 Idh2 Isocitrate dehydrogenase [NADP], mitochondrial precursor 3 -1.59 2 5.96 
MGI:107899 Cd36 Platelet glycoprotein 4 9 -1.81 3 23.17 
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Table 3.3 Regulated proteins in LPS stimulated BMMϕs compared to Media 
Accession Protein Peptides Fold change 
Number of 
Peptides used for 
quantitation 
CV [%] 
Up-regulated 
MGI:98257 Msr1 macrophage scavenger receptor 1 isoform a 3 3.33 2 17.42 
MGI:1913391 Ifitm3 Interferon-inducible protein homolog 4 2.78 3 9.06 
MGI:2445284 Lrrc25 Leucine-rich repeat-containing protein 25 precursor 2 2.50 2 4.38 
MGI:88318 Cd14 Monocyte differentiation antigen CD14 precursor 9 2.13 2 3.38 
MGI:99523 Prdx1 Peroxiredoxin-1 14 2.00 5 9.69 
MGI:95896 H2-Q2; H2-L; H2-Q1; H-2D cell surface glycoprotein (Fragment) 7 1.92 3 10.08 
MGI:109618 Atp6v1b2 Vacuolar ATP synthase subunit B 13 1.56 2 21.88 
Down-regulated 
MGI:97050 Mdh2 Malate dehydrogenase 14 -1.54 3 8.55 
MGI:3651246 Hspd1 Isoform 1 of 60 kDa heat shock protein 16 -1.57 3 12.72 
MGI:96794 Lmna Isoform A of Lamin-A/C 34 -1.57 3 6.43 
MGI:99600 Aldh2 Aldehyde dehydrogenase 20 -1.58 4 8.03 
MGI:95753 Glud1 Glutamate dehydrogenase 1 12 -1.61 3 12.75 
MGI:107801 Atp5b ATP synthase subunit beta 33 -1.65 2 4.38 
MGI:1934765 Gpnmb Transmembrane glycoprotein NMB precursor 6 -1.76 2 9.34 
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Table 3.4 GO term enrichment analysis in terms of biological process 
Biological process 
0-3hRP LPS 
Up-regulated 
Term % (27*) k** Term % (7) k 
GO:0065007: biological regulation 70.4 19 GO:0065007: biological regulation 71.4 5 
GO:0050896: response to stimulus 51.9 14 GO:0050896: response to stimulus 57.1 4 
GO:0008152: metabolic process 48.1 13 GO:0002376: immune system process 57.1 4 
GO:0044237: cellular metabolic process 44.4 12 GO:0006950: response to stress 42.9 3 
GO:0071704: organic substance metabolic 
process 40.7 11 GO:0045087: innate immune response 42.9 3 
GO:0006950: response to stress 40.7 11 GO:0008152: metabolic process 28.6 2 
GO:0023051: regulation of signaling 25.9 7 GO:0002252: immune effector process 28.6 2 
GO:0002376: immune system process 25.9 7 GO:0009605: response to external stimulus 28.6 2 
GO:0045087: innate immune response 14.8 4 
 
GO:0009605: response to external stimulus 14.8 4 
GO:0043408: regulation of MAPK cascade 11.1 3 
GO:0002252: immune effector process 11.1 3 
Down-regulated 
Term % (3) k Term % (6) k 
GO:0050896: response to stimulus 100 3 GO:0008152: metabolic process 66.7 4 
GO:0006950: response to stress 100 3 GO:0071704: organic substance metabolic process 50 3 
GO:0023052: signaling 66.7 2 GO:0044237: cellular metabolic process 50 3 
GO:0007165: signal transduction 66.7 2 GO:0050896: response to stimulus 33.3 2 
 GO:0023051: regulation of signaling 33.3 2 * Number in parenthesis represents total number of hits based on which percentages are calculated. 
** k is the number of hits that associate to a category. 
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Table 3.5 Cellular localization GO term enrichment analysis 
Cellular localization 
0-3hRP LPS 
Up-regulated 
Term % (30*) k** Term % (7) k 
GO:0016020: membrane 76.7 23 GO:0005575: cellular_component 100 7 
GO:0031982: vesicle 66.7 20 GO:0016020: membrane 85.7 6 
GO:0005886: plasma membrane 43.3 13 GO:0031982: vesicle 85.7 6 
GO:0005739: mitochondrion 30.0 9 GO:0005886: plasma membrane 71.4 5 
GO:0042995: cell projection 30.0 9 GO:0005829: cytosol 42.9 3 
GO:0005829: cytosol 20.0 6 GO:0009986: cell surface 42.9 3 
GO:0009986: cell surface 20.0 6 GO:0005634: nucleus 28.6 2 
GO:0005783: endoplasmic reticulum 20.0 6 GO:0005764: lysosome 28.6 2 
GO:0005634: nucleus 16.7 5 
 GO:0005764: lysosome 16.7 5 
GO:0005794: Golgi apparatus 6.7 2 
Down-regulated 
Term % (3) k Term % (6) k 
GO:0016020: membrane 66.7 2 GO:0016020: membrane 66.7 4 
GO:0005739: mitochondrion 66.7 2 GO:0005739: mitochondrion 66.7 4 
 
GO:0031982: vesicle 66.7 4 
GO:0005886: plasma membrane 50.0 3 
* Number in parenthesis represents total number of hits based on which percentages are calculated. 
** k is the number of hits that associate to a category. 
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Table 3.6 qPCR array genes 
Genes 
Actb Col1a1 Il1b Mapk11 Pglyrp1 
Agfg1 Creb1 Il1r1 Mapk12 Ppara 
Araf Crebbp Il2 Mapk13 Ptgs2 
Atf2 Csf2 Il6 Mapk14 Rac1 
Btk Csf3 Il6ra Mapk3 Raf1 
Casp8 Cxcl10 Irak1 Mapk6 Rb1 
Ccl2 Dlk1 Irak2 Mapk7 Rel 
Ccna1 E2f1 Irf1 Mapk8 Rela 
Ccna2 Egfr Irf3 Mapk8ip1 Ripk2 
Ccnb1 Egr1 Jun Mapk8ip2 Sfn 
Ccnb2 Eif2ak2 Kcnn1 Mapk8ip3 Smad4 
Ccnd1 Elk1 Kras Mapk9 Tbk1 
Ccnd2 Ets1 Ksr1 Mapkapk2 Ticam1 
Ccnd3 Ets2 Lamtor3 Mapkapk5 Ticam2 
Ccne1 Fadd Lta Max Tirap 
Cd14 Fos Ly86 Mef2c Tlr1 
Cd80 Gapdh Ly96 Mknk1 Tlr2 
Cd86 Grb2 Map2k1 Mos Tlr3 
Cdc42 Gusb Map2k2 Muc13 Tlr4 
Cdk2 Hmgb1 Map2k3 Myc Tlr5 
Cdk4 Hprt Map2k4 Myd88 Tlr6 
Cdk6 Hras1 Map2k5 Nfatc4 Tlr7 
Cdkn1a Hsp90ab1 Map2k6 Nfkb1 Tlr8 
Cdkn1b Hspa1a Map2k7 Nfkb2 Tlr9 
Cdkn1c Hspa5 Map3k1 Nfkbia Tnf 
Cdkn2a Hspb1 Map3k2 Nfkbib Tnfaip3 
Cdkn2b Ifnb1 Map3k3 Nfkbil1 Tnfrsf1a 
Cdkn2c Ifng Map3k4 Nfrkb Tollip 
Cdkn2d Ikbkb Map3k7 Nr2c2 Tradd 
Cebpb Il10 Map4k1 Nras Traf6 
Chuk Il12a Mapk1 Pak1 Trp53 
Clec4e Il1a Mapk10 Peli1 Ube2n 
  Ube2v1 
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4 Signaling pathways in BMMϕs exposed to cercarial 
E/S products 
4.1 Introduction 
TLRs can be localized on the cell surface (e.g. TLR2 and TLR4) or in 
endosomes (e.g. TLR3, 7, 9, 10 & 11) and can form homodimers (e.g. TLR4) or 
heterodimers with more than one TLR (e.g. TLR2/1 or TLR2/6) (Akira & Takeda, 
2004; Kagan & Iwasaki, 2012) when binding to specific ligands. Upon 
dimerisation several adaptor proteins can be recruited to the intracellular 
domains of TLRs to activate multiple signaling pathways (Bonham et al, 2014). 
Most TLRs utilize MyD88 as their main adaptor molecule, however TLR4 and 
TLR3 can also use TRIF (Adachi et al, 1998; Bonham et al, 2014; Donnelly et 
al, 2010; Kagan & Iwasaki, 2012; Laird et al, 2009; Liu et al, 2012; Muzio et al, 
1997; Shi et al, 2011; Warner & Nunez, 2013; Wesche et al, 1997). Typically, a 
cascade of kinases is triggered upon TLR-ligand binding, particularly MAP3K7, 
which phosphorylates of IKKβ leading to the activation of the NF-κB system, 
which is made out of several different proteins (such as p65, p105 and its 
degradation product p50). These subunits form homodimers or heterodimers 
upon release from the NF-κB complex and direct transcription of pro-
inflammatory cytokines (such as IL-12, IL-6 and IL-1), chemokines, as well as 
other transcription factors (Adachi et al, 1998; Hinz & Scheidereit, 2014; Hoesel 
& Schmid, 2013; Iwasaki et al, 2011; Muzio et al, 1997; Oeckinghaus et al, 
2011; Ruland, 2011; van Berlo et al, 2010; Warner & Nunez, 2013; Wesche et 
al, 1997; Yu et al, 2011). 
The kinase cascades triggered by TLR binding will lead to the activation of 
several MAPKs. This family of proteins is involved in a broad range of immune 
processes, as well as in growth and development (Arthur & Ley, 2013; 
Bandyopadhyay et al, 2010; Deak et al, 1998; Farhan et al, 2010; Gehart et al, 
2010). Multiple MAPKs have more than one isoform, and it is often difficult to 
study the role, if any, of each one (Beardmore et al, 2005; Braem et al, 2011; 
Deak et al, 1998). Crosstalk between different axes of the MAPK family has 
often been reported, increasing the complexity and diversity of the system. 
MAPKs can be directly activated downstream of TLRs by MAP3K7 (which 
phosphorylates the kinases upstream of p38 and JNK) or by the NF-κB system. 
Phosphorylated p105 is degraded, releasing Tumor progression locus 2 (Tpl2) 
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or MAP3K8 to phosphorylate MEK1/2, which then phosphorylates Erk1/2 
(Arthur & Ley, 2013; Braem et al, 2011; Elcombe et al, 2013; Laird et al, 2009; 
Lawrenz et al, 2012; Mayer et al, 2013; Medina et al, 2010; Pinto et al, 2011; 
Rommel et al, 1999; Salmeron et al, 1996; Yan et al, 2010; Yang et al, 2010). 
MAPKs regulate transcription through the phosphorylation of several 
transcription factors, such as CREB, AP-1 and c-Jun (Elcombe et al, 2013; 
MacKenzie et al, 2013; Mayer et al, 2013; Strippoli et al, 2012; van Vliet et al, 
2013; Wen et al, 2010). 
The TLR system, leading to the activation of the signals described above, has 
been traditionally linked with pro-inflammatory mediators and antimicrobial 
activity. Consequently, the production of anti-inflammatory cytokines by 
macrophages, such as IL-10, which confers these cells a regulatory function, is 
poorly understood. Indeed, few studies deal with the initiators and sources of IL-
10, compared to IL-10 targets (Ambarus et al, 2012; Ananieva et al, 2008; 
Antoniv & Ivashkiv, 2011; Elcombe et al, 2013; Kamanaka et al, 2006; Kuhn et 
al, 1993; MacKenzie et al, 2013; Sabat et al, 2010; Saraiva & O'Garra, 2010; 
Wilson et al, 2011). Nonetheless, the transcription of IL-10 in macrophages has 
been shown to require CREB, c-MAF, NF-κB p50 homodimers and C/EBPβ 
(see 1.5), and some studies have found that the promoter region of the IL-10 
gene undergoes significant chromatin remodeling, particularly by 
phosphorylation of histones (Lucas et al, 2005; Saraiva et al, 2005; Zhang et al, 
2006). 
The technique of choice to study changes in chromatin and recruitment of 
transcription factors is chromatin immunoprecipitation (ChIP) (Whitfield et al, 
2012; Yip et al, 2012). Covalently linked chromatin is fractionated by sonication 
into small fragments that can be isolated using antibodies for a specific target, 
typically histone marks or a transcription factor. Precipitated fragments can then 
be sequenced or analyzed using PCR to map regions of the genome with which 
the target was interacting in the cells (Consortium et al, 2007). In this manner, 
antibodies against transcription factors can be used to demonstrate the role of 
these molecules in the initiation of the transcription of a gene, such as IL-10. 
The association between helminth products and TLRs is not unheard of 
(Correale & Farez, 2009; Donnelly et al, 2010; Everts et al, 2010; Goodridge et 
al, 2001; Kane et al, 2004; Puneet et al, 2011; van Riet et al, 2009)
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Schistosoma larval and egg antigens have been shown to interact with TLRs in 
mononuclear phagocytes (Brännström et al, 2009; Burton et al, 2010; Correale 
& Farez, 2009; Gao et al, 2012; Holmfeldt et al, 2007; Jenkins et al, 2005; Joshi 
et al, 2008; Meevissen et al, 2011; Retra et al, 2008; Zhang et al, 2011). Only a 
small fraction of those studies have sought to describe the signaling pathways 
triggered in the cells, or indeed link them to the production of specific cytokines 
(Gao et al, 2012; Meevissen et al, 2011; van Liempt et al, 2007). 
In the previous chapter, a holistic view of changes that occur in BMMϕs 
exposed to 0-3hRP was presented. A strong modulation of several genes 
associated with TLR signaling and MAPKs was discovered, both at the mRNA 
and protein level, as well as a distinct activation state, which is triggered in 
these cells. IL-10 mRNA was rapidly produced after exposure to cercarial E/S 
products and its production matched the activation of a subset of MAPKs (p38α, 
Erk2, RSK2, CREB) that peaked in activity 30min after stimulation with the 
antigen preparation. 
In the following chapter, the links between TLRs and the responses to 0-3hRP 
observed in BMMϕs will be investigated with particular attention placed on the 
production of IL-10. Ultimately, I will present a mechanism by which BMMϕs 
activate different signaling pathways leading to the production of IL-10. 
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4.2 Chapter specific material and methods 
4.2.1 MAPKs inhibitors 
MEK1/2 inhibitor U0126 and p38 inhibitor SB203580 were purchased from Cell 
Signalling Technology®. JNK inhibitor II was purchased from Calbiochem®. 
4.2.2 Chromatin Immunoprecipitation 
This protocol was adapted from the instruction manual of the Chromatin 
Immunoprecipitation Assay kit® (Merck Millipore). BMMϕs were generated as 
described in 2.3 and exposed to 50µg/ml of 0-3hRP with 2µg/ml of PMB for 
30min in 6 well plates. BMMϕs were washed twice with PBS, removed by 
scraping and then fixed in suspension with 1% formaldehyde in PBS for 10min 
at room temperature at a concentration of 1x106 cells/ml. Fixation was stopped 
with 125mM Glycine (from kit). Aliquots of 5x106 cells were used per 
immunoprecipitation (IP). Cells were lysed for 10min on ice in 600µl lysis buffer 
containing 50mM Tris-HCl pH 8.1, 10mM EDTA and 1% SDS, supplemented 
with Protease Inhibitor Cocktail® (SIGMA-ALDRICH) and Phosphatase Inhibitor 
Cocktail Set II® (Calbiochem). 
A volume of 900µl dilution buffer containing 20mM Tris-HCl, 150mM NaCl pH 
8.1, 1% Triton X-100 and 1mM EDTA was added to give a final volume of 
1.5ml. Cells were sonicated on ice using a Bioruptor plus® (Diagenode). The 
Bioruptor’s tank was cooled to 4°C before starting the first round of sonication 
and it was kept cold by replacing ice every 10min. Samples were sonicated for 
45min with the settings as 30s ON and 30s OFF at HIGH setting. 
Sonicated cellular lysate was centrifuged at 15000g for 10min at 4°C. 
Supernatants were transferred to a clean tube and an aliquot was saved as the 
input control. Supernatants were pre-cleared with 30µl of Protein A 
Agarose/Salmon sperm DNA (50% slurry) for 30min at 4 °C with agitation. 
Agarose was removed by brief centrifugation (500g 4°C 1min) and supernatants 
were incubated with the following antibodies:  
Target Clone Dilution Source  
P-CREB 87G3 1:50 Cell Signaling Technology 
CREB 48H2 1:50 Cell Signaling Technology 
RNA Pol II CTD4H8 1:1500 Merck Millipore 
CD36 JC63.1 1:1500 Cayman 
No antibody - - - 
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After overnight incubation (with gentle agitation at 4°C), 30µl of Protein A 
Agarose/Salmon sperm DNA (50% slurry) were added to the supernatant-
antibody mixture and incubated for 1 hour at 4°C with gentle agitation. The 
agarose pellet with bound DNA was recovered by gentle centrifugation (500g 
4°C 1min) and supernatants discarded. Pellets were washed with 1ml of low 
salt buffer from the kit for 5min at 4°C with agitation and the agarose pellets 
were recovered by gentle centrifugation (500g 4°C 1min). The same process 
was repeated for the high-salt buffer, then the LiCl buffer, and finally twice with 
the TE buffer, all provided by the manufacturer. 
DNA was recovered by resuspending the agarose pellet in an Elution Buffer 
containing 20mM Tris–HCl, pH 7.5, 5mM EDTA, 50mM NaCl, 1% SDS and 
50µg/ml proteinase K (Promega). Resuspended pellets were incubated for 2 
hours at 68ºC with vigorous shaking. Agarose was removed by gentle 
centrifugation (500g 4°C 1min), and supernatants transferred to a clean tube. 
DNA was extracted from supernatants (ChIP DNA) or input controls using a 
phenol-chloroform extraction protocol. Extracted DNA was dissolved in 50µl of 
PCR grade water and used for PCR. 
4.2.2.1 PCR of precipitated DNA 
ChIP DNA or input controls were tested for the presence of several regions of 
the IL-10 promoter using conventional PCR (for primer sequences see Table 
2.2). Briefly, reactions were carried out in 25uL containing 1X PCR buffer 
(Invitrogen), 4mM MgCl2 (Invitrogen), 0.2mM dNTPs (Fermentas), 0.5U Taq 
Polymerase (Invitrogen), 1µM of each Primer and 5µL of DNA. 
Thermal cycler was set for an initial step of 95°C for 3min, followed by 35 cycles 
of 95°C for 30s, 60°C for 1min and 72°C for 1min. After a final elongation step 
of 72°C for 3min, samples were analyzed on a 2% agarose gel. Gel was 
revealed using SYBR® Safe (Life technologies) and densitometry analysis was 
performed using a GelDoc® and ImageLab® by Biorad.  
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4.3 Results 
4.3.1 Dynamics of cytokine production in BMMϕs exposed to 0-3hRP 
As seen in chapter III, BMMϕs exposed to 0-3hRP tightly regulate the 
production of Il10 and Il12b mRNA levels. The dynamics of the transcription of 
those two genes were shown in 3.3.5.2, however secretion of protein has not 
been explored over a similar time course. To that end, BMMϕs were stimulated 
with 0-3hRP (50µg/ml) for different periods of time and culture supernatants 
analyzed by specific ELISAs (2.5) for these two cytokines. 
As with mRNA, IL-10 protein production first appeared at an earlier time point 
than IL-12p40 (Figure 4.1). IL-10 was initially detected after 100min of 
stimulation (Figure 4.1A), and continued to increase until 1000min (18h), 
although the rate of increase declined after 300min. On the other hand, IL-
12p40 was only detected in the culture supernatant after 300min (Figure 4.1B) 
and continued to increase. Unlike IL-10, which eventually started to decrease, 
IL-12p40 protein production continued to increase until the last time point 
measured (1000min). 
As discussed previously, rapid IL-10 production matches the activation of the 
kinases seen in 3.3.4 whilst the production of IL-12p40 is comparatively 
delayed. 
4.3.2 BMMϕs require TLRs to produce cytokines in response to 0-3hRP  
Previous studies have shown that MyD88, an adaptor protein used by several 
TLRs for signal transduction, is essential for the production of IL-6 and IL-12p40 
by peritoneal macrophages in response to 0-3hRP (Jenkins et al, 2005). TLR4 
was only partially required, the role of TLR2 was not investigated and no 
indication was given of the effect of MyD88 or TLR4 on the production of IL-10 
(Jenkins et al, 2005). 
4.3.2.1 BMMϕs from MyD88, TLR4 or TLR2 deficient mice are 
phenotypically comparable to WT BMMϕs, but respond differentially to innate 
immune ligands/stimuli. 
BMMϕs from WT or mice deficient for MyD88, TLR4 or TLR2 were made as 
described in 2.3. After 7 days in culture, cells were labeled with antibodies 
against F4/80, CD11b and a cell viability discrimination dye (see 2.4). BMMϕs 
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obtained from all strains of mice were positive for F4/80 and CD11b; 
representative flow plots of 5 independent experiments are shown in Figure 4.2, 
gated on live single cells. 
BMMϕs from all strains exposed overnight to 1ng/ml of LPS, a TLR4 ligand, 
5µg/ml of Pam3CSK4, a TLR2 ligand, or left un-stimulated (Media) were tested 
for their ability to secrete IL-12p40 overnight into the culture supernatant (see 
2.5). MyD88-/- BMMϕs did not produce IL-12p40 in response to LPS or 
Pam3CSK4  (Figure 4.3). TLR4-/- BMMϕs also did not produce IL-12p40 in 
response to LPS, although they produced equivalent levels of this cytokine as 
WT BMMϕs when exposed to Pam3CSK4. On the other hand, TLR2-/- BMMϕs 
produced as much IL-12p40 in response to LPS as WT BMMϕs, whilst these 
cells did not respond to Pam3CSK4. Levels of IL-10 in response to both stimuli in 
all four mouse-strains were below (or just above) the detection limit of the assay 
(data not shown). Combined, these results indicate that phenotypically 
comparable BMMϕs obtained from MyD88, TLR4 and TLR2 deficient mice were 
not prevented from responding to TLR ligands specific to receptors other than 
the one they lacked. Consequently, BMMϕs from these strains were used to 
assess the roles of TLR4 and TLR2, and their associated signaling pathways, in 
response to stimulation with 0-3hRP. 
4.3.2.2 MyD88, TLR4 and TLR2 are required for IL-10 and IL-12p40 
production in BMMϕs exposed to 0-3hRP 
BMMϕs from WT plus MyD88, TLR4 and TLR2 deficient mice were exposed 
overnight to 0-3hRP (50µg/ml), or left un-stimulated (Media) and the culture 
supernatants tested for the presence of IL-10 and IL-12p40 by ELISA (2.5). 
MyD88-/- BMMϕs did not produce IL-10 in response to 0-3hRP (Figure 4.4). 
These cells also did not produce IL-12p40, which demonstrates that MyD88 is 
essential for the production of these particular cytokines in response to 0-3hRP. 
In contrast, TLR4-/- BMMϕs exhibited only partially impaired production of both 
IL-10 and IL-12p40 when compared with WT cells. Similarly, TLR2-/- BMMϕs 
had impaired production of both cytokines, particularly IL-10, which was as low 
as Media in 2 of the experiments performed. 
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4.3.3 Dynamics of BMMϕ activation of several signaling molecules in 
response to 0-3hRP 
The findings described in chapter III highlighted the tight temporal regulation of 
the production of Il10 and Il12b transcripts, as well as the activation of several 
MAPKs by phosphorylation. To validate the results obtained with the Proteome 
profiler (3.3.4), a flow cytometric approach was taken for different MAPKs that 
were activated in response to 0-3hRP (2.4.2). 
4.3.3.1 Levels of phosphorylated Erk1/2 but not total Erk1/2 change in 
BMMϕs exposed to 0-3hRP 
BMMϕs exposed to 0-3hRP or left un-stimulated for 0, 10, 30 or 100min were 
labeled with antibodies against phosphorylated Erk1/2 (P-Erk), or total Erk1/2 
(tErk) and analyzed using flow cytometry. Single cells were selected based on 
size and granularity. Shifts in the MFI of the entire population (presented as 
histograms) are indicative of phosphorylation of studied proteins. 
Levels of tErk remained constant across treatments and time points (Figure 
4.5A), with no significant differences in the MFI of the population (Figure 4.5B). 
Levels of P-Erk changed dramatically in 0-3hRP stimulated macrophages after 
30min of exposure, and remained significantly elevated after 100min (Figure 
4.6A & B). The increased activation of Erk1/2 matches the dynamic of 
phosphorylation found in 3.3.4, validating those results. 
4.3.3.2 Levels of phosphorylated p38, CREB and RSK are increased in 
BMMϕs stimulated with 0-3hRP 
Having validated the activation of Erk1/2 in 3.3.4, the same was performed for 
other identified MAPKs and so BMMϕs stimulated with 0-3hRP, were labeled 
with antibodies against phosphorylated p38 (P-p38), CREB (P-CREB), RSK (P-
RSK) and Akt (P-Akt) and analyzed as above using flow cytometry. 
p38 and CREB were highly phosphorylated in BMMϕs exposed to 0-3hRP 
compared to Media. Both MAPKs were active after 10min, peaked by 30min 
and then decreased after 100min (but remained significantly higher than Media) 
(Figure 4.7 & Figure 4.8A, B). The phosphorylation of RSK was modest (Figure 
4.7), but its dynamic matches that of other measured kinases (Figure 4.8C). 
BMMϕs exposed to 0-3hRP only had significantly higher levels of P-RSK after 
30min, and then dropped below Media levels after 100min. Phosphorylation of 
 103 
Akt was slight and did not follow a dynamic like the others proteins tested 
(Figure 4.7 & Figure 4.8D), confirming earlier results determined by Proteome 
profiler (3.3.4). Combined these data reveal that Erk1/2, p38, CREB and 
RSK1/2, but not Akt, have similar patterns of dynamic regulation in BMMϕs 
shortly after exposure to 0-3hRP, hinting at a common signaling pathway. 
4.3.3.3 BMMϕs require MyD88, TLR4 and TLR2 to phosphorylate MAPKs 
in response to 0-3hRP 
BMMϕs from WT plus MyD88, TLR4 and TLR2 deficient mice were exposed for 
30min to 0-3hRP were labeled with antibodies against phosphorylated Erk1/2, 
p38 and CREB for analysis with flow cytometry.  
Levels of P-Erk in MyD88-/- BMMϕs stimulated with 0-3hRP were no different 
from Media, and were significantly lower than WT BMMϕs stimulated with 0-
3hRP (Figure 4.9A & B). Similarly, TLR4 deficient and TLR2 deficient BMMϕs 
had significantly lower levels of P-Erk compared to WT BMMϕs (p<0.01-0.001). 
Levels of total Erk1/2, or other proteins measured in the present study, have not 
been reported to differ between TLR or MyD88 deficient strains compared to 
WT. tErk was compared between WT, TLR4 and MyD88 deficient mice on one 
occasion in the course of this work and no differences were detected (data not 
shown). Levels of both P-p38 (Figure 4.10) and P-CREB (Figure 4.11) were not 
increased in MyD88-/- BMMϕs in response to 0-3hRP, whilst in TLR4-/- and 
TLR2-/- BMMϕs both proteins were greatly impaired compared to WT cells. 
Thus, BMMϕs phosphorylate Erk1/2, p38 and CREB in response to 0-3hPR 
with the peak of activation at 30min, by using TLR2 and TLR4, in a MyD88 
dependent manner. 
4.3.4 Hierarchy of signaling pathways in BMMϕs exposed to 0-3hRP 
4.3.4.1 Phosphorylation of Erk1/2 in BMMϕs exposed to 0-3hRP depends 
on NF-κB activation and Tpl2 release 
Erk1/2 phosphorylation downstream of TLRs occurs when p105 is 
phosphorylated by IKKβ. Phosphorylated p105 (P-p105) is degraded, releasing 
Tpl2 to phosphorylate MEK1/2, which then phosphorylates Erk1/2 (see 4.1). 
Flow cytometric analysis of 0-3hRP treated BMMϕs revealed that they 
phosphorylated p105 with a similar dynamic as other kinases measured (Figure 
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4.12). Peak levels of P-p105 occurred after 30min of exposure to 0-3hRP 
although they were also significantly elevated at 10 and 100min (Figure 4.12A & 
B; p<0.0001). 
As p105 is being phosphorylated, it is possible that Tpl2 may be responsible for 
the phosphorylation of Erk1/2 in BMMϕs exposed to 0-3hRP. WT and Tpl2-/- 
BMMϕs prepared as before (see 2.3) were determined to exhibit comparable 
expression of F4/80 and CD11b (Figure 4.13). Levels of P-Erk were significantly 
reduced in Tpl2-/- BMMϕs in response to 0-3hRP compared to WT BMMϕs 
(Figure 4.14 A & B, p<0.0001). Indeed, in Tpl2-/- BMMϕs there was no 
difference in the levels of P-Erk in response to 0-3hRP compared to Media. 
Levels of P-CREB were also significantly reduced in Tpl2-/- BMMϕs exposed to 
0-3hRP compared to WT BMMϕs (Figure 4.14 C & D, p<0.0001).  
These findings complement the information already gathered. BMMϕs 
phosphorylate MAPKs in response to 0-3hRP by using TLR2 plus TLR4 and 
recruiting MyD88, which triggers the activation of NF-κB (p105) and p38. The 
phosphorylation of p105, releases Tpl2 that then phosphorylates MEK1/2, 
which phosphorylates Erk1/2. CREB is partially activated by the Erk1/2 
pathway. 
4.3.4.2 Chemical inhibition of Erk1/2 and p38 pathways reduces the 
phosphorylation of CREB and RSK 
To further elucidate the contribution of p38 and Erk1/2 to the activation of RSK 
and CREB, chemical inhibition of both pathways was used. BMMϕs were pre-
treated for 2 hours with a MEK1/2 inhibitor (U0126 at 10µM) or a p38 inhibitor 
(SB203580 at 1µM) and then exposed for 30min to 0-3hRP, or left un-
stimulated. Concentrations of inhibitors used were in line with manufacturer’s 
recommendations. BMMϕs were then labeled with antibodies for P-Erk, P-p38, 
P-CREB or P-RSK as above. 
MEK1/2 inhibition of Erk1/2 phosphorylation effectively abrogated the levels of 
P-Erk in 0-3hRP treated BMMϕs (Figure 4.15 A), whereas inhibition of p38 had 
no effect on the levels of P-Erk, which is to be expected as p38 is not upstream 
of Erk1/2. Phosphorylation of p38 (Figure 4.15B) was largely unaffected by both 
inhibitors. SB203580 prevents p38 from phosphorylating its targets, but does 
not prevent p38 itself from being phosphorylated (Kumar et al, 1999). MEK1/2 
 105 
inhibition with U0126 did not affect levels of P-p38, in agreement with Erk1/2 
not being upstream of p38 and that the inhibitor does not have off target effects 
on this protein. 
Phosphorylation of RSK was greatly affected by inhibition of MEK1/2 but not 
p38 (Figure 4.15C). MEK1/2 inhibition significantly reduced the levels of P-RSK 
in response to 0-3hRP (p<0.0001). Consequently, RSK is downstream of 
Erk1/2. Both MEK1/2 and p38 inhibition had significant, and comparable, effects 
on the levels of phosphorylated CREB (Figure 4.15D, p<0.05). Both inhibitors 
reduced the levels of P-CREB by half, indicating that this transcription factor is 
downstream from both pathways. 
4.3.4.3 Other components of NF-κB are activated by 0-3hRP in BMMϕs 
In 4.3.4.1, phosphorylation of p105, a component of NF-κB, was reported. This 
suggests that additional proteins of this complex are likely to be activated in 
response to 0-3hRP. To test this, BMMϕs were exposed to 0-3hRP and then 
labeled with antibodies for phosphorylated p65 (P-p65). In some experiments, 
BMMϕs were pre-treated for 2 hours with the MEK1/2 inhibitor U0126 (10µM) or 
the p38 inhibitor SB203580 (1µM) before being exposed for 30min to 0-3hRP. 
Like P-p105 (Figure 4.12), p65 becomes phosphorylated in BMMϕs after 
exposure to 0-3hRP by 30min (Figure 4.16A&B, p<0.0001). However, unlike P-
p105, the levels of P-p65 remain significantly elevated even after 100min 
(Figure 4.16B, P<0.0001). Neither MEK1/2 or p38 inhibition diminished 
phosphorylation of p65, indicating that p65 is not downstream of either of those 
pathways (Figure 4.16). With MEK1/2 inhibition, there was a slight, yet 
significant (p<0.01), increase in the MFI of P-p65 in 0-3hRP-stimulated BMMϕs 
compared to untreated controls (Figure 4.16B), however this is unlikely to be 
biologically relevant, as it is minimal compared to differences in MFI as a result 
of stimulating cells with 0-3hRP or Media controls. 
4.3.5 Signaling pathways modulate the production of cytokines in 
BMMϕs exposed to 0-3hRP 
Findings in the previous section demonstrated that 0-3hRP binds TLR2 and 
TLR4 in BMMϕs, which results in the recruitment of MyD88 and subsequent 
activation of NF-κB and MAPKs (Diagram 4.1). Three distinct signaling 
cascades have been identified.  
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First (Diagram 4.1, 1.), at least two components of the NF-κB system are 
activated. Phosphorylation of p65 is quick and sustained, whereas 
phosphorylation of p105 is transient. Second (Diagram 4.1, 2.), phosphorylation 
of p105 results in the release Tpl2, which triggers MEK1/2, which activates 
Erk1/2, which phosphorylates RSK. Third (Diagram 4.1, 3.), p38 is activated, 
most likely by MAP3K7, which is upstream from NF-κB as well. Finally both the 
Tpl2-MEK-Erk-RSK axis and the p38 axis result in the phosphorylation of 
CREB. Some of these associations had already been made with other ligands, 
as discussed in Diagram 3.1, but they had not all been integrated into the same 
pathway, with a common activator and in response to a helminth antigen. 
Diagram 4.1 Signaling pathways in BMMϕs exposed to 0-3hRP 
 
4.3.5.1 Chemical inhibition of signaling pathways results in modulation of 
cytokine responses 
In 4.3.2.2, TLR signaling was linked with the production of cytokines in 
response to 0-3hRP, however the activation of MAPKs has not been directly 
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associated with cytokine production. Consequently, BMMϕs were pre-treated 
for 2 hours with increasing doses of the MEK1/2 inhibitor U0126, the p38 
inhibitor SB203580, and a JNK inhibitor (JNK inhibitor II). BMMϕs were then 
exposed overnight to 0-3hRP, or left un-stimulated (Media) and their culture 
supernatants tested for IL-10 and IL-12p40 by ELISA. 
MEK1/2 inhibition resulted in a significant decrease in the production of IL-10 by 
BMMϕs exposed to 0-3hRP (Figure 4.17A). As the dose of the inhibitor 
increased, the production of this cytokine was further reduced. Conversely, IL-
12p40 production increased significantly as the dose of the inhibitor increased. 
Inhibition of p38 had a strikingly similar effect on cytokine production (Figure 
4.17B). As the dose of inhibitor administered increased, IL-10 was reduced 
whilst IL-12p40 was increased. The effects of this inhibitor were more potent, 
likely due to its modest effect on Erk1/2 (see 4.3.4.2). 
JNK inhibition did not have a significant effect on the production of either 
cytokine in BMMϕs exposed to 0-3hRP (Figure 4.17C). The observed 
reductions were minimal and not a function of the inhibitor dose. Results 
obtained with the proteome profiler showed that JNK2 was activated in 
response to 0-3hRP (see 3.3.4.3), however, its inhibition did not have a decisive 
effect on IL-10 and IL-12p40 production. No positive control for JNK inhibition 
was included in the experiments, but doses used were in line with instructions 
by manufacturers. 
In summary, the phosphorylation of Erk1/2 and p38, and importantly, their 
downstream targets, primarily CREB, lead to the production of IL-10 and limit 
the induction of IL-12p40. 
4.3.5.2 Abrogation of Erk1/2 phosphorylation in Tpl2-/- BMMϕs in 
response to 0-3hRP modulates the production of IL-10 and Il-12p40 
BMMϕs exposed to 0-3hRP require Tpl2 to phosphorylate Erk1/2 (see 4.3.4.1). 
Therefore, in light of the results outlined above, Tpl2-/- BMMϕs exposed to 0-
3hRP should have reduced production of IL-10 and increased production of IL-
12p40 compared to WT BMMϕs. As expected, Tpl2-/- BMMϕs significantly 
reduced the levels of IL-10 produced in response to 0-3hRP (Figure 4.18A), 
albeit this reduction was very modest. Conversely, IL-12p40 was dramatically 
increased in Tpl2-/- BMMϕs (Figure 4.18B). Both observations confirm the 
 108 
results obtained with chemical inhibition (4.3.4.1). Moreover, the slight decrease 
in IL-10, matches the phosphorylation of CREB in Tpl2-/- BMMϕs exposed to 0-
3hRP, that was also only modestly reduced compared to WT BMMϕs (Figure 
4.14D). 
4.3.5.3 MAPK signaling in BMMϕs limits IL-12p40 production 
independently of IL-10 
Preventing the phosphorylation of Erk1/2 and p38 through chemical inhibition or 
by using genetically modified mice, results in a significant increase in the 
production of IL-12p40 (Figure 4.17). This increase was accompanied by a 
reduction in IL-10, raising the possibility that its reduction causes the increase 
of pro-inflammatory IL-12p40. An alternative explanation is that MAPKs directly 
limit the production of IL-12p40 by negatively regulating its transcription. 
Consequently, BMMϕs were derived from IL-10 deficient mice (see 2.3). As with 
other protein deficient strains, IL-10-/- BMMϕs were comparable to WT BMMϕs 
with regards to F/4/80 and CD11b percentages of positive cells (Figure 4.19). 
Subsequently, IL-10-/- BMMϕs were pre-treated for 2 hours with the MEK1/2 
inhibitor U0126 or the p38 inhibitor SB203580 and then exposed overnight to 0-
3hRP. IL-10-/- BMMϕs exposed to 0-3hRP produced significantly higher levels of 
IL-12p40 compared to WT BMMϕs (Figure 4.20), however, MEK1/2 inhibition 
also resulted in a significant increase in the production of IL-12p40 in both 
strains of mice (Figure 4.20A). Similarly, p38 inhibition significantly increased 
the production of IL-12p40 in both WT and IL-10-/- BMMϕs (Figure 4.20B).  
As IL-12p40 production increased as a result of the inhibition of MEK1/2 and 
p38 in the absence of IL-10, it follows that both signaling pathways are limiting 
the production of IL-12p40 in an IL-10 independent manner, potentially by 
preventing Il12b transcription. Therefore, mRNA was extracted from both WT 
and IL-10-/- BMMϕs and transcript levels of IL10 and IL12b measured (see in 
3.3.5.2). After 100min of stimulation, which is the earliest time point when both 
transcripts are abundant (see Figure 3.13), and levels of IL-10 protein are still 
low (see 4.3.1), both MEK1/2 and p38 inhibition significantly reduced IL-10 
mRNA in BMMϕs exposed to 0-3hRP (Figure 4.21A). Importantly, the use of 
both inhibitors also significantly increased the levels of IL-12p40 mRNA (Figure 
4.21B). In summary, TLR mediated activation of MAPKs in BMMϕs exposed to 
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0-3hRP limits the amount of IL-12p40 produced by these cells independently of 
IL-10. 
4.3.6 CREB is recruited to the IL-10 promoter to induce the activation of 
its transcription in BMMϕs exposed to 0-3hRP 
Evidence presented thus far shows that BMMϕs use TLR2 and TLR4 to 
recognize 0-3hRP, leading to MyD88 mediated activation of two axes of MAPKs 
signaling that converge in the phosphorylation of CREB. Therefore, it is 
possible that CREB, which is a transcription factor, is recruited to the IL-10 
promoter where it participates in the initiation of IL-10 mRNA synthesis. 
In order to investigate this hypothesis, BMMϕs stimulated with 0-3hRP for 
30min were processed for ChIP as described in 4.2.2. Fragment size of 
sonicated chromatin was estimated to be ~200bp using agarose gel 
electrophoresis (Figure 4.22), which is the recommended size for ChIP (Landt 
et al, 2012). After an aliquot of sonicated chromatin was saved as input DNA 
control, ChIP was carried out with antibodies against phosphorylated CREB (α-
P-CREB) and total CREB (α-CREB). Antibodies against RNA Polymerase II (α-
Pol II) were used as positive controls, given that the IL-10 gene is 
transcriptionally active after 30min of stimulation with 0-3hRP. Antibodies 
against a non-nuclear protein (CD36) were used as a negative control (α-CD36) 
alongside a no antibody control (No Ab). 
Precipitated DNA and input DNA were used for PCR with 4 sets of primers 
mapping the IL-10 promoter region (for sequences see Table 2.2) and 
densitometry analysis performed as described in 4.2.2.1. Designed primers 
provided coverage of 1000bp of the IL-10 promoter (Figure 4.23A). In the 
schematic diagram, genomic DNA (black) is divided into 4 regions by each 
primer set (red dashed boxes). The portion of Il10 covered includes the start of 
transcription (0bp, RNA in green) and translation (+64bp, protein in blue). Of the 
four fragments analyzed, only the 4th region was detected by PCR (Figure 
4.23B, red arrows). This was the case for chromatin precipitated with both α-P-
CREB and α-CREB, indicating that a regulatory element for CREB is likely to be 
in that region of the gene, and not elsewhere. Densitometry analysis of PCR 
results confirmed the initial observations, with enrichment only apparent in the 
4th region investigated (Figure 4.23C). Although the experiment was performed 
in 4 separate occasions with similar results, densitometry measures were not 
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combined due to differences in background levels and exposure times. 
Chromatin precipitated with α-Pol II only produced a strong signal with the 4th 
set of primers (Figure 4.23D), just as with α-P-CREB and α-CREB. Negative 
controls (i.e. α-CD36 and No Ab) were negative for all the primer pairs. 
It is therefore concluded that phosphorylated CREB is recruited to the IL-10 
promoter in BMMϕs after 30min of exposure to 0-3hRP, where it is likely to 
modulate the transcription of this cytokine. 
 111 
4.4 Discussion 
4.4.1 BMMϕs carefully orchestrate the production of IL-10 and IL-12p40 
in response to 0-3hPR 
The results presented in this chapter highlight the very detailed control 
macrophages stimulated with S. mansoni cercarial E/S products have over the 
production of IL-10 and IL-12p40. Rather than producing both cytokines shortly 
after encountering the stimulus, BMMϕs stagger their synthesis, initially 
producing anti-inflammatory IL-10 prior to the production of IL-12p40. The 
production of IL-10 peaks and then starts to decrease even when IL-12p40 
continues to rise. This difference in dynamics of cytokine production is likely to 
be the cause of the regulation of the signaling pathway described in this 
chapter. IL-10 is triggered earlier by MAPKs that at the same time limit the 
activation of IL-12p40. Moreover, different components of 0-3hRP might be 
responsible for the induction of different cytokines. IL-10 production significantly 
affects the course of S. mansoni infection, preventing resistance to this parasite 
from being established (Wilson et al, 2011). The fact that BMMϕs first response 
to cercarial E/S products is to produce IL-10, hints at the importance innate cells 
might have in conditioning the immune response to S. mansoni very early on. 
Cercarial invasion of the skin, and the subsequent release of E/S products, 
occurs within hours of the start of infection (Paveley et al, 2009). Therefore, no 
T cell-derived signals would reach macrophages exposed to 0-3hRP in the skin 
at these early time points. Nevertheless, macrophages must respond to 
cercarial E/S products as soon as they encounter them. These studies have 
shown that BMMϕs directly recognize 0-3hRP using TLRs. Despite their 
accepted association with pro-inflammatory cytokines, the TLR family of 
receptors, which includes TLR2 and TLR4, appears responsible for the 
production of IL-10 in a MyD88 dependent manner. Other studies show that 
TLR2 can have a more regulatory role than TLR4, by limiting the ability of 
antigen presenting cells to induce a Th1 response (Agrawal et al, 2003; Gao et 
al, 2012; van Riet et al, 2009), blocking the production of pro-inflammatory 
cytokines (Correale & Farez, 2009), regulating susceptibility to bacterial 
infection (Blanchet et al, 2014) or promoting the production of IL-10 (van Vliet et 
al, 2013). Indeed, TLR2 deficiency in BMMϕs exposed to 0-3hRP resulted in a 
more pronounced defect in the induction of IL-10, compared to TLR4 deficient 
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cells. Conversely, the absence of TLR2 had a relatively small effect on IL-
12p40, unlike TLR4, which greatly reduced the production of this cytokine in 
response to 0-3hRP. 
Thus, TLR2 mediated IL-10 production by macrophages exposed to S. mansoni 
cercarial secretions, would give macrophages a regulatory phenotype, and limit 
their ability to contribute to the induction of Th1 responses. 
4.4.2 BMMϕs use MAPKs downstream of TLRs to produce IL-10 in 
response to 0-3hPR 
Unlike semi-quantitative methods to measure phosphorylation (i.e. Western 
blotting) that require normalization based on total protein vs. phosphorylated 
protein and constitutively expressed genes (i.e. GAPDH, α-tubulin), flow 
cytometry measures directly the amount of phosphorylated protein in individual 
cells (as fluorescence intensity). Consequently, comparisons can be made 
between treatments for homogenous populations of cells in the absence of the 
mentioned normalizers. This is apparent from the results obtained in this 
chapter where the constant levels of tErk as measured by flow cytometry, albeit 
informative, bare no significance in the analysis made on the changing levels of 
P-Erk. 
As macrophages rely heavily on the TLR system to produce cytokines, it follows 
that the activation of MAPKs and NF-κB would be timed to match the dynamic 
of cytokine production. In fact, p105, Erk1/2, RSK, p38, and CREB have 
maximal activity after 30min of stimulation with cercarial E/S products. This 
activation depended directly on MyD88 and was strongly impacted by the 
absence of TLR2, whose function was complemented by TLR4. The 
phosphorylation of p105, which occurred after 30min of exposure to 0-3hRP, 
results in its degradation into p50, releasing Tpl2 from an inactive cytoplasmic 
complex. p65 also became phosphorylated after 30min of stimulation. Released 
p50 and activated p65 are then free to form a heterodimer. The p50/p65 
complex is a well-known transcription factor and among its prime targets are 
pro-inflammatory cytokines such as IL-1 and IL-6 (Hoesel & Schmid, 2013), and 
as both cytokines, along other pro-inflammatory mediators, were induced at the 
transcript level by 0-3hRP, it is possible to assume that the p50/p65 dimer is 
actively directing the transcription of this genes in 0-3hRP treated BMMϕs. 
However, the release of Tpl2 results in the activation of MEK1/2 and 
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subsequent phosphorylation of Erk1/2. In BMMϕs exposed to cercarial E/S 
products, these events led to the activation of RSK and CREB. The association 
between Erk1/2 and CREB has been reported in the past with other innate 
immune stimuli, such as Zymosan or Leishmania parasites, and receptors 
including TLRs (Elcombe et al, 2013; Nandan et al, 2012; Nandan & Reiner, 
2005; van Vliet et al, 2013), however, it has not been reported in the context of 
helminth antigens. 
In the present studies inhibition of MEK1/2 and p38, and their downstream 
targets, resulted in a significant impairment of the production of IL-10, proving 
the close link between these signals and the transcription and translation of this 
regulatory cytokine. This association has been made by others (Arthur & Ley, 
2013; Elcombe et al, 2013; Lucas et al, 2005; Mayer et al, 2013; van Vliet et al, 
2013; Zhang et al, 2006), but not in the context of a helminth antigen, and only 
rarely as a result of TLR signaling. However, these MAPKs are also acting to 
limit the production of IL-12p40 in an IL-10 independent manner. In particular, 
p38 is well known for causing increased IL-12 p40 secretion in the absence of 
IL-10 (Deak et al, 1998; Elcombe et al, 2013; Mayer et al, 2013). The disruption 
of Erk1/2 activation in Tpl2 deficient macrophages had a similar effect, and the 
use of other MEK1/2 inhibitors (PD98059, AZ6244) also impaired IL-10 
production, whilst enhancing IL-12p40 (data not shown). 
4.4.3 Phosphorylated CREB is recruited to the IL-10 promoter to 
modulate its transcription in BMMϕs exposed to 0-3hRP 
The Tpl2-MEK-Erk-RSK and p38 axes converge on the activation of CREB in 
BMMϕs exposed to 0-3hRP. This convergence and the strong association 
between these pathways and the production of IL-10, led to the assumption that 
CREB facilitated the transcription of IL-10. Here it is shown that in BMMϕs 
exposed to cercarial E/S products, phosphorylated CREB is recruited to the IL-
10 promoter in a region that overlaps with the first exon of the gene, which is 
different from what was reported in the past (Ananieva et al, 2008). This 
recruitment is apparent after 30 minutes of stimulation with the parasite’s 
secretions, at which point there is a peak in the activation of CREB. Both the 
abundant levels of phosphorylated CREB and its strong interaction with the IL-
10 promoter, place this transcription factor in a privileged place to effectively 
regulate the transcription of this cytokine. 
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Several other studies have linked CREB and IL-10 (Elcombe et al, 2013; 
MacKenzie et al, 2013; Mayer et al, 2013; Nandan et al, 2012; van Vliet et al, 
2013; Wen et al, 2010) by using chemical inhibition, siRNA or genetically 
modified cells. However, only two of studies showed an interaction between 
CREB and DNA from the IL-10 gene. One in a highly artificial system (Nandan 
et al, 2012) and another in conjunction with another transcription factor 
(Ananieva et al, 2008). Others have used ChIP to investigate the changes in the 
IL-10 promoter following stimulation with different antigens, finding interactions 
with other transcription factors like NF-κB or cMAF (1.5), and have linked this 
with Erk1/2, but have confined their studies to histone modification (Lucas et al, 
2005; Zhang et al, 2006). In this study a novel regulatory element has been 
found in the IL-10 promoter, where CREB binds as a result of TLR stimulation in 
a process that enhances transcription of IL-10.  
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4.5 Summary 
S. mansoni cercarial E/S products bind TLR2 and TLR4 in BMMϕs, which 
results in the recruitment of MyD88 and subsequent activation of NF-κB and 
MAPKs (Diagram 4.2). Three distinct signaling cascades are triggered by these 
interactions.  
Diagram 4.2 IL-10 biogenesis in BMMϕs exposed to cercarial E/S products 
 
Firstly, at least two components of the NF-κB system are activated. 
Phosphorylation of p65 is quick and sustained, whereas phosphorylation of 
p105 is transient, peaking after 30 minutes of stimulation. As p105 is degraded 
into p50, it becomes free to form heterodimers with p65 and orchestrate the 
transcription of pro-inflammatory genes. Secondly, degradation of p105 also 
results in the release of Tpl2, which phosphorylates MEK1/2, which activates 
Erk1/2, which phosphorylates RSK. Thirdly, p38 is activated, most likely by 
MAP3K7, which is also upstream from NF-κB. Finally both the Tpl2-MEK-Erk-
RSK axis and the p38 axis result in the phosphorylation of CREB. This 
transcription factor is then able to go to nucleus, find the IL-10 promoter and 
increase the production of this cytokine. 
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Figure 4.1 Time course of cytokine production in BMMϕs exposed to 0-
3hRP 
Supernatants from BMMϕs exposed to 0-3hRP (50µg/ml) or left un-stimulated 
(Media) were tested for the presence of (A) IL-10 and (B) IL-2p40. Means 
±SEM of three technical replicates are presented. ANOVA and then Sidak’s 
multiple comparisons test were performed to examine differences between the 
means of 0-3hRP stimulated cells compared to Media at each time point (* = 
p<0.05; ** = p<0.01; *** = p<0.001; **** = p<0.0001; ns = p>0.05). Results are 
representative of three independent experiments. 
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Figure 4.2 BMMϕs deficient on MyD88, TLR4 or TLR2 are phenotypically 
similar to WT BMMϕs 
WT, MyD88-/-, TLR4-/- or TLR2-/- BMMϕs were obtained after 7 days of culture of 
bone marrow from WT or specific receptor/protein deficient mice. Differentiated 
cells were labeled with antibodies against F4/80 and CD11b. Representative 
flow plots of single live cells (based on a cell viability exclusion dye) are shown. 
Results are representative of five independent experiments. 
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Figure 4.3 BMMϕs deficient on MyD88, TLR4 or TLR2 are selectively able 
to respond to specific PAMPS 
WT, MyD88-/-, TLR4-/- or TLR2-/- BMMϕs were obtained after 7 days of culture of 
bone marrow from WT or specific receptor/protein deficient mice. Culture 
supernatants from BMMϕs exposed overnight to LPS (1ng/ml), Pam3CSK4 
(5µg/ml) or left un-stimulated (Media) were analyzed for IL-12p40 production. 
Means +SEM of three technical replicates are presented. ANOVA and then 
Dunnett’s multiple comparisons test were performed to examine differences 
between the means of stimulated cells from all deficient strains compared to WT 
(**** = p<0.0001; ns = p>0.05). Results are representative of two independent 
experiments. 
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Figure 4.4 BMMϕs require TLRs for cytokine production in response to 0-
3hRP 
Supernatants from WT, MyD88-/-, TLR4-/- or TLR2-/- BMMϕs exposed to 0-3hRP 
(50µg/ml) or left un-stimulated (Media) were tested for the production of (A) IL-
10 and (B) IL-12p40. Limits of detection for ELISA were 32pg/ml for IL-10 and 
IL12p40. Means +SEM of three technical replicates are presented. ANOVA and 
then Dunnett’s multiple comparisons test were performed to examine 
differences between the means of stimulated protein deficient cells compared to 
stimulated WT cells (*** = p<0.001). Results are representative of three 
independent experiments. 
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Figure 4.5 Changes in levels of tErk in BMMϕs exposed to 0-3hRP 
BMMϕs exposed to 0-3hRP (50µg/ml) or left un-stimulated (Media) for 0, 10, 30 
or 100min were labeled with antibodies against total Erk1/2 (tErk). (A) 
Representative overlaid histograms of single cells are presented from Isotype 
control (dashed line), Media control (black line) or 0-3hRP treatment (red line). 
(B) Mean ±SEM of MFI for each time point are also given from three technical 
replicates. ANOVA and then Sidak’s multiple comparisons test were performed 
to examine differences between the means of 0-3hRP treated cells compared to 
Media control at each time point (ns = p>0,05). Results are representative of 
three independent experiments. 
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Figure 4.6 Changes in levels of P-Erk in BMMϕs exposed to 0-3hRP 
BMMϕs exposed to 0-3hRP (50µg/ml) or left un-stimulated (Media) for 0, 10, 30 
or 100min were labeled with antibodies against phosphorylated Erk1/2 (P-Erk). 
(A) Representative overlaid histograms of single cells are presented from Media 
control (black line) or 0-3hRP treatment (red line). (B) Mean ±SEM of MFI for 
each time point are also given from three technical replicates. ANOVA and then 
Sidak’s multiple comparisons test were performed to examine differences 
between the means of 0-3hRP treated compared to Media control at each time 
point (* = p<0.05; **** = p<0.0001; ns = p>0,05). Results are representative of 
three independent experiments. 
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Figure 4.7 BMMϕs activate p38, CREB and RSK, but not Akt, in response 
to 0-3hRP 
BMMϕs exposed to 0-3hRP (50µg/ml) or left un-stimulated (Media) for 30min 
were labeled with antibodies against phosphorylated p38, CREB, RSK and Akt. 
Representative overlaid histograms of single cells from 0-3hRP treated (red) or 
Media (black) are shown. Results are representative of three independent 
experiments. 
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Figure 4.8 Quantitation of phosphorylated p38, CREB, RSK and Akt in 
BMMϕs exposed to 0-3hRP 
BMMϕs exposed to 0-3hRP (50µg/ml) or left un-stimulated (Media) for 0, 10, 30 
or 100min were labeled with antibodies against phosphorylated (A) p38, (B) 
CREB, (C) RSK and (D) Akt. Means ±SEM of MFIs for each time point are 
presented from three technical replicates. ANOVA and then Sidak’s multiple 
comparisons test were performed to examine differences between the means of 
0-3hRP treated cells at each time point compared to Media (* = p<0.05; ** = 
p<0.01; *** = p<0.001 **** = p<0.0001; ns = p>0.05). Results are representative 
of three independent experiments. 
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Figure 4.9 Phosphorylation of Erk1/2 in response to 0-3hRP is dependent 
on TLR signaling 
WT, MyD88-/-, TLR4-/- or TLR2-/- BMMϕs exposed for 30min to 0-3hRP 
(50µg/ml) or left un-stimulated (Media) were labeled with antibodies against 
phosphorylated Erk1/2 (P-Erk). (A) Representative overlaid of histograms with 
0-3hRP treated cells (red) and Media control (black) and (B) means +SEM of 
MFIs for each mouse strain are given from 3 biological replicates. ANOVA and 
then Bonferroni’s multiple comparisons test were performed to examine 
differences between the means of stimulated protein deficient cells compared to 
WT cells (** = p<0.01; *** = p<0.001 **** = p<0.0001; ns = p>0.05). Results are 
representative of three independent experiments. 
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Figure 4.10 Phosphorylation of p38 in response to 0-3hRP is dependent 
on TLR signaling 
WT, MyD88-/-, TLR4-/- or TLR2-/- BMMϕs exposed for 30min to 0-3hRP 
(50µg/ml) or left un-stimulated (Media) were labeled with antibodies against 
phosphorylated p38 (P-p38). (A) Representative overlaid of histograms with 0-
3hRP treated cells (red) and Media control (black) and (B) means +SEM of 
MFIs for each mouse strain are given from 3 biological replicates. ANOVA and 
then Bonferroni’s multiple comparisons test were performed to examine 
differences between the means of stimulated protein deficient cells compared to 
WT cells (*** = p<0.001 **** = p<0.0001; ns = p>0.05). Results are 
representative of three independent experiments. 
P-p38
0-3hRP Media
0
10
20
30
40
p3
8 
ph
os
ph
or
yl
at
io
n 
(M
FI
)
WT
MyD88-/-
TLR4-/-
TLR2-/-
***
****
****
A
B
TLR4-/- WT TLR2-/- MyD88-/- 
P-p38 Media&
0(3hRP&
 126 
 
Figure 4.11 Phosphorylation of CREB in response to 0-3hRP is dependent 
on TLR signaling 
WT, MyD88-/-, TLR4-/- or TLR2-/- BMMϕs exposed for 30min to 0-3hRP 
(50µg/ml) or left un-stimulated (Media) were labeled with antibodies against 
phosphorylated CREB (P-CREB). (A) Representative overlaid histograms with 
0-3hRP treated cells (red) and Media control (black) and (B) means +SEM of 
MFIs for each mouse strain are given from 3 biological replicates. ANOVA and 
then Bonferroni’s multiple comparisons test were performed to examine 
differences between the means of stimulated protein deficient cells compared to 
WT cells (*** = p<0.001 **** = p<0.0001; ns = p>0.05). Results are 
representative of three independent experiments. 
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Figure 4.12 NF-κB (p105) is activated in BMMϕs exposed to 0-3hRP 
BMMϕs exposed to 0-3hRP (50µg/ml) or left un-stimulated (Media) for 0, 10, 30 
or 100min were labeled with antibodies against phosphorylated p105 (P-p105). 
(A) Representative overlaid histograms of single cells are presented from Media 
control (black line) or 0-3hRP treatment (red line) after 30min of stimulation. (B) 
Mean ±SEM of MFI for each time point are also given from three technical 
replicates. ANOVA and then Sidak’s multiple comparisons test were performed 
to examine differences between the means of 0-3hRP treated compared to 
Media control at each time point (**** = p<0.0001; ns = p>0,05). Results are 
representative of three independent experiments. 
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Figure 4.13 BMMϕs deficient for Tpl2 are similar to WT BMMϕs 
WT or Tpl2-/- BMMϕs were obtained after 7 days of culture of bone marrow from 
WT or Tpl2 deficient mice. Differentiated cells were labeled with antibodies 
against F4/80 and CD11b. Representative flow plots of single live cells (based 
on a cell viability exclusion dye) are shown. Results are representative of three 
independent experiments. 
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Figure 4.14 Phosphorylation of Erk1/2 and CREB in response to 0-3hRP is 
dependent on Tpl2 
WT or Tpl2-/- BMMϕs exposed for 30min to 0-3hRP (50µg/ml) or left un-
stimulated (Media) were labeled with antibodies against phosphorylated (A & B) 
Erk1/2 (P-Erk) and (C & D) CREB (P-CREB). Representative overlaid 
histograms with 0-3hRP treatment (red) or Media (black) (A & C) and means 
+SEM of MFIs (B & D) for each mouse strain are given from three technical 
replicates. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between the means of stimulated Tpl2 
deficient cells compared to WT cells (** = p<0.01; **** = p<0.0001). Results are 
representative of three independent experiments. 
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Figure 4.15 Chemical inhibition of MAPKs in BMMϕs exposed to 0-3hRP 
reveals pathway hierarchy 
BMMϕs pre-treated for 2 hours with a MEK1/2 inhibitor (U0126 at 10µM) or a 
p38 inhibitor (SB203580 at 1µM) were exposed to 0-3hRP (50µg/ml) or left un-
stimulated (Media) for 30min. BMMϕs were then labeled with antibodies against 
(A) P-Erk, (B) P-p38, (C) P-RSK and (D) P-CREB. Means +SEM of MFIs are 
given from three technical replicates. ANOVA and then Tukey’s multiple 
comparisons test were performed to examine differences between the means of 
inhibitor treated stimulated cells compared to control (* = p<0.05; ** = p<0.01; 
*** = p<0.001; **** = p<0.0001; ns = p>0.05). Results are representative of 
three independent experiments. 
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Figure 4.16 Activation of NF-κB (p65) in BMMϕs exposed to 0-3hRP is not 
dependent on Erk1/2 or p38 signaling 
BMMϕs were exposed to 0-3hRP (50µg/ml) or left un-stimulated (Media) for 0, 
10, 30 and 100min and labeled with antibodies against phosphorylated p65 (P-
p65). (A) Representative overlaid histogram after 30min of stimulation with 0-
3hRP (red) or Media control (black) plus (B) means ±SEM of MFIs for each time 
point are given from three technical replicates. Additionally, BMMϕs pre-treated 
for 2 hours with a MEK1/2 inhibitor (U0126 at 10µM) or a p38 inhibitor 
(SB203580 at 1µM) were exposed to 0-3hRP (50µg/ml) or left un-stimulated 
(Media) for 30min. (C) BMMϕs were then labeled with antibodies against P-
p105. Means +SEM of percentages are given from three technical replicates. 
ANOVA and then Sidak’s (B) or Dunnett’s (C) multiple comparisons test were 
performed to examine differences between the means of stimulated cells 
compared to Media control at each time point (B) or between the means of 
inhibitor treated stimulated cells compared to control cells (** = p<0.01; **** = 
p<0.0001; ns = p>0.05). Results are representative of three independent 
experiments. 
0 10 10030
15
20
25
30
35
Time (min)
p6
5 
ph
os
ph
or
yl
at
io
n 
(M
FI
) P-p65
ns
****
****
****
0-3hRP Media
B
A
P-p65 
!
Media!
0(3hRP!
Control p38 inh. MEK1/2 inh.
0
10
20
30
40
50
p6
5 
ph
os
ph
or
yl
at
io
n 
(M
FI
) P-p65
ns
**
C
Media 0-3hRP
 132 
 
Figure 4.17 Chemical inhibition of signaling pathways regulates cytokine 
production in BMMϕs exposed to 0-3hRP 
BMMϕs were pre-treated for 2 hours with increasing doses of (A) a MEK1/2 
inhibitor (U0126), (B) a p38 inhibitor (SB203580) and (C) a JNK inhibitor (JNK 
inhibitor II) in separate experiments. BMMϕs were then exposed overnight to 0-
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3hRP (50µg/ml) or left un-stimulated (Media) and culture supernatants tested 
for IL-10 and IL-12p40 by ELISA. Means ±SEM from three technical replicates 
are given. BMMϕs without pre-treatment with inhibitors are represented with 
open circles (0-3hRP) or open triangles (Media). ANOVA and then Dunnett’s 
multiple comparisons test were performed to examine differences between the 
means of inhibited BMMϕs compared to untreated control (* = p<0.05; ** = 
p<0.01; *** = p<0.001; **** = p<0.0001; ns = p>0.05). Results are 
representative of three independent experiments. 
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Figure 4.18 Tpl2 deficient BMMϕs have reduced IL-10 production and 
increased IL-12p40 production in response to 0-3hRP 
Supernatants from WT or Tpl2-/- BMMϕs exposed to 0-3hRP (50µg/ml) 
overnight or left un-stimulated (Media) were tested for the presence of (A) IL-10 
and (B) IL-12p40. Means +SEM of three technical replicates are presented. 
ANOVA and then Dunnett’s multiple comparisons test were performed to 
examine differences between the means of stimulated Tpl2 deficient cells 
compared to WT cells (* = p<0.05; *** = p<0.001). Results are representative of 
three independent experiments. 
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Figure 4.19 BMMϕs deficient for IL-10 are similar to WT BMMϕs 
WT or IL-10-/- BMMϕs were obtained after 7 days of culture of bone marrow 
from WT or IL-10 deficient mice. Differentiated cells were labeled with 
antibodies against F4/80 and CD11b. Representative flow plots of single live 
cells (based on a cell viability exclusion dye) are shown. Results are 
representative of three independent experiments. 
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Figure 4.20 Chemical inhibition of signaling pathways regulates IL-12p40 
production in IL-10-/- BMMϕs exposed to 0-3hRP 
WT and IL-10-/- BMMϕs were pre-treated for 2 hours with (A) a MEK1/2 inhibitor 
(U0126 at 10µM) or (B) a p38 inhibitor (SB203580 at 1µM). BMMϕs were then 
exposed overnight to 0-3hRP (50µg/ml) or left un-stimulated (Media) and 
culture supernatants tested for IL-12p40 by ELISA. Means +SEM from three 
technical replicates are given. ANOVA and then Dunnett’s multiple comparisons 
test were performed to examine differences between the means of inhibitor 
treated stimulated cells compared to control cells within each strain, and 
between 0-3hRP stimulated WT and IL-10 deficient cells (* = p<0.05; ** = 
p<0.01; *** = p<0.001; **** = p<0.0001). Results are representative of three 
independent experiments. 
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Figure 4.21 Chemical inhibition of signaling pathways regulates IL-10 and 
IL-12p40 mRNA in BMMϕs exposed to 0-3hRP 
BMMϕs were pre-treated for 2 hours with a MEK1/2 inhibitor (U0126 at 10µM) 
or a p38 inhibitor (SB203580 at 1µM) and then exposed to 0-3hRP (50µg/ml) or 
left un-stimulated (Media). After 100min RNA was extracted and transcript 
levels of (A) Il10 and (B) Il12b calculated using the delta delta Ct method with 
Media as reference and Gapdh as a HKG. Means +SEM are presented for 
three technical replicates. ANOVA and then Dunnett’s multiple comparisons test 
were performed to examine differences between the means of inhibitor treated 
stimulated cells compared to control cells (**** = p<0.0001). Results are 
representative of two independent experiments. 
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Figure 4.22 Fragment size of sonicated chromatin in BMMϕs 
Cross-linked chromatin from BMMϕ lysates (lanes 1 and 2) was sonicated, 
taking aliquots every 5min (lanes 3-10). After 45min (lanes 11 and 12) cross-
linking was reversed, proteins digested and DNA extracted and run on a 2% 
agarose gel.  
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Figure 4.23 Phosphorylated CREB is recruited to the promoter of IL-10 in 
BMMϕs exposed to 0-3hRP 
Sonicated chromatin from BMMϕs exposed for 30min to 0-3hRP (50µg/ml) was 
precipitated with antibodies against phosphorylated CREB (α-P-CREB), total 
CREB (α-CREB), RNA Polymerase II (α-Pol II), CD36 (α-CD36) and a no 
antibody control (No Ab). (A) Schematic of the IL-10 promoter depicting four 
regions investigated (red dashed boxes), the start of transcription (0bp, RNA in 
green) and the start of translation (+64bp, protein in blue) is given. (B) Input, α-
P-CREB and α-CREB DNA purified from precipitates was analyzed by PCR for 
of the specified regions and (C) densitometry analysis of results. (D) α-P-CREB, 
α-CREB, α-Pol II, α-CD36 and No Ab DNA purified from precipitates were also 
analyzed by PCR for of the 4th region alone. Results are representative of 4 
independent experiments. 
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5 Internalization of S. mansoni cercarial E/S products 
by BMMϕs is required for cytokine production 
5.1 Introduction 
Macrophages are phagocytic cells that constantly sample their environment by 
actively internalizing molecules and particles. That process, which is broadly 
referred to as endocytosis, is tightly regulated as it is energy costly (Watts, 
2011), and can severely impact signaling pathways (Kagan & Iwasaki, 2012; 
Shilo & Schejter, 2011). To accommodate endocytosis, and thereafter traffic of 
the endosomes to the right compartments in the cells, actin polymerization and 
Ca+ signaling are required (Huotari & Helenius, 2011; Watts, 2011). 
Macrophages employ several families of phagocytic receptors to take up 
pathogen-associated material from their surroundings (Baranova et al, 2012; 
Goodridge et al, 2011; Joshi et al, 2006; Kagan & Iwasaki, 2012), however 
some of these receptor families require opsonization of the material (with 
complement or antibodies) before they can be engaged (Joshi et al, 2006). 
Other receptor families, such as CLRs (i.e. MR) or scavenger receptors, can 
interact directly with the particles by binding to carbohydrate (Gringhuis et al, 
2007; Martinez-Pomares et al, 2001; Svajger et al, 2011) or lipid (Baranova et 
al, 2012; Oury, 2014) moieties. 
The coordinated process of endocytosis described above, involving remodeling 
of the cytoskeleton and the recruitment of several adaptor molecules, requires 
different signaling pathways (Traub, 2011; Watts, 2011). Recruitment of adaptor 
molecules in particular, is mediated by the phosphorylation of lipids on the 
membrane, making it accessible to different proteins. The PI3K family of 
kinases participate in the rearrangement of membrane structures and trafficking 
in cells by phosphorylating lipids on the cell membrane and endosomes 
(Stephens et al, 2002; Vanhaesebroeck et al, 2012). As such, this family of 
kinases contributes to triggering signaling pathways leading to phagocytosis 
and other processes. 
Moreover, a growing body of literature has considered the possibility that TLRs, 
whose function has been traditionally restricted to the cell surface (i.e. TLR2 
and TLR4), are in fact also able to direct signaling pathways from endosomal 
compartments (Aksoy et al, 2012; Bonham et al, 2014; Kagan & Iwasaki, 2012). 
 141 
Indeed, some studies reveal the intricate interplay between TLRs on the surface 
and in the endosomes in the responses to bacterial products, as TLR4 (in the 
surface) and TLR9 (in the endosome) cooperated to direct signals triggered by 
these pathogens (Wolf et al, 2011). Furthermore, helminth products can 
sequester TLR components limiting their responses to other stimuli (Pineda et 
al, 2014). 
S. mansoni cercarial E/S products have been shown to be internalized in vitro 
by bone marrow derived dendritic cells and macrophages, as well as in vivo by 
some cell populations in the skin, including F4/80+ macrophage-like cells 
(Paveley et al, 2009). The uptake of cercarial E/S products by macrophages is 
partly mediated by the MR (Paveley et al, 2011). Furthermore, the present 
study has shown that the protein levels of other phagocytic receptors, 
particularly CD36 and MSRI (see 3.3.3.3), are regulated in response to 0-3hRP. 
Thus far, this work has made no reference to the ability of BMMϕs to 
phagocytize 0-3hRP, or indeed how that process could affect the signaling 
pathways described, or whether TLR recognition of 0-3hRP occurs at the 
surface or inside the cell. In the current chapter, the impact of 0-3hRP uptake 
by BMMϕs on MAPK activation and cytokine production will be established. As 
a result, a model of S. mansoni cercarial E/S products uptake by BMMϕs and its 
links to the cytokine responses observed in macrophages will be proposed. 
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5.2 Chapter specific material and methods 
5.2.1 Fluorescent labeling of S. mansoni cercarial E/S products 
Cercarial E/S products were labeled by incubating the protein preparation for 3 
hours with Alexa Fluor® 633 (Invitrogen) at a concentration of 1µg of dye per 
100µg of 0-3hRP. Excess dye was removed by washing with PBS using a filter 
spin column with a molecular weight cut off of 5kDa at 4°C and 14000g for 1.5 
hours. Flow though was removed at frequent intervals and more PBS was 
added to the mixture. Media control was treated in the same manner (i.e. 1µg of 
dye per a medium volume equivalent to that of 100µg 0-3hRP). 
5.2.2 Uptake inhibitors 
Cytochalasin D was purchased from SIGMA-ALDRICH. PI3K family inhibitor 
LY294002 was purchased from Cell Signalling Technology® and p110-δ 
inhibitor was kindly donated by Dr Klaus Okkenhaug, University of Cambridge, 
Cambridge, UK. Cell viability was checked via trypan blue staining and/or 
fluorescent live/dead discrimination dyes (see 2.4). 
5.2.3 Confocal microscopy of BMMϕs exposed to fluorescently labeled 
cercarial E/S products 
BMMϕs were obtained as described before (see 2.3) and allowed to adhere to 
glass cover slips for two hours in 24 well plates (1x106 cells/well). BMMϕs were 
exposed to labeled 0-3hRP (50µg/ml) for 100min and then washed twice with 
PBS. Cells were fixed on to cover slips for 20min with 4% PFA in PBS at room 
temperature, and then placed in 0.05% saponin 0.2% BSA (staining buffer) for 
30min at room temperature. 
Cover slips were incubated for 1 hour at room temperature with polyclonal 
rabbit antibody against EEA-1 (1:200, Abcam) in staining buffer. Cover slips 
were washed 3 times with staining buffer (5 min each) and then incubated for 1 
hour with goat anti-rabbit Alexa Fluor® 547 (1:1000, Life Technologies) in 
staining buffer. Finally, cover slips were washed twice (5 min each) in staining 
buffer, adding DAPI (2µg/ml) (SIGMA) in the second washing step, and then 
rinsed with deionized water. Cover slips were mounted on glass slides using 
Prolong® Gold (Life Technologies) and sealed with nail varnish. Images were 
acquired using a Zeiss LSM 710 invert microscope using ZEN microscope 
software. 
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5.3 Results 
5.3.1 BMMϕs internalize 0-3hRP  
To test the ability of macrophages to internalize 0-3hRP, the preparation was 
linked to AF633 as described (5.2.1) and BMMϕs exposed to the labeled 
material for different periods of time in 96 well plates. 
5.3.1.1 0-3hRP is internalized by BMMϕs via endocytosis in an actin 
dependent manner. 
Flow cytometric analysis of stimulated BMMϕs revealed a rapid increase in the 
fluorescence of the cells, indicative of the amount of fluorescently labeled 0-
3hRP bound to, or internalized, by them (Figure 5.1A). Thus, After 30min 
exposure to the preparation, more than a third of the cells (~34%) were positive 
for labeled 0-3hRP, which was significantly higher than media control (~0.04%, 
Figure 5.1A, p<0.0001, significance in purple). Positive cells for labeled 0-3hRP 
could be quantified as a percentage within the positive gate based on Media 
(Figure 5.1B), or as an increase on MFI of the whole population (Figure 5.1C), 
which indicates the amount of labeled 0-3hRP bound, or internalized, by the 
cells. For both indicators, uptake of the labeled preparation was significant at all 
time points measured (Figure 5.1B & C, p<0.05-0.0001, significance in purple). 
To examine if BMMϕs were interacting with 0-3hRP on their surface through a 
receptor or if the parasite material was indeed internalized, microscopy of 
BMMϕs exposed to labeled 0-3hRP was employed. Confocal microscopy of 
BMMϕs after 60min exposure to labeled 0-3hRP (Figure 5.1D) confirmed 
internalization of 0-3hRP as it was contained in discreet compartments (Figure 
5.1D, red punctae) within the cell and not on the outer plasma membrane. This 
was further confirmed by z-stack imaging of cells, with 0-3hRP containing 
vesicles seen at the level of the nucleus of the cell (data not shown). Moreover, 
plasma membrane staining is not seen as punctae, but rather as elongated 
arcs. Similar, patterns of internalization were observed at 30min, although the 
amounts detected were less abundant (data not shown). At least a portion of 0-
3hRP remained in early endosomes, as evidenced by co-localization with EEA-
1 (Figure 5.1D, white arrow) further confirming that 0-3hRP is taken up by 
BMMϕs via endocytosis. 
 144 
Treatment with Cytochalasin D (CytD), an actin polymerization inhibitor, 
revealed that the process of 0-3hRP uptake required actin remodeling. This 
inhibitor prevented 0-3hRP uptake from as early as 10min after exposure to the 
secretions (Figure 5.1C, p<0.05, significance in black), but also at all other time 
points measured (Figure 5.1A, B & C, p<0.001-0.0001, significance in black). 
Media control with CytD-treated BMMϕs was not different from Media control in 
un-treated cells (data not shown). As stated above, differences in percentages 
(Figure 5.1B) or MFI (Figure 5.1C) quantify different aspects of the uptake. As a 
percentage, a significant proportion of CytD-treated BMMϕs internalized labeled 
0-3hRP after 300min (Figure 5.1B, ~80%), however, the amount of labeled 
material contained in these BMMϕs was reduced more than ten-fold compared 
to un-treated cells (Figure 5.1C, MFI of 450 vs. 40 in the absence vs. presence 
of CytD respectively). 
5.3.1.2 0-3hRP uptake by BMMϕs depends partly on PI3K signaling 
Kinases of the PI3K family are well known mediators of trafficking and 
endocytosis. Treatment of BMMϕs with PI3K family inhibitor LY294002 (25µM) 
was enough to significantly limit the uptake of labeled 0-3hRP at 30 min (Figure 
5.2A). The percentage of 0-3hRP positive cells was significantly lower at 30 and 
100min (Figure 5.2B, p<0.0001, significance in black), although not at 300min 
(p>0.05, significance in black). LY294002 only treatment was not different from 
Media control (data not shown). The MFI of the cell population incubated with 
labeled 0-3hRP plus LY294002 inhibitor was reduced at 30min (36 in untreated 
controls vs. 28 in treated cells) but not significantly. However, the MFI of treated 
BMMϕs greatly reduced at 100min, but also at 300min (Figure 5.2C, p<0.0001, 
significance in black), indicating that even if all cells contained some 0-3hRP, as 
evidenced by the percentage of positive cells, the amount of material taken up 
in the presence of inhibitor was still significantly reduced compared to un-
inhibited BMMϕs (~2-fold reduction). 
5.3.2 MAPK activation in BMMϕs exposed to 0-3hRP is partly dependent 
on internalization 
As reported in chapter IV, BMMϕs employ TLR2 and TLR4 to activate MAPKs 
in response to 0-3hR, however, as discussed in the introduction to this chapter, 
TLR signaling can originate from activation of receptors on the cell surface, or 
from within endosomes. By using CytD to limit the amount of 0-3hRP 
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internalized by BMMϕs, the impact of this process on MAPK activation was 
addressed. 
Levels of P-Erk were greatly reduced after exposure to 0-3hRP in CytD-treated 
BMMϕs compared to untreated control (Figure 5.3, p<0.0001). Slight 
differences observed between Media and cells treated with CytD only are 
unlikely to be biologically relevant, as potent stimulation with 0-3hRP induces a 
much greater response. 
Equally significant reductions were observed with P-p38 in CytD-treated 
BMMϕs exposed to 0-3hRP compared to un-treated controls (Figure 5.4, 
p<0.0001). Similarly, P-CREB levels in CytD-treated BMMϕs exposed to 0-
3hRP were significantly reduced compared to un-treated cells (Figure 5.5, 
p<0.0001). Consequently, internalization of 0-3hRP is required for complete 
activation of MAPK, suggesting that TLR recognition may be occurring within 
the endosomes. 
As PI3K inhibition had an effect on the internalization of 0-3hRP by BMMϕs 
(Figure 5.2), its effect on MAPK activation was tested. Similar to CytD, levels of 
P-Erk (Figure 5.6), P-p38 (Figure 5.7) and P-CREB (Figure 5.8) were greatly 
reduced in response to 0-3hRP in BMMϕs where the PI3K family inhibitor 
LY294002 was used. To address which protein in the PI3K family might be 
involved in this process, a specific inhibitor for the catalytic subunit of the PI3K 
family p110-δ (IC87114) was used. As before, levels of P-Erk (Figure 5.6), P-
p38 (Figure 5.7) and P-CREB (Figure 5.8) were significantly reduced 
(p<0.0001) in IC87114 treated BMMϕs exposed to 0-3hRP compared to un-
treated cells. 
This evidence further confirms the links between these Erk, p38 and CREB (see 
chapter IV), however, it highlights the role of internalization on the activation of 
these MAPKs, and emphasizes the possibility that 0-3hRP-TLR binding occurs 
in the endosome of macrophages. 
5.3.3 IL-10 and IL-12p40 production is dependent on internalization of 0-
3hRP by BMMϕs 
MAPK activation in BMMϕs exposed to 0-3hRP is linked to cytokine production 
(4.3.5). As blocking internalization of cercarial E/S products impairs that 
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activation, it was possible that production of IL-10 and IL-12p40 would also be 
affected. 
In line with the inhibition of MAPK activation, CytD treatment of BMMϕs 
exposed to 0-3hRP significantly reduced the production of IL-10 and IL-12p40 
compared to controls (Figure 5.9, p<0.001-0.0001). However, increasing doses 
of PI3K family inhibitor LY294002 or p110-δ inhibitor IC87114 only affected IL-
10 production (Figure 5.10A & B), which was significantly impaired. IL-12p40 
production (Figure 5.10A & B), was neither enhanced, as seen with the 
inhibition of other kinases (4.3.5.1), nor reduced as detected in the presence of 
CytD (Figure 5.9). Thus, 0-3hRP internalization is required for complete 
activation of MAPKs and cytokine production. 
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5.4 Discussion 
5.4.1 Uptake of 0-3hRP by BMMϕs requires actin polymerization and 
intact PI3K signaling 
Previous studies have shown that S. mansoni E/S products are taken up by 
macrophages in the skin and by BMMϕs in vitro (Paveley et al, 2009). Indeed, 
here it was established that the uptake of 0-3hRP by BMMϕs is a rapid process 
that reaches its zenith after 300min of exposure to the labeled secretions. It is 
clear, from the MFI measurement, that as early as 10min after stimulation, the 
whole population of BMMϕs contains traces of the material. Nonetheless, after 
only 30min, a substantial amount of 0-3hRP can be found inside the cells. This 
coincides with the peak in the activation of several MAPKs reported earlier (see 
4.3.3), as well as the earliest detection of IL-10 mRNA in response to 0-3hRP 
(see 3.3.5.2). 
Confocal microscopy of stimulated BMMϕs revealed that labeled 0-3hRP was 
indeed taken by cells into small (2µm) well-defined vesicles located in the 
cytoplasm, an observation confirmed by 3 dimensional imaging of the cells 
(data not shown). Some of those vesicles were positive for early endosomal 
marker EEA-1 after 60min of exposure to 0-3hRP, confirming the cytoplasmic 
localization of 0-3hRP and its trafficking through endosomes. 
This uptake process requires both actin polymerization, as revealed following 
inhibition with cytochalasin D, and PI3K signaling, as shown by inhibition with a 
PI3K family inhibitor. Potential toxic effects of the inhibitors employed were 
partly discarded by checking cell viability via microscopy with trypan blue and 
via flow cytometry with live/dead discrimination dyes (data not shown). 
Responsiveness of inhibited BMMϕs to stimuli independent from the pathways 
targeted by the drugs would be required to completely rule out the toxic effects 
of these inhibitors. However, concentrations used were always in line with 
published doses (Paveley et al, 2009; Vlahos et al, 1994). Moreover, PI3K 
inhibition did not prevent IL-12p40 production by BMMϕs, meaning cells were 
not only viable but also able to produce cytokines. Both actin polymerization 
and PI3K activity require ATP, therefore it is likely that cell surface receptors in 
BMMϕs orchestrate the uptake of 0-3hRP as it will be energetically costly. S. 
mansoni egg antigens have been shown to be internalized by C-type lectin 
receptors (Everts et al, 2012; van Liempt et al, 2007). Cercarial E/S products 
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are known for being highly glycosylated (Jang-Lee et al, 2007) and partly 
require the MR for internalization (Paveley et al, 2011). Earlier, evidence of 
other phagocytic receptors (CD36 and MSRI) that were regulated by 0-3hRP-
stimulation was presented (see 3.3.3.3), so their involvement in the uptake of 0-
3hRP warrants further investigation.  
0-3hRP is a complex mixture of proteins, some of which are glycosylated and 
potentially linked to lipids as lipoproteins. It would therefore be unsurprising that 
more than one of the diverse mechanisms described above is involved in the 
uptake of this material. Certainly, the macrophage MR is partly involved, despite 
not having a cytoplasmic signaling domain, but CD36 and MSRI, both 
scavenger receptors with lipid affinity, which trigger signaling pathways, could 
play an important role. 
5.4.2 MAPK activation and cytokine production in BMMϕs exposed to 0-
3hRP is dependent on uptake 
In this study, S. mansoni cercarial E/S products have been shown to affect 
multiple aspects of macrophage biology, with particular attention given to the 
production of IL-10. Others have shown that 0-3hRP modulates its trafficking 
through BMMϕs (Paveley et al, 2009), and it is well established that TLR 
ligands can affect the maturation of phagosomes (Kagan & Iwasaki, 2012). 
Consequently, the signaling pathways triggered in macrophages as a result of 
its uptake warranted examination. 
Inhibition of uptake using cytochalasin D resulted in significant reductions in the 
activation of Erk1/2, p38 and CREB. Previously, it was determined that TLR2 
and TLR4, both abundantly available in the surface of BMMϕs, were 
responsible for the activation of these signals (see 4.3.3.3). From the evidence 
presented in this chapter, it is possible to conclude that a significant portion of 
the activation of MAPKs in BMMϕs occurs as a consequence of 0-3hRP uptake, 
and that these molecules could be recognized in endosomes by TLR2 or TLR4. 
As mentioned in the introduction of this chapter, the importance of TLR4 
signaling from the endosomes is a nascent field, and similar reports for TLR2 
are not available. Thus, these findings open up the exciting possibility that 
TLR2, as well as TLR4, have functional roles in the recognition of 0-3hRP in 
endosomal compartments. Moreover, the kinetics of activation of MAPKs and 
production of IL-10 support this hypothesis. 0-3hRP is evident within cells from 
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10 minutes after exposure, and is abundant in BMMϕs at 30min, when MAPKs 
signals peak and IL-10mRNA is detected. Thus 0-3hRP binding TLRs in the 
endosomes is a possibility that warrants further examination. Genetic tools that 
modify the recruitment of TIRAP to the cell membrane, affecting MyD88 
interaction with cell surface TLRs, would be ideal to address this question. 
Another possibility is that the signaling cascades triggered by TLR2 and TLR4 
are sustained by another receptor in an endosomal compartment, as reported 
by other with respect to a TLR4-TLR9 interplay (Wolf et al, 2011). Of the two 
possibilities, the first one is more likely, as at least TLR4 has been shown to 
signal from endosomes and accumulate in phagolysosomes (Kagan & Iwasaki, 
2012), however, the use of macrophages deficient in endosomal TLRs would be 
necessary to rule out any potential contribution from these receptors. 
Blocking 0-3hRP using Cytochalasin D also resulted in a significant reduction in 
the production of IL-10 and IL12p40. This reduction is in line with the observed 
reduction in MAPK activation, and congruent with the hypothesis that TLR 
binding to 0-3hRP occurs in endosomal compartments. Moreover, experiments 
performed with LPS stimulation of BMMϕs showed that Cytochalasin D 
inhibition also resulted in IL-12p40 reduction (data not shown), further 
supporting the evidence that highlights the role of uptake/endosomal 
recognition of PAMPs. 
Unlike blocking actin polymerization, PI3K inhibition not only prevents 
phagocytosis, but also impacts the recruitment of adaptor molecules to different 
cellular compartments (Vanhaesebroeck et al, 2012). In fact, inhibition of p110-
δ has been shown to prevent TLR4 internalization and enhance its ability to 
signal from the cell surface (Aksoy et al, 2012), and PI3K signaling is required 
for adequate recruitment of TIRAP to TLRs (Bonham et al, 2014). 
Consequently, the observed effects by inhibiting PI3K signaling in BMMϕs 
exposed to 0-3hRP are not only a result of limiting its uptake, despite this being 
a consequence of inhibition. It is necessary to assume, in light of the mentioned 
literature, that the recruitment of adaptor molecules is also affected. Thus, the 
significant reductions in phosphorylation of Erk1/2, p38 and CREB could be a 
consequence of the reduced uptake, of blocking TLR receptor trafficking, of 
blocking TIRAP-MyD88 recruitment, or a combination of the three. 
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To shed light on ambiguity of the interpretation of the results of this inhibition, it 
is pertinent to observe the effects of chemical inhibition on cytokine production. 
IL-10 was greatly impaired by PI3K inhibition in BMMϕs exposed to 0-3hRP, 
whereas IL-12p40 was largely unaffected. As P-Erk, P-p38 and P-CREB are 
also greatly reduced, a decrease of IL-10 is expected based on previous 
inhibition of MAPK (see 4.3.5.1), as it is indeed the case with PI3K inhibition. 
However, earlier findings suggest that IL-12p40 would increase if the levels of 
MAPKs were reduced. In the context of PI3K inhibition, IL-12p40 in response to 
0-3hRP remains unchanged. Nonetheless, blocking 0-3hRP uptake with 
Cytochalasin D, reduces the amount of IL-12p40. Consequently, PI3K inhibition 
is having a double effect on BMMϕs. First, it is blocking the uptake of 0-3hRP, 
but to a lesser extent than Cytochalasin D, which results in a reduction of both 
IL-10 and IL-12p40. Second, PI3K inhibition results in the reduction in MAPKs 
due to the defect in uptake of 0-3hRP but also by an additional mechanism, 
further decreasing the levels of IL-10. However, this boosts IL-12p40 production 
back to the levels of uninhibited cells. 
Finally, the maturation of endosomes during 0-3hRP trafficking was not 
addressed. Earlier reports suggest that endosome maturation is affected by 0-
3hRP-stimulation (Paveley et al, 2009) and uptake of E. coli particles is indeed 
affected by exposure to S. mansoni cercarial products (data not shown). The 
acidification of lysosomes, which could also be regulated by 0-3hRP-stimulation 
was not studied, but could be addressed using chemical inhibitors (i.e. 
bafilomycin). 
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5.5 Summary 
S. mansoni cercarial E/S products are recognized by BMMϕs via one or more 
phagocytic receptors, which leads to their internalization in an actin dependent 
manner. This process is also partly dependent on intact PI3K signaling. Both 
from the surface of the cell, but also from an endosomal compartment, 0-3hRP 
binds to TLR2 and TLR4, leading to the activation of several MAPKs. The 
activation of those signaling pathways requires the recruitment of MyD88 and 
other adaptor molecules, which are likely to be affected by the inhibition of 
PI3K. Activated MAPKs orchestrate the production of IL-10, whilst limiting the 
induction of IL-12p40. 
In the next chapter, evidence for the production of IL-10 from macrophages at 
the skin site of S. mansoni skin invasion will be sought. 
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Figure 5.1 0-3hRP uptake by BMMϕs requires actin polymerization 
BMMϕs pre-treated for 2 hours with Cytochalasin D (10µg/ml), washed and then 
were exposed to labeled 0-3hRP (50µg/ml) or Media control for different lengths 
of time. (A) Representative flow plots at 30min, (B) means ±SEM of 
percentages and (C) mean MFI ±SEM are given from three technical replicates. 
(D) A representative confocal image of a BMMϕ containing labeled 0-3hRP 
(red) within EEA-1 positive endosomes (green) is also shown after 60min 
exposure to 0-3hRP. ANOVA and then Sidak’s multiple comparisons test were 
performed to examine differences between the means of untreated BMMϕs 
exposed to 0-3hRP compared to inhibitor treated BMMϕs (significance in black) 
or compared to Media controls (significance in purple) at every time point (* = 
p<0.05; **** = p<0.0001; ns = p>0.05). Results are representative of three 
independent experiments. 
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Figure 5.2 PI3K inhibition of BMMϕs limits uptake of 0-3hRP 
BMMϕs pre-treated for 2 hours with a PI3K family inhibitor (LY294002 at 25µM) 
were exposed to labeled 0-3hRP (50µg/ml) or Media control for different lengths 
of time. (A) Representative flow plots at 30min, (B) means ±SEM of 
percentages and (C) mean MFI ±SEM are given fro three technical replicates. 
ANOVA and then Sidak’s multiple comparisons test were performed to examine 
differences between the means of untreated BMMϕs exposed to 0-3hRP 
compared to inhibitor treated BMMϕs (significance in black) or compared to 
Media controls (significance in purple) at every time point (* = p<0.05; **** = 
p<0.0001; ns = p>0.05). Results are representative of three independent 
experiments. 
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Figure 5.3 Chemical inhibition of uptake in BMMϕs exposed to 0-3hRP 
limits Erk1/2 phosphorylation 
BMMϕs pre-treated for 2 hours with Cytochalasin D (10µg/ml) were exposed to 
0-3hRP (50µg/ml) or left un-stimulated (Media) for 30min. BMMϕs were then 
labeled with antibodies against P-Erk. (A) Representative overlaid histograms of 
0-3hRP (red) or Media (black) samples and (B) means + SEM of MFIs are 
given from three technical replicates. ANOVA and then Dunnett’s multiple 
comparisons test were performed to examine differences between the means of 
inhibitor treated stimulated cells compared to control cells (**** = p<0.0001). 
Results are representative of three independent experiments. 
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Figure 5.4 Chemical inhibition of uptake in BMMϕs exposed to 0-3hRP 
limits p38 phosphorylation 
BMMϕs pre-treated for 2 hours with Cytochalasin D (10µg/ml) were exposed to 
0-3hRP (50µg/ml) or left un-stimulated (Media) for 30min. BMMϕs were then 
labeled with antibodies against P-p38. (A) Representative overlaid histograms 
of 0-3hRP (red) or Media (black) samples and (B) means + SEM of MFIs are 
given from three technical replicates. ANOVA and then Dunnett’s multiple 
comparisons test were performed to examine differences between the means of 
inhibitor treated stimulated cells compared to control cells (**** = p<0.0001). 
Results are representative of three independent experiments. 
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Figure 5.5 Chemical inhibition of uptake in BMMϕs exposed to 0-3hRP 
limits CREB phosphorylation 
BMMϕs pre-treated for 2 hours with Cytochalasin D (10µg/ml) were exposed to 
0-3hRP (50µg/ml) or left un-stimulated (Media) for 30min. BMMϕs were then 
labeled with antibodies against P-CREB. (A) Representative overlaid 
histograms of 0-3hRP (red) or Media (black) samples and (B) means + SEM of 
MFIs are given from three technical replicates. ANOVA and then Dunnett’s 
multiple comparisons test were performed to examine differences between the 
means of inhibitor treated stimulated cells compared to control cells (**** = 
p<0.0001). Results are representative of three independent experiments. 
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Figure 5.6 PI3K inhibition of BMMϕs exposed to 0-3hRP limits Erk1/2 
phosphorylation 
BMMϕs pre-treated for 2 hours with a PI3K family inhibitor (LY294002 at 25µM) 
or a p110-δ inhibitor (IC87114 at 5µg/ml) were exposed to 0-3hRP (50µg/ml) or 
left un-stimulated (Media) for 30min. BMMϕs were then labeled with antibodies 
against P-Erk. (A) Representative overlaid histograms of 0-3hRP (red) and 
Media (black) and (B) means +SEM of MFIs are given for three technical 
replicates. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between the means of inhibitor treated 
stimulated cells compared to control cells (**** = p<0.0001). Results are 
representative of three independent experiments. 
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Figure 5.7 PI3K inhibition of BMMϕs exposed to 0-3hRP limits p38 
phosphorylation 
BMMϕs pre-treated for 2 hours with a PI3K family inhibitor (LY294002 at 25µM) 
or a p110-δ inhibitor (IC87114 at 5µg/ml) were exposed to 0-3hRP (50µg/ml) or 
left un-stimulated (Media) for 30min. BMMϕs were then labeled with antibodies 
against P-p38. (A) Representative overlaid histograms of 0-3hRP (red) and 
Media (black) and (B) means +SEM of MFIs are given for three technical 
replicates. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between the means of inhibitor treated 
stimulated cells compared to control cells (**** = p<0.0001). Results are 
representative of three independent experiments. 
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Figure 5.8 PI3K inhibition of BMMϕs exposed to 0-3hRP limits CREB 
phosphorylation 
BMMϕs pre-treated for 2 hours with a PI3K family inhibitor (LY294002 at 25µM) 
or a p110-δ inhibitor (IC87114 at 5µg/ml) were exposed to 0-3hRP (50µg/ml) or 
left un-stimulated (Media) for 30min. BMMϕs were then labeled with antibodies 
against P-CREB. (A) Representative overlaid histograms of 0-3hRP (red) and 
Media (black) and (B) means +SEM of MFIs are given for three technical 
replicates. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between the means of inhibitor treated 
stimulated cells compared to control cells (**** = p<0.0001). Results are 
representative of three independent experiments. 
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Figure 5.9 Chemical inhibition of 0-3hRP uptake inhibits cytokine 
production in BMMϕs 
BMMϕs were pre-treated for 2 hours with Cytochalasin D (10µg/ml), exposed 
overnight to 0-3hRP (50µg/ml) or left un-stimulated (Media) and culture 
supernatants tested for IL-10 and IL-12p40 by ELISA. Means +SEM from three 
technical replicates are given. ANOVA and then Dunnett’s multiple comparisons 
test were performed to examine differences between the means of CytD treated 
BMMϕs compared to untreated control ( *** = p<0.001; **** = p<0.0001). 
Results are representative of three independent experiments. 
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Figure 5.10 Chemical inhibition of PI3K regulates cytokine production in 
BMMϕs exposed to 0-3hRP 
BMMϕs were pre-treated for 2 hours with increasing doses of (A) a PI3K family 
inhibitor (LY294002) or (B) a p110-δ inhibitor (IC87114), exposed overnight to 
0-3hRP (50µg/ml) or left un-stimulated (Media) and culture supernatants tested 
for IL-10 and IL-12p40 by ELISA (detection limit for IL-10 ELISA was at 
32pg/ml). Means ±SEM from three technical replicates are given. BMMϕs 
without pre-treatment with inhibitors are represented with open circles (0-3hRP) 
or open triangles (Media). ANOVA and then Dunnett’s multiple comparisons test 
were performed to examine differences between the means of inhibitor treated 
cells compared to untreated control (* = p<0.05; ** = p<0.01; *** = p<0.001; **** 
= p<0.0001; ns = p>0.05). Results are representative of three independent 
experiments. 
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6 Macrophages in the skin condition the immune 
response to S. mansoni cercariae by producing IL-10 
6.1 Introduction 
Immunological responses in the skin are unlike any other site, due to its special 
function as a barrier, both physically and immunologically (Nestle et al, 2009). 
The skin plays host to a billion bacteria per square inch, and must respond 
appropriately to both pathogens and commensal microbiota (Belkaid & Naik, 
2013). This balance is achieved largely by a network of tissue resident immune 
cells that work to limit pathology (Belkaid et al, 2001; Malissen et al, 2014; 
Sanchez Rodriguez et al, 2014; Staumont-Salle et al, 2014). 
S. mansoni cercariae penetrate mammalian skin by releasing molecules from 
their acetabular glands that aid remodeling of the extracellular matrix (Curwen 
et al, 2006; Paveley et al, 2009; Wilson, 2012) and to aid migration of larvae 
through the skin to reach blood vessels thereby facilitating onward migration  
(Cook et al, 2011; Coulson & Wilson, 1997; Incani & McLaren, 1984). Upon 
penetration of the skin different populations of cells are recruited to the site of 
infection, including several types of mononuclear cells (macrophages and 
dendritic cells), as well as eosinophils and neutrophils (Cook et al, 2011). 
Indeed, F4/80+, CD11c+, and Gr1+ cells (considered to be macrophages, 
dendritic cells and neutrophils respectively) have been shown to interact with 
and take up cercarial E/S products in the skin (Paveley et al, 2009). However, 
the relative roles of these cells in the course of S. mansoni skin infection, 
particularly macrophages, are not fully defined (see 1.2.3). 
Several cytokines are produced in the skin as a cascade after infection with live 
S. mansoni cercariae, including IL-10, IL-12, IL-6, IL-1β and IL-18, many of 
which reached their peaks of production 4 days after infection (Hogg et al, 
2003a). In particular, IL-10 limits the amount of IL-12p40 produced in vivo after 
exposure to radiation-attenuated S. mansoni cercariae (Hogg et al, 2003a; 
Hogg et al, 2003b), which in turn affects the development of Th1 responses in 
the skin draining lymph nodes (Hogg et al, 2003a). IL-12p40 production in the 
skin after S. mansoni infection with radiation-attenuated cercariae is 
predominantly from a CD11b+CD11c+ population of dendritic cells (Hogg et al, 
2003b). 
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Despite the importance of IL-10 production after S. mansoni infection (Turner et 
al, 2013; Wilson et al, 2011), the cellular source of this cytokine is known only in 
later stages (after 4 weeks) of the disease (Scheer et al, 2014). As IL-10 is 
difficult to detect by conventional intracellular cytokine staining, particularly in 
granulocytes, reporter mice have been employed to discover the cell types 
responsible for the production of this cytokine (Bouabe, 2012). Tiger mice (IL-
10+/gfp) were developed to track the production of IL-10 by introducing GFP after 
the 5th exon of the IL-10 gene (Kamanaka et al, 2006). Consequently, IL-10 
protein is fluorescent and can be visualized inside cells as it is being produced 
(Kamanaka et al, 2006). IL-10+/gfp mice have already been used to study the 
sources of IL-10 after 4 weeks of S. mansoni infection (Scheer et al, 2014). 
BMMϕs internalize S. mansoni E/S products (chapter V) and tightly regulate the 
production IL-10 by activating the transcription factor CREB in a TLR dependent 
manner (chapter IV). In this chapter, the source of IL-10 in the skin will be 
determined, with a view to link the in vitro production of IL-10 by BMMϕs to their 
in vivo counterparts.  
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6.2 Chapter specific materials and methods 
6.2.1 Skin infection with S. mansoni cercariae 
S. mansoni cercariae were obtained as described previously (see 2.2) and 
diluted to 150 parasites/ml in water to perform percutaneous skin infection. 
Female mice (6 weeks of age) from strains previously described (see 2.1) were 
anesthetized with an intra-peritoneal (i.p.) injection of Domitor (Medetomodine, 
Fort Dodge) at 0.1mg/kg plus Ketaset (Ketamine, Fort Dodge) at 90mg/kg. Both 
pinnae of anesthetized animals were moistened and submerged in 1ml of 
parasite-containing water for 20min. After infection of both ears, mice were 
revived by subcutaneous administration of 100µl of diluted (1:25) Antisedan 
(Zoetis) (regardless of weight). 
6.2.2 Dermal exudate cells 
Naïve, and infected mice (on days 1, 2 or 4 days post-exposure to S. mansoni 
cercariae), were humanly killed; pinnae were removed, briefly sterilized with 
ethanol, air-dried and split along the central cartilage into two halves to obtain 
dermal cell suspension as described previously (Cook et al, 2011; Mendez et al, 
2004). Briefly, split pinnae were floated overnight at 37°C and 5% CO2 on RPMI 
medium (Gibco) containing 10% FCS, 2mM L-Glutamine solution (Gibco), 
50U/ml penicillin, 50µg/ml streptomycin and 50µM 2-mercaptoethanol 
(Complete RPMI) in non-adherent 24-well plates. Floating tissue was removed 
after 20 hours of incubation and supernatants containing dermal exudate cells 
(DEC) were centrifuged at 1000g for 7min at 4°C. Pelleted DEC were re-
suspended in FACS buffer and counted using a hemocytometer, whilst cell-free 
culture supernatants were preserved at -20°C and analyzed for cytokines by 
ELISA as previously described (see 2.5). DEC were prepared for flow cytometry 
as detailed before (see 2.4). 
6.2.2.1 Detection of intracellular IL-10 in DEC 
Detection of IL-10 production in different cell types in DEC was achieved by 
using IL-10+/gfp mice (see 2.1). WT and IL-10+/gfp mice were infected and pinnae 
harvested as described above. Split pinnae were incubated with complete RPMI 
for 12 hours, prior to the addition of 1X Brefeldin A (BreA) (eBioscience) 
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following the manufacturer’s instructions. After a further 8 hours DEC were 
prepared for flow cytometric analysis as described above. 
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6.3 Results 
6.3.1 Different populations of cells in the skin change after S. mansoni 
infection 
Skin infected with S. mansoni cercariae was analyzed by flow cytometry to 
determine the early changes to the composition of immune cells in the DEC. 
Typically, DEC were harvested, counted and labeled with a Live/Dead 
discrimination dye to select for viable cells, which were then gated based on 
size and granularity, and finally as singlets (Figure 6.1A). Subsequent gates for 
cells positive for different specific antibodies were made based on relevant 
isotype controls for each antibody (Figure 6.1B & C). This approach was 
common to all experiments. 
6.3.1.1 Global changes in DEC populations after S. mansoni cercariae 
infection 
Viable single DEC were initially separated based on the expression of F4/80 
and MHC-II (Figure 6.1C, left plot), which produced 5 clearly distinguishable 
populations, some of which have been characterized previously elsewhere 
(Cook et al, 2011). These populations were F4/80-MHC-II- cells (R1), 
F4/80+MHC-II- eosinophils (R2), F4/80+MHC-IIlow inflammatory monocytes (R3), 
F4/80-MHC-IIhigh DCs (R4) and F4/80+MHC-IIhigh cells (R4A). F4/80-MHC-II- 
cells (R1) were further separated based on the expression of CD11b and CD4 
(Figure 6.1C, right plot), resulting in four populations. CD11b-CD4- cells 
comprised a small numbers (less than 1%) of CD3+CD8a+ presumably cytotoxic 
T lymphocytes and CD3-B220+ B lymphocytes, whilst the majority were 
uncharacterized cells (data not shown). CD11bmidCD4- cells were not positive 
for CD3, B220, NK1.1 or CD8, however, CD11b-CD4+ cells were all CD3+, 
compared to isotype control (Figure 6.1B, right plot), and so were considered to 
be CD4+ T lymphocytes (Figure 6.1D, left plot). Finally, CD11bhighCD4- cells, 
which were also high for Gr1, were considered to be neutrophils (Figure 6.1D, 
right plot). 
As infection progressed (for four days), the total number of cells in the skin 
increased compared to naïve tissues (Figure 6.2), but was only significantly 
greater on days 2 and 4 (both p<0.001). The percentages (Figure 6.3) and 
numbers (Figure 6.4) of the aforementioned cell populations in DEC changed 
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dramatically after infection with S. mansoni cercariae. F4/80-MHC-IIhigh DCs in 
R4 increased significantly in proportion (Figure 6.3A) and number (Figure 6.4A) 
on day 2 after infection but did not change substantially by day 4. F4/80+MHC-
IIhigh cells in R4A decrease significantly in proportion (Figure 6.3B, p<0.01) on 
day 1 after infection compared to naïve. Thereafter, this population regained its 
previous abundance, with a significant increase between day 1 and 2 (p<0.05), 
but no difference was detected by day 4, or indeed between days 2, 4 and 
naïve. Numbers of these F4/80+MHC-IIhigh cells increased significantly only by 
day 2 after infection (p<0.05) and did not change by day 4 (Figure 6.4B).  
Neutrophils (F4/80-MHC-II-CD11bhigh) in R1, inflammatory monocytes 
(F4/80+MHC-IIlow) in R3 and eosinophils (F4/80+MHC-II-) in R2 all increased 
significantly in proportion (Figure 6.3C, D & F) and number (Figure 6.4C, D & F) 
by day 1, and remained elevated on subsequent days, although R2 eosinophils 
decreased slightly on day 2 compared to day 1 as a proportion (Figure 6.3D). 
CD4+ T cells in R1 were only significantly higher as a proportion, or as numbers 
on day 4 after infection (Figure 6.3E & Figure 6.4E). 
6.3.1.2 Further characterization of monocyte populations in the skin after 
S. mansoni cercariae infection 
The three populations of mononuclear cells found in the skin after S. mansoni 
infection based on expression of F4/80 and MHC-II, were F4/80-MHC-IIhigh, 
F4/80+MHC-IIlow and F4/80+MHC-IIhigh cells. To further characterize these 
mononuclear populations, CD11c expression (based on the MFI) on each 
population 4 days after infection was analyzed by flow cytometry (Figure 6.5). 
Indeed, CD11c was observed to be significantly elevated on F4/80-MHC-IIhigh 
cells compared to F4/80+MHC-IIlow and F4/80+MHC-IIhigh cells (both p<0.0001). 
F4/80-MHC-IIhighCD11chigh cells are likely to be dendritic cells, as high CD11c 
expression is associated with DCs. The remaining monocyte populations could 
be a mixture of blood-recruited monocytes, tissue resident macrophages and 
other types of dendritic cells. 
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6.3.2 IL-10 is produced by whole skin biopsies after S. mansoni infection 
6.3.2.1 Skin infected with S. mansoni cercariae produces IL-10 and IL-
12p40 
Cercarial E/S products are released as S. mansoni larvae penetrate the skin, 
causing tissue damage (see 1.2). As demonstrated in previous chapters 
(chapter III, IV & V), F4/80+ BMMϕs produce IL-10 and IL-12p40 when exposed 
to these secretions. To test the ability of cells in the skin to produce these 
cytokines in response to larval invasion, supernatants from in vitro-cultured skin 
biopsies from infected mice were analysed for the presence of IL-10 and IL-
12p40 by ELISA (2.5). 
Significantly higher levels of IL-10 were produced by skin samples obtained 4 
days after infection with S. mansoni cercariae compared to naïve biopsies 
(Figure 6.6A, p<0.01). Likewise, IL-12p40 production was significantly 
increased in supernatants from infected skin (Figure 6.6B, p<0.01). 
6.3.2.2 Dynamics of IL-10 production by infected skin in culture 
Unlike other strains of IL-10 reporter mice (Bouabe, 2012), IL-10+/gfp mice 
express one copy of IL-10 with a GFP construct after the 5th exon. To measure 
IL-10 produced by cells in these mice, it was necessary to initially determine the 
dynamics of IL-10 production. Consequently, culture supernatants from skin 
biopsies from infected mice (day 4) were tested for IL-10 at regular intervals. It 
was apparent that the bulk of IL-10 was detected after the initial 6 hours of 
culture (Figure 6.7A). Consequently, BreA was added to the media after 12 
hours of incubation, and cells harvested 8 hours later (total = 20 hours). 
Incubation with BreA resulted in a significant (p<0.05) decrease in the amount 
of IL-10 secreted by infected skin as detected by ELISA (Figure 6.7B), with only 
a slight effect on the viability of DEC assessed by incorporation of Trypan blue 
(Sigma) using light microscopy or later by flow cytometry using fluorescent 
live/dead discrimination dyes (data not shown). 
6.3.2.3 IL-10 producing cells are increased in skin infected with S. 
mansoni cercariae 
Pinnae from WT and IL-10+/gfp S. mansoni infected mice were harvested 1, 2 or 
4 days after infection and compared to samples from naïve mice. Pinnae were 
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split and cultured for a total of 20 hours in media in the absence of added 
parasite antigen, but with BreA added during the last 8 hours. WT controls were 
used to set GFP+ gates on live single cells obtained as described before (6.3.1) 
(Figure 6.8A). 
GFP was detected in cells obtained from all groups of IL-10+/gfp mice including 
naïve compared to WT controls (Figure 6.8A & B). However, IL-10 positive cells 
were significantly increased in DEC on days 2 and 4 after infection (p<0.01-
0.0001), with the highest percentage and number being observed on day 4 
(Figure 6.8B). 
6.3.3 F4/80+ cells in the skin produce IL-10 in response to S. mansoni 
cercariae 
Closer analysis of GFP+ cells with the markers described before (6.3.1.1), 
revealed that only two of the aforementioned populations were predominant in 
producing IL-10 in the skin after S. mansoni infection. 
On the basis of F4/80 and MHC-II expression, GFP+ was exclusively detected in 
naive DEC by F4/80+MHC-IIhigh cells (Figure 6.9A). Indeed, nearly 80% of GFP+ 
cells from naive mice were F4/80+MHC-IIhigh (Figure 6.9C). However, 1, 2 or 4 
days after S. mansoni infection, the detected GFP signal was split between 
GFP+ F4/80+MHC-IIhigh and GFP+ F4/80-MHC-II- cells, which where all CD4+ 
(Figure 6.9B). On day 1, the contribution detected IL-10 from CD4+ T cells was 
similar to that of F4/80+MHC-IIhigh cells (Figure 6.9D). Subsequently, 
F4/80+MHC-IIhigh cells became the main source of IL-10 on day 2 after infection 
(Figure 6.9E) but by day 4 the main contribution to the production of IL-10 came 
from CD4+ T cells (Figure 6.9F), which coincides with the numerical expansion 
of the CD4+ T cell population (Figure 6.3G & Figure 6.4F). Nevertheless, GFP+ 
F4/80+MHC-IIhigh cells continued to be significantly more abundant than other 
mononuclear cells in the DEC (Figure 6.9F, p<0.01-0.0001) and indeed the 
numbers of GFP+ F4/80+MHC-IIhigh cells on days 2 and 4 after infection was 
significantly greater than the number of these cells in naïve skin (Figure 6.10, 
p<0.01-0.001). 
In line with previous results (Figure 6.5), GFP+ F4/80+MHC-IIhigh cells had a 
significantly lower expression of CD11c than GFP+ F4/80-MHC-IIhigh cells 
(Figure 6.11, p<0.0001), meaning they are likely to be tissue resident 
macrophages and not DCs. 
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6.3.4 Higher proportion CD3+CD4+ T cells in the skin produce IL-10 in 
response to S. mansoni cercariae 
Analysis of GFP+ cells within each population revealed that only a small 
proportion of F4/80+MHC-IIlow (R3), F4/80-MHC-IIhigh (R4) or F4/80+MHC-IIhigh 
(R4A) were positive for GFP+ as a percentage of the total population (~1%, data 
not shown). Further more, while numbers of GFP+ F4/80+MHC-IIhigh (R4A) cells 
were significantly higher on days 2 and 4 after infection compared to naïve 
(Figure 6.10), numbers of GFP+ F4/80+MHC-IIlow (R3) and GFP+ F4/80-MHC-
IIhigh (R4) were only significantly higher than naïve non day 4 after infection 
(data not shown). 
However, the percentage of GFP+ cells within the CD3+CD4+ T cell population 
was greater than those found for these populations of monocytes. Indeed, on 
day 4 of infection ~7% of CD4+ T cells were positive for GFP+, and this was 
significantly different from naïve and on day 1 and 2 after infection (Figure 
6.12A, p<0.001). Moreover, the number of GFP+ CD4+ T cells was also 
significantly increased on day 4 after infection compared to naïve, day 1 and 
day 2 (Figure 6.12B, p<0.0001). These findings highlight the significant 
contribution to the production of IL-10 by CD4+ T cells in the skin, specifically at 
the later stages of skin infection. 
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6.4 Discussion 
6.4.1 S. mansoni infection alters the proportions and numbers of immune 
cells in the skin 
S. mansoni larvae invade the host, releasing the contents of their acetabular 
glands and initiating an inflammatory process at the site of infection. Reports on 
the type and proportion of immune cells recruited to the skin after S. mansoni 
infection are scarce. The findings presented in this chapter are the first 
comprehensive report using modern tools to identify the populations of immune 
cells that are recruited to the site of infection. The first leukocytes recruited to 
the site are granulocytes, such as neutrophils and eosinophils, as well as a 
population of F4/80+MHC-IIlowCD11clow inflammatory monocytes. These three 
groups of immune cells predominantly remain in the skin as schistosomula 
migrate through this tissue, which occurs mostly within the first three days 
(Incani & McLaren, 1984; Mountford & Harrop, 1998; Wheater & Wilson, 1979) 
and are likely to be the source of early pro-inflammatory cytokines in the skin 
such as IL-6 and IL-1 (Hogg et al, 2003a). Furthermore, neutrophils have been 
shown to take up the secretions of the parasite (Paveley et al, 2009) and 
alongside eosinophils and macrophages, could be involved in causing and 
repairing tissue damage (Chen et al, 2012). Moreover, eosinophils are often 
recruited to sites of helminth infection and are thought to mediate parasite 
clearance (Falcone et al, 2001; Gentil et al, 2014; Magalhães et al, 2010) which 
they could be attempting in the skin. Blood recruited monocytes, represented 
here by F4/80+MHC-IIlowCD11clow cells, are plastic and can adopt several 
phenotypes, including alternatively activated macrophages (Girgis et al, 2014), 
or more typical classically activated pro-inflammatory macrophages (Benoit et 
al, 2008; Gundra et al, 2014). In the multiple S. mansoni skin infection model, 
these cells appear to become alternatively activated (Cook et al, 2011). 
As the infection progresses, other types of leukocytes are recruited to the site of 
infection, specifically cells with antigen presenting function. In the context of S. 
mansoni infection, these APCs include F4/80-MHC-IIhighCD11chigh DCs, which 
are increased in the skin only after 2 days of infection. DCs play a fundamental 
role in the immune system by polarizing T helper cell responses, and have been 
heavily implicated in S. mansoni chronic infection (Cook et al, 2012; Everts et 
al, 2012; Pearce & MacDonald, 2002), as well as immune processes in 
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response to other helminthic parasites (Everts et al, 2010). The F4/80-MHC-
IIhighCD11chigh DCs are also likely to be the previously reported source of IL-
12p40 (Hogg et al, 2003a), allowing them to polarize the infiltrating CD4+ T cells 
to Th1. 
DCs are presumably responsible for the increased numbers and proportion of 
CD4+CD3+ T cells in the skin by driving local proliferation of antigen specific 
CD4+ T cells, as CD4+ T cells are dramatically elevated after 4 days of infection. 
Resident CD4+CD3+ T cells, whose numbers were unchanged at day 1 and 2 
after infection, have vastly different roles than proliferative antigen specific 
infiltrating CD4+ T cells seen at day 4. Those tissue resident cells will include 
several populations of regulatory T cells, which are FoxP3+CD25+ (Belkaid et al, 
2002; Campanelli et al, 2006), or Type 1 regulatory 1 (Tr1) cells, positive for 
CD223 and CD49b (Gagliani et al, 2013). 
Yet another resident population of immune cells in the skin is the F4/80+MHC-
IIhighCD11cmid mononuclear cells whose proportion is significantly reduced upon 
schistosoma infection. The number of these cells in the skin is initially 
unchanged, however it increases at day 2, restoring their original proportion. 
F4/80+MHC-IIhighCD11cmid cells are most likely to represent tissue resident 
F4/80+ macrophages, which have been the focus of intense research in recent 
years (Davies et al, 2013). 
Tissue resident macrophages are able to proliferate in situ (Jenkins et al, 2011). 
They are seeded in most tissues from the embryonic state and maintain their 
levels through local proliferation (Jenkins et al, 2013; Schulz et al, 2012). 
However, in the skin, tissue resident macrophages come from the bone marrow 
(Jakubzick et al, 2013). Their role in infectious processes is still an area of 
heated debate. Some propose that it is blood-recruited monocytes that hold the 
most immunomodulatory role (Girgis et al, 2014; Gundra et al, 2014), yet others 
argue that resident macrophages are more important in helminth infections 
(Davies et al, 2013; Jenkins et al, 2011). Similar studies have not been 
conducted in the skin, however the evidence presented here shows that these 
cells are responding to S. mansoni infection alongside other mononuclear cells. 
Better markers for tissue resident macrophages would be required to 
conclusively demonstrate that these cells can be assigned that classification. In 
recent years, several new markers to discriminate between these cells and 
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other monocytes have been proposed (i.e. Ly6C, MerTK, CD115, CD64) (Girgis 
et al, 2014; Nascimento et al, 2014), yet they were not used in the present 
study. 
Several populations of immune cells were found in the skin after S. mansoni 
infection based on expression of F4/80, MHC-II, CD11c, CD11b, CD4 and CD3. 
The remaining uncharacterized cells are likely to include basophils, mast cells, 
B cells, CD8+ T cells, γδ T cells, NK cells and other innate lymphoid cells. 
However, theses populations are small in number and difficult to characterize or 
find in the DEC. The identified populations responded robustly by increasing in 
number at different times and are likely to attempt parasite clearance 
(neutrophils and eosinophils), orchestrate adaptive immune responses (DCs 
and CD4+ T cells), condition the immune environment as a source of cytokines 
plus antigen presentation (inflammatory monocytes), and limit the amount of 
tissue damage plus inducing its repair (tissue residents macrophages and 
regulatory CD4+ T cells). The exact causes of the influx of immune cells into the 
skin after S. mansoni infection are unknown. Signals triggered by the parasite 
secretions, particularly the production of CCL2 by macrophages shown in 
3.3.5.1, have the potential to account for the recruitment of monocytes. 
Moreover, levels of IL-5 are increased in the skin after S. mansoni infection 
(data not shown), which could explain the recruitment of eosinophils. However, 
a comprehensive study on the chemokines involved in this process has not 
been carried out. 
6.4.2 S. mansoni infection triggers the production of IL-10 by tissue 
resident macrophages 
Several cytokines are secreted by S. mansoni infected skin, including IL-1, IL-
18, IL-6 and TNF-α (Hogg et al, 2003a). In this study, IL-10 and IL-12p40 were 
measured and both were found elevated on day 4 after cercarial invasion. 
Using IL-10 reporter mice, it was determined that IL-10 was produced in the 
skin as a response to infection as early as day 1, and that this production 
continued to increase until at least day 4.  
The cellular source of IL-10, which has been investigated in later stages of S. 
mansoni infection (Scheer et al, 2014), and the importance of which in 
schistosomiasis has been highlighted frequently in this thesis (1.5.1), in the skin 
was completely unknown. Here it was shown, that two populations of immune 
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cells in the skin were responsible for the vast majority of IL-10 production; tissue 
resident F4/80+MHC-IIhighCD11cmid macrophages and CD4+ T cells. 
IL-10 is important after primary S. mansion skin infection by limiting the 
recruitment of neutrophils, preventing excessive tissue damage and dampening 
local proliferation of T cells. These features become further enhanced after 
multiple exposures to the parasite, as evidenced in IL-10 deficient animals 
(manuscript in preparation). Consequently the relative contribution to IL-10 
production by populations of cells in S. mansoni infected skin and the 
mechanisms that drive that production need to be elucidated.  
The production of IL-10 by CD4+ T cells was surprising as parasite antigen- 
specific cells would not have had enough time to clonally expand by day 1 and 
few DCs to prime T cells were available in the skin at this stage of the infection.  
Nevertheless, CD4+ T cells accounted for a significant portion of the initial 
production of IL-10 (day 1) in response to S. mansoni larvae. Consequently, it is 
likely that these rapidly responding CD4+ T cells are in fact tissue resident cells 
responding to the skin microbiota. Likely candidates for these cells are a 
number of regulatory T cells mentioned earlier, including FoxP3+CD25+ T cells 
(Belkaid et al, 2001; Belkaid & Naik, 2013; Campanelli et al, 2006; Naik et al, 
2012; Sanchez Rodriguez et al, 2014) and suppressive Tr1 cells (Gagliani et al, 
2013; Sabat et al, 2010). These cells have been shown to be detrimental for 
pathology by preventing parasite clearance in Leishmania infections (Belkaid et 
al, 2001; Campanelli et al, 2006), and can be retained in inflamed skin 
(Staumont-Salle et al, 2014; Suffia et al, 2005). The involvement of these IL-10+ 
CD4+ T cells in the early response to S. mansoni opens up an exciting 
possibility: namely, are schistosomula exploiting the tolerance induced by skin 
commensals to promote migration through the skin? Indeed, the absence of T 
regulatory cells has been shown to facilitate worm clearance in other settings 
(Sawant et al, 2014). To test this it would be necessary to carry out an infection 
in germ-free or antibiotic treated mice. However, cercariae are obtained from a 
non-sterile environment, so these experiments would also require a completely 
sterile life cycle of the parasite, which would be technically challenging and 
expensive.  
By day 2, these tolerance-maintaining CD4+ T cells contribute significantly less 
to the production of IL-10. However, by day 4, when APCs have had a chance 
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to prime T cells, these activated S. mansoni specific CD4+ T cells become the 
main source of IL-10 in the skin. Indeed, the proportion of T cells that produced 
IL-10 increased as infection progressed beyond any other IL-10+ population. 
CD4+ T cells are also the main sources of IL-10 at later stages of S. mansoni 
infection in the mesenteric lymph node (Scheer et al, 2014). No IFN-γ or IL-4 
could be detected at this stage by ELISA, and the vast majority of day 4 IL-10+ 
CD4+ T cells were not T regulatory cells (data not shown) leaving the question 
of what T helper cell subset these cells might be open. However, in vitro 
stimulation of DEC from infected mice has suggested that these T cells could be 
Th2 cells (manuscript in preparation). Consequently, the question of how these 
Th2 cells are primed/polarized in the skin is wide open, but the mechanism 
could involve elevated levels of IL-10 produced by local antigen presenting cells 
in response to cercarial E/S products. 
As discussed earlier, the role of tissue resident macrophages is highly 
contentious. In naïve skin, a subset of F4/80+MHC-IIhighCD11cmid macrophages, 
probably tissue resident, produced IL-10, and is likely to be in response to the 
mechanical disruption of the tissue during skin biopsy processing. However, it is 
clear that these tissue resident macrophages, and not any other mononuclear 
cells in the DEC, are poised to respond to tissue damage by limiting 
inflammation in an IL-10 dependent manner. 
However, F4/80+MHC-IIhighCD11cmid tissue resident macrophages produced 
elevated levels of IL-10 at every stage of infection in the skin compared to naïve 
DEC. The increase in numbers of GFP+ F4/80+MHC-IIhighCD11cmid 
macrophages at day 2 and 4 after cercarial invasion indicates that progressively 
more of these cells participate in the response to the invading larvae by limiting 
inflammation. Macrophage derived IL-10 has been shown to confer 
susceptibility to helminth infections (Specht et al, 2012), which adds weight to 
the potential role of this early IL-10 production in the course of S. mansoni 
infection. Unlike in vitro assays used in previous chapters, IL-10 production by 
skin F4/80+MHC-IIhighCD11cmid macrophages obtained ex vivo will be the result 
of several conflicting signals, including cercarial E/S products released during 
parasite penetration, antigens from migrating larvae through the skin, tissue 
damage caused by migrating larvae, and the presence of skin commensal 
microorganisms. Skin commensals are likely to be most relevant only on day 1 
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of infection, as seen with the early CD4+ T cell production of IL-10. Tissue 
damage induced by cercariae is an important factor, but it is likely to be dwarfed 
by the mechanical disruption of the tissue when samples were processed. 
Therefore, the dominant signal driving IL-10 production from these cells must 
be the schistosomula and/or their secretions. To determine whether myeloid or 
lymphoid derived IL-10 holds the balance of preventing excessive inflammation 
in the skin will require lineage specific IL-10 deficient animals. It is possible that 
early IL-10 by both macrophages and T cells (in a mixed response to 
commensals and S. mansoni E/S products) drives T cells towards a Th2 
phenotype, with abundant secretion of IL-10. 
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6.5 Summary 
S. mansoni infection in the skin induces significant changes in the populations 
of tissue resident cells and immune cells recruited to the site, or are proliferating 
locally. An inflammatory process marked by the arrival of neutrophils, 
eosinophils and inflammatory monocytes develops, alongside the appearance 
of DCs, and later CD4+ T cells. However, it falls to tissue resident macrophages 
and regulatory CD4+ T cells to produce the majority of IL-10 in response to the 
advancing cercariae. Each population is likely to be responding to different 
stimuli. Tissue resident macrophages will produce IL-10 in response to cercarial 
E/S products and skin microbiota, whereas CD4+ T cells would only respond to 
the latter on day 1. As the parasite migrates through the dermis, F4/80+MHC-
IIhighCD11cmid macrophages produce more IL-10 than any other population of 
cells in the skin. By day 4 however, schistosoma antigen-specific CD4+ T cells 
will expand in the skin and produce IL-10 alongside tissue resident 
macrophages. 
A mechanism by which tissue resident macrophages can recognize cercarial 
E/S products and produce IL-10 as a result of that interaction has been 
proposed using in vitro cultured BMMϕs (Diagram 4.2). In combination, these 
findings demonstrate that macrophages within murine skin also produce IL-10 
in vivo in response to S. mansoni E/S products. 
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Figure 6.1 Flow cytometric analysis of cell populations in DEC after S. 
mansoni cercariae invasion 
Pinnae from C57BL/6 mice were split longitudinally 4 days after infection with S. 
mansoni cercariae infection and floated overnight in complete RPMI. DEC, 
which had migrated from the split pinnae were, labeled with (A) live/dead 
discrimination dye, gated according to FSC and SSC, and selected for single 
cells. (B) Gating strategy was defined with respect to relevant isotype controls 
for antibodies as used in C. DEC were labeled for antibodies against (C) F4/80 
and MHC-II (left-hand panel), and against CD11b plus CD4 (right-hand panel).  
(D) CD4+CD11b- cells were subsequently analyzed for their expression of CD4+ 
and CD3 (left-hand panel); CD11bhigh cells were subsequently analysed for their 
expression of Gr1 (right-hand panel). Representative flow plots of DEC from 1 
pinna gated on live single cells are presented. 
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Figure 6.2 Total cell numbers in DEC after infection of pinnae with S. 
mansoni cercariae 
Total number of DEC from naïve pinnae (open circles), or pinnae 1, 2 or 4 days 
after infection (closed circles) with S. mansoni cercariae. Mean ±SEM from 4-5 
mice (8-10 pinnae) are given. ANOVA and then Sidak’s multiple comparisons 
test were performed to examine differences between the means of all infected 
groups compared to naïve (*** = p<0.001; ns = p>0.05). 
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Figure 6.3 Proportions of cell populations in DEC after infection of pinnae 
with S. mansoni cercariae 
DEC from naïve pinnae (open circles), or pinnae 1, 2 or 4 days after S. mansoni 
infection (closed circles) were grouped into five distinct populations based on 
the expression of F4/80, MHC-II, CD11b, CD4 and CD3. Mean ±SEM of 
percentages from 4-5 mice (8-10 pinnae) of (A) F4/80-MHC-IIhigh, (B) 
F4/80+MHC-IIhigh, (C) F4/80+MHC-IIlow, (D) F4/80+MHC-II-, (E) CD3+CD4+ 
(CD11b-F4/80-MHC-II-), (F) F4/80-MHC-II-CD11bhigh are given. ANOVA and 
then Tukey’s multiple comparisons test were performed to examine differences 
between the means of selected groups (* = p<0.05; ** = p<0.01; *** = p<0.001; 
**** = p<0.0001; ns = p>0.05). This experiment was repeated twice. 
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Figure 6.4 Numbers of cell populations in DEC after infection of pinnae 
with S. mansoni cercariae 
DEC from naïve pinnae (open circles), or pinnae 1, 2 or 4 days after S. mansoni 
infection (closed circles) were grouped into five distinct populations based on 
the expression of F4/80, MHC-II, CD11b, CD4 and CD3. Mean ±SEM of 
absolute numbers from 4-5 mice (8-10 pinnae) of (A) F4/80-MHC-IIhigh, (B) 
F4/80+MHC-IIhigh, (C) F4/80+MHC-IIlow, (D) F4/80+MHC-II-, (E) CD3+CD4+ 
(CD11b-F4/80-MHC-II-), (F) F4/80-MHC-II-CD11bhigh are given. ANOVA and 
then Tukey’s multiple comparisons test were performed to examine differences 
between the means of selected groups (* = p<0.05; ** = p<0.01; *** = p<0.001; 
**** = p<0.0001; ns = p>0.05). This experiment was repeated twice. 
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Figure 6.5 CD11c expression on MHC-II+ DEC populations recovered from 
mice 4 days after exposure of pinnae to S. mansoni cercariae 
Three populations of cells with variable levels of MHC-II and F4/80 expression 
in DEC recovered on day 4 after exposure to S. mansoni cercariae were 
analyzed via flow cytometry for the expression of CD11c. Mean MFI ±SEM of 
each population from 5 mice (10 pinnae) are given. ANOVA and then Tukey’s 
multiple comparisons test were performed to examine differences between the 
means of selected populations (* = p<0.05; ** = p<0.01; *** = p<0.001; **** = 
p<0.0001; ns = p>0.05). This experiment is representative of three independent 
experiments. 
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Figure 6.6 Cytokine production from in vitro cultured skin biopsies from 
mice infected with S. mansoni cercariae 
Pinnae obtained from mice 4 days after exposure to S. mansoni cercariae were 
cultured in vitro overnight and supernatants tested for production of IL-10 and 
IL-12p40 by ELISA (detection limit for IL-10 ELISA was at 16pg/ml). 
Supernatants were from infected (closed circles) and age matched naïve 
control (open circles) mice. Means ±SEM for each group of 3-4 mice (6-8 
pinnae) are presented. Two tailed t-tests were performed to find statistically 
significant differences between the means for the two groups of mice (** = 
p<0.01; *** = p<0.001). 
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Figure 6.7 IL-10 production time course from skin infected with S. 
mansoni cercariae 
(A) Culture supernatants were analyzed for IL-10 after 0.5, 2, 4, 6, 18 and 21 
hours. Means ±SEM for each time point of 2 mice (4 pinnae) are presented. (B) 
Brefeldin A (BreA) was added to culture supernatant (6 pinnae) at 12 hours of 
incubation (closed circles), and IL-10 production compared with un-treated 
cultures (open circles; 4 pinnae) when samples were taken after 20 hours of 
incubation. Two tailed t-tests were performed to examine differences between 
the means (* = p<0.05). 
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Figure 6.8 Proportions of GFP+DEC after infection with S. mansoni 
cercariae 
(A) Representative flow plots from DEC from WT or IL-10+/gfp naïve mice, or 
mice 1, 2 and 4 days after exposure to S. mansoni cercariae. Gates (and 
percentage values) represent proportion of GFP+DEC at each time point. (B) 
Mean ±SEM of percentages from 2-3 mice (4-6 pinnae) for WT (black) or IL-
10+/gfp (green) mice at each time point are given. ANOVA and then Sidak’s 
multiple comparisons test were performed to examine differences between the 
means of selected groups (* = p<0.05; ** = p<0.01; *** = p<0.001; **** = 
p<0.0001; ns = p>0.05). This experiment was performed twice. 
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Figure 6.9 Proportions of GFP+ cell populations in DEC after exposure of 
pinnae to S. mansoni cercariae 
(A-B) Representative flow plots from GFP+ DEC (gated for as shown in Figure 
6.8), labeled with antibodies against MHC-II, F4/80, CD11b, and CD4, from IL-
10+/gfp naïve mice or IL-10+/gfp infected mice. (C-F) Proportions of different 
groups of cells obtained from naive mice and at day 1, 2 and 4 after infection 
with S. mansoni cercariae. Mean ±SEM of percentages from 2-3 mice (4-6 
pinnae) are given. ANOVA and then Sidak’s multiple comparisons test were 
performed to examine differences between the means of selected groups (* = 
p<0.05; ** = p<0.01; *** = p<0.001; **** = p<0.0001; ns = p>0.05). This 
experiment was performed twice. 
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Figure 6.10 Number of GFP+ F4/80+MHC-IIhigh cells in DEC from mice after 
exposure S. mansoni cercariae 
GFP+ F4/80+MHC-IIhigh cells in DEC from IL-10+/gfp naïve mice (open circles) or 
IL-10+/gfp mice infected for 1, 2 or 4 days (closed circles) were analyzed via flow 
cytometry, and in conjunction with cell counts used to calculate the total number 
of cells in each group. Mean ±SEM of numbers from 2-3 mice (4-6 pinnae) are 
given. ANOVA and then Dunnett’s multiple comparisons test were performed to 
examine differences between the means of each group compared to naïve (** = 
p<0.01; *** = p<0.001). 
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Figure 6.11 CD11c expression on MHC-II+GFP+ DEC populations from mice 
4 days after exposure to S. mansoni cercariae  
Three populations of GFP+ DEC with differential levels of MHC-II and F4/80 
expression were analyzed via flow cytometry for the expression of CD11c. 
Mean MFI ±SEM of each population from 3 mice (6 pinnae) are given. ANOVA 
and then Tukey’s multiple comparisons test were performed to examine 
differences between the means of selected groups (**** = p<0.0001). 
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Figure 6.12 Percentages and number of GFP+ CD3+CD4+ cells in DEC from 
mice after exposure S. mansoni cercariae 
GFP+ CD3+CD4+ cells in DEC from IL-10+/gfp naïve mice (open circles) or IL-
10+/gfp mice infected for 1, 2 or 4 days (closed circles) were analyzed via flow 
cytometry, and in conjunction with cell counts used to calculate the total number 
of cells in each group. Mean ±SEM of (A) percentages and (B) absolute 
numbers from 2-3 mice (4-6 pinnae) are given. ANOVA and then Sidak’s 
multiple comparisons test were performed to examine differences between 
selected means (** = p<0.01; **** = p<0.0001). 
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7 Discussion 
7.1 S. mansoni cercarial E/S products have a profound impact 
on macrophage phenotype 
E/S products have diverse roles in the modulation of the immune response 
during different helminth infections and they can act on several different cells of 
the immune system (Hewitson et al, 2009). All S. mansoni life stages in the 
mammalian host secrete molecules into their environment (Wilson, 2012). For 
example, adult worms release a cysteine protease that is associated with a Th2 
bias (de Oliveira Fraga et al, 2010).  Also S. mansoni eggs are thought to 
secrete a chemokine binding protein which retains immune cells in the 
granulomas (Smith et al, 2005), whilst egg secretions have recently been 
proposed to facilitate the exit from the host through the Peyer’s patches (Turner 
et al, 2012). It is therefore unsurprising that the E/S products released by 
invading S. mansoni larvae have a profound impact on macrophages. 
0-3hRP elicited cytokine production in BMMϕs was significantly different from 
other PAMPs, and was independent of possible endotoxin contamination. RNA 
levels of cytokines conventionally associated with innate immune cells, such as 
TNFα, IL-1and IL-6 (Benoit et al, 2008; Hertzog et al, 2011; Ioannou & 
Voulgarelis, 2010; Rathinam et al, 2012; Ruland, 2011), were greatly increased 
in 0-3hRP stimulated cells (3.3.5.1). However, 0-3hRP consistently induced 
higher levels of IL-10 and lower levels of IL-12 than LPS (both as RNA and 
protein). IL-10 was produced first, in close association with the uptake of the 
secretions. This IL-10 induction bias underpins the special nature of 0-3hRP as 
an innate stimulus, driving a mixed immune response that has a strong anti-
inflammatory component.  
An exciting discovery was made using label-free quantitative proteomics of 
membrane proteins from 0-3hRP stimulated BMMϕs. A significant increase in 
the expression of proteins linked with the metabolism of organic substances 
was demonstrated. This could mean that processing and responding to 0-3hRP 
is costly from an energy point of view, which occurs to a greater extent than 
responding to LPS. Moreover, SEA has been shown to up-regulate proteins 
involved with metabolic processes in dendritic cells (Ferret-Bernard et al, 2012), 
and a growing body of research is beginning to explore the interplay and 
intimate linkage between metabolism and the immune response (Arnoult et al, 
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2011; Everts et al, 2014; Ferret-Bernard et al, 2012; Gehart et al, 2010; 
Pulendran & Artis, 2012; Vanhaesebroeck et al, 2012; West et al, 2011). The 
enhanced metabolic activity in 0-3hRP stimulated BMMϕs requires further 
exploration. For example, the use of targeted inhibitors acting on proteins 
associated with metabolism, or the use of genetically deficient BMMϕs that lack 
one or more of those proteins would begin to address their potential role in the 
immune responses to 0-3hRP. Similarly, direct measures of metabolic activity in 
these cells (e.g. rate of extracellular acidification, or the rate of oxygen 
consumption) would confirm, or refute, my proteomic results, and highlight 
potential differences between the metabolic demands of 0-3hRP and other 
PAMPs. 
0-3hRP stimulated macrophages also regulated membrane-associated proteins 
with known immunological functions. As such, MSR1 and CD36 are both 
scavenger receptors that could be implicated in uptake of 0-3hRP, as is the 
case with other ligands for these receptors (Baranova et al, 2012; Blanchet et 
al, 2014; Fonager et al, 2012; Mukhopadhyay et al, 2011; Oury, 2014; Sulahian 
et al, 2008). CD36 is also an accessory receptor to TLR2 (Lee et al, 2012), and 
the fact that its expression is reduced in response to 0-3hRP indicates that 
stimulated macrophages will have limited availability of this receptor on the 
surface. CD14 is perhaps the best characterized co-receptor for the TLR 
system (Akira & Takeda, 2004; Ambarus et al, 2012; Baumann et al, 2010; 
Ioannou & Voulgarelis, 2010; Valanne et al, 2011), and its expression is up-
regulated in 0-3hRP treated BMMϕs, further suggesting a role for this family of 
receptors in the recognition of parasite secretions. Although the contribution of 
CD14 and MSR1 to the responses observed in 0-3hRP stimulated BMMϕs was 
not addressed in this work, blocking antibodies against both could provide initial 
evidence about their role in the recognition, or uptake of 0-3hRP. Moreover, as 
CD36 was observed to be down-regulated in stimulated BMMϕs, a more 
appropriate experiment would be to use genetically modified BMMϕs that over-
express that protein. 
Macrophages are dramatically altered by exposure to S. mansoni cercarial E/S 
products. These cells become highly active metabolically and start producing a 
mixture of pro and anti-inflammatory cytokines. Importantly, these changes do 
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not include increases in co-stimulatory molecules or MHC-II.  Rather these cells 
start producing significant amounts of regulatory IL-10. 
7.2 TLR2 and TLR4 drive the production of IL-10 by 
macrophages in response to cercarial E/S products  
Macrophages exert a very detailed control over the production of IL-10 and IL-
12p40 in response to S. mansoni cercarial E/S products. My studies show that 
BMMϕs directly recognize 0-3hRP using TLR2 and TLR4, which are 
responsible for the production of IL-10 in a MyD88-dependent manner. Other 
studies on different ligands show that TLR2 can have a more regulatory role 
than TLR4, by limiting the ability of antigen presenting cells to induce a Th1 
response (Agrawal et al, 2003; Gao et al, 2012; van Riet et al, 2009), blocking 
the production of pro-inflammatory cytokines (Correale & Farez, 2009), 
regulating susceptibility to bacterial infection (Blanchet et al, 2014), and/ or 
promoting the production of IL-10 (van Vliet et al, 2013). Indeed, TLR2 
compared to TLR4, deficiency in BMMϕs exposed to 0-3hRP resulted in a more 
pronounced defect in the induction of IL-10. Conversely, the absence of TLR2 
had a relatively small effect on IL-12p40, unlike TLR4 that greatly reduced the 
production of this cytokine in response to 0-3hRP. Furthermore, at least one of 
the components of 0-3hRP, the protein Sm16, is able to block TLR4 driven 
cytokine production (8.4). Recombinant Sm16 can in fact significantly limit the 
LPS-IFN-γ driven oxidative burst and IL-12p40 production in macrophages. 
Moreover, this protein is significantly enriched in a fraction of 0-3hRP that was 
found to retain a higher proportion of the IL-10 inducing potential of the 
antigenic preparation (8.3). This Sm16 rich fraction, with the IL-10 inducing 
potential, was also able to block IL-12p40 production in response to LPS. Thus, 
TLR2 mediates IL-10 production by macrophages exposed to S. mansoni 
cercarial secretions, limiting their ability to contribute to the induction of Th1 
responses. 
Proteomic studies showed that BMMϕs stimulated with 0-3hRP up-regulated 
proteins that modulate MAPK responses, a category absent from LPS-treated 
cells (3.3.3.2). In conjunction with the regulation of elements of the TLR system 
(CD14 and CD36) and the involvement of TLR2 and TLR4 in the production of 
IL-10 elicited by the parasite secretions, MAPKs appeared to be a likely link 
between the exposure to 0-3hRP and the downstream immune response. 
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Indeed, p105, Erk1/2, RSK, p38, and CREB have maximal phosphorylation 
30min after stimulation with cercarial E/S products, as measured by flow 
cytometry, confirming data obtained using a proteome profiler array, where 
similarities in the phosphorylation of p38α, MSK2, ERK2, RSK2 and CREB also 
suggested links in the activation of these kinases. The activation of these 
proteins was further demonstrated to depend directly upon MyD88 and is 
strongly impacted by the absence of TLR2, whose function is complemented by 
TLR4. 
Activation of p38 downstream from TLRs is well characterized and mediated by 
the phosphorylation of MAP3K7. This protein will activate MKK3/6, which 
phosphorylates p38 and then activates several targets (Akira & Takeda, 2004; 
Arthur & Ley, 2013; Yang et al, 2010). p38α is known to phosphorylate MSK2 
(Yang et al, 2010) which has been reported to phosphorylate CREB 
downstream of p38 (Ananieva et al, 2008; Deak et al, 1998; Elcombe et al, 
2013; Mayer et al, 2013). In addition, the phosphorylation of p105 results in its 
degradation into p50, releasing Tpl2 from an inactive cytoplasmic complex. The 
release of Tpl2, results in the activation of MEK1/2 and subsequent 
phosphorylation of Erk1/2, which can in turn activate RSK2 (Bain et al, 2007; 
Mayer et al, 2013; van Vliet et al, 2013). In BMMϕs exposed to cercarial E/S 
products, p105 and Erk1/2 phosphorylation leads to the activation of RSK and 
CREB. The association between Erk1/2 and CREB has been reported in the 
past with other innate immune stimuli, such as Zymosan or Leishmania 
parasites, and receptors including TLRs (Elcombe et al, 2013; Nandan et al, 
2012; Nandan & Reiner, 2005; van Vliet et al, 2013), however, this association 
has not been reported in the context of helminth antigens. 
The hierarchy of phosphorylation events and their link to cytokine production 
was established in macrophages exposed to 0-3hRP using a combination of 
genetically deficient mice and chemical inhibitors. The pathway of events that I 
propose (Diagram 7.1) shows how S. mansoni cercarial E/S products 
coordinate the production of IL-10, whilst limiting the production of IL-12p40. 
The production of pro-inflammatory cytokines is likely to be a result of the 
phosphorylation of p65, which would associate with released p50 forming a 
heterodimer. The p50/p65 complex is a well-known transcription factor, and 
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among its prime targets are pro-inflammatory cytokines such as IL-1β, IL-6 and 
importantly IL-12p40 (Cao et al, 2006; Hoesel & Schmid, 2013). 
Diagram 7.1 IL-10 biogenesis in macrophages exposed to S. mansoni 
cercarial E/S products 
 
Main phosphorylation events (orange dashed line) in BMMϕs, which have taken 
up S. mansoni cercarial E/S products (red). 
Similar pathways have been proposed by others for ligands such as LPS or 
Zymosan (Arthur & Ley, 2013; Elcombe et al, 2013; Lucas et al, 2005; Mayer et 
al, 2013; van Vliet et al, 2013; Zhang et al, 2006), that included MSK1/2 
(Ananieva et al, 2008), that was also found to be to be phosphorylated in 
response to 0-3hRP. However, no other study has demonstrated this pathway 
in the context of a helminth antigen, and only infrequently as a result of TLR 
signaling. Most studies have limited their demonstration of the link between IL-
10 and CREB by using chemical inhibition, siRNA or genetically modified cells. 
However, only two studies showed an interaction between CREB and DNA from 
the IL-10 gene. One in a highly artificial system (Nandan et al, 2012) and the 
other in conjunction with another transcription factor (Ananieva et al, 2008).  
Here it is demonstrated that in BMMϕs exposed to cercarial E/S products, 
phosphorylated CREB is recruited to the IL-10 promoter in a region that 
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overlaps with the first exon of the gene, which is different from what was 
reported in the past (Ananieva et al, 2008). This recruitment is apparent 30 
minutes after stimulation with the parasite’s secretions, at which point there is a 
peak in the activation of CREB. Both the abundant levels of phosphorylated 
CREB and its strong interaction with the IL-10 promoter, place this transcription 
factor in a privileged place to effectively regulate the transcription of this 
cytokine. 
Phosphorylated CREB is unlikely to limit its role to IL-10 regulation in the 
context of 0-3hRP-stimulation. The most highly expressed transcript in 0-3hRP 
stimulated BMMϕs after 30min was the transcription factor Egr1. Erk and CREB 
have been shown to be upstream from Egr1 (Pagel & Deindl, 2011; Shen et al, 
2011). Egr1 targets several hundred genes and is often associated with tissue 
damage, however some of genes regulated by this protein are related to 
inflammation. However, the role of Egr1 in that regulation is not clear (Fu et al, 
2003). Thus, it is likely that 0-3hRP induced CREB activation enhances the 
transcription of Egr1. 
As both Egr1 and IL-10 appear to be under the control of phosphorylated 
CREB, a more detailed exploration of the genes regulated by this protein is 
required. ChIP-Seq would provide a comprehensive description of the regions 
of the chromatin with which this transcription factor is interacting in 
macrophages committed to the production of IL-10 in the manner proposed 
above (Diagram 7.1). Bioinformatic analysis of this information would arm us 
with the precise knowledge of how CREB phosphorylation in macrophages 
conditions the overall phenotype in these cells, greatly contributing to their 
plasticity. To that effect, DNA fragments precipitated with anti-P-CREB Ab from 
0-3hRP stimulated BMMϕs have been prepared and sent for sequencing 
(results pending).  
7.3 Endosomal recognition of cercarial E/S products by 
macrophages is likely to play an important role in cytokine 
responses 
The receptor(s) involved in the uptake of 0-3hRP is not fully known. Other S. 
mansoni antigens (i.e. SEA) can be internalized by CLRs (Everts et al, 2012; 
van Liempt et al, 2007). 0-3hRP is a similarly complex mixture of proteins 
(Curwen et al, 2006), some of which are glycosylated (Jang-Lee et al, 2007), 
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and partly requires the mannose receptor for internalization into macrophages 
(Paveley et al, 2011). Additionally, at least MSR1 is up-regulated by 0-3hRP 
(3.3.3.3) raising the possibility that this receptor could be involved in 0-3hRP 
uptake. 
A growing body of literature has considered the possibility that TLRs abundant 
on the cell surface are also able to direct signaling pathways from endosomal 
compartments (Aksoy et al, 2012; Bonham et al, 2014; Kagan & Iwasaki, 2012). 
Indeed, some studies reveal the intricate interplay between TLRs on the surface 
and in the endosomes in responses to bacterial products (Wolf et al, 2011). In 
particular, TLR4 has been shown to accumulate in phagolysosomes (Kagan & 
Iwasaki, 2012), and helminth products can sequester TLR components limiting 
their responses to other stimuli (Pineda et al, 2014). 
The activation of the MAPK pathway described (Diagram 7.1) linked with the 
early detection of IL-10 mRNA in response to the 0-3hRP, matches the uptake 
of 0-3hRP by BMMϕs. Previous studies have shown that S. mansoni E/S 
products are taken up by macrophages in the skin and by BMMϕs in vitro 
(Paveley et al, 2009). This uptake process requires both actin polymerization 
and PI3K signaling and involves the trafficking of 0-3hRP though early 
endosomes (as determined by EEA-1 staining, see 5.3.1.1). Furthermore, 
inhibition of uptake resulted in significant reductions in the activation of Erk1/2, 
p38 and CREB, and also the production of IL-10. With the knowledge that TLR2 
and TLR4 are responsible for the activation of these signals and the production 
of IL-10, this evidence strongly supports the possibility that 0-3hRP is binding 
TLR2 or TLR4 in endosomes. Additional experiments would be required to 
demonstrate this, for example isolation of 0-3hRP loaded vesicles in 
macrophages followed by the detection of TLR2 or TLR4. In that manner, it is 
hoped to demonstrate which “cell surface” TLR is/are able to travel with their 
ligands to the endosome and use certain adaptor molecules to influence 
macrophage phenotype. As stated before, TLR4 has already been found in the 
endosomes (Aksoy et al, 2012), but similar studies are lacking for TLR2. Even if 
TLR2 or TLR4 were found in 0-3hRP loaded vesicles, teasing out the 
consequences of those potential interactions would require complex genetic 
manipulation of macrophages, a process primary cells are not amenable to, 
unlike some macrophage cell lines (e.g. RAW 264.7). Furthermore, discarding 
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the possibility that TLR2 or TLR4 are in fact acting in concert with an endosomal 
TLR would be required. This could be demonstrated by performing stimulation 
experiments with macrophages deficient for endosomal TLRs. 
Unlike blocking actin polymerization, PI3K inhibition not only prevents 
phagocytosis, but also impacts the recruitment of adaptor molecules to different 
cellular compartments (Vanhaesebroeck et al, 2012). In fact, inhibition of p110-
δ has been shown to prevent TLR4 internalization and enhance its ability to 
signal from the cell surface (Aksoy et al, 2012), while PI3K signaling is required 
for adequate recruitment of TIRAP to TLRs (Bonham et al, 2014). TOR is 
downstream of PI3K. The strong and prolonged activation of TOR, which 
started 30min after stimulation with 0-3hRP as demonstrated with the proteome 
profiler, further suggests that PI3K signaling plays a role in 0-3hRP responses. 
However, other members of this signaling pathway were not found to be active 
(such as the Akt family). To further elucidate the relevance of TOR activation in 
macrophages stimulated with 0-3hRP chemical inhibition of that molecule (i.e. 
Rapamycin) could be used. 
PI3K signaling could be very relevant in orchestrating 0-3hRP trafficking 
through BMMϕs. 0-3hRP is delayed in appearing in early endosomes (Paveley 
et al, 2009) and it contains a significant portion of particulate material that has 
strong immunomodulatory power (8.3). The size and shape of this particulate 
material could play an important role in the phenotype of 0-3hRP stimulated 
cells, as observed with other particles (Flach et al, 2011). Detailed trafficking 
studies, involving confocal microscopy of macrophages labeled with antibodies 
against several components of the endocytosis pathway (e.g. RAB proteins and 
LAMP1) exposed to labeled parasite material would be necessary (in the 
presence and absence of selective PI3K inhibitors). Similarly, the naturally 
fluorescent properties of a fraction of 0-3hRP (see 8.3.6) could be exploited to 
investigate the relevance of particulate vs. soluble processing of 0-3hRP, by 
investigating the trafficking of each one in isolation and linking this differential 
processing with the distinctive stimulatory properties of the fractions of these 
cercarial secretions. 
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7.4 Macrophages in the skin are an important source of IL-10 
in S. mansoni cercarial infection 
Several cytokines are secreted by S. mansoni infected skin, including IL-1β, IL-
18, IL-6 and TNF-α (Hogg et al, 2003b) plus IL-12p40 and IL-10. Similarly, 
several distinct populations of immune cells were found in the skin after S. 
mansoni infection. These cells responded robustly by increasing in number, like 
neutrophils, eosinophils and inflammatory monocytes (likely to attempt parasite 
clearance), DCs and CD4+ T cells (probably orchestrating adaptive immune 
responses) and tissue resident macrophages (most likely limiting the amount of 
tissue damage plus inducing its repair). Detailed description of the earliest 
changes to skin immune cells after S. mansoni infection is scarce in modern 
literature. However, these novel findings require further investigation. Moreover, 
the cellular source of most of the cytokines in the skin remains unknown. Whilst 
it is likely that inflammatory monocytes, eosinophils and neutrophils are the 
primary producers of IL-1β, TNF-α and IL-6 (Nestle et al, 2009), keratinocytes 
could be a potential source of IL-1α (Pasparakis et al, 2014). Consequently, 
cytokine reporter mice should be employed to determine the source of these 
important early immune mediators. Alternatively, conditional cell-specific 
deficient animals could be employed to address the contribution of each cell 
type to the production of cytokines and the overall immune response in the skin 
after S. mansoni infection. 
Importantly, three populations of mononuclear cells were found in the skin after 
S. mansoni infection. First, blood recruited F4/80+MHC-IIlowCD11clow cells that 
are plastic and can adopt several phenotypes including AAMϕs (Cook et al, 
2011; Girgis et al, 2014), or CAMϕs (Benoit et al, 2008; Gundra et al, 2014). 
Second, DCs represented by F4/80-MHC-IIlhighCD11chigh cells, have an 
important role in polarizing the immune response (Agrawal et al, 2003; de Jong 
et al, 2002; MacDonald et al, 2002) and can also become alternatively activated 
(Cook et al, 2012). Finally, tissue resident macrophages, represented by 
F4/80+MHC-IIhighCD11cmid cells, which are able to proliferate in situ (Jenkins et 
al, 2011), are seeded in most tissues from the embryonic state and can 
maintain their levels through local proliferation (Jenkins et al, 2013; Schulz et al, 
2012). However, in the skin tissue resident macrophages come from the bone 
marrow (Jakubzick et al, 2013). The role of this cell population in infectious 
processes is contentious, with some proposing that blood-recruited monocytes 
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hold the most immunomodulatory role (Girgis et al, 2014; Gundra et al, 2014), 
yet others argue that resident macrophages that have immune modulatory role 
are more important in helminth infections (Davies et al, 2013; Jenkins et al, 
2011).  
The full contribution of these three types of myeloid mononuclear cells to S. 
mansoni skin infection is unclear. However, the evidence presented here shows 
that despite the fact that all these cells are responding to S. mansoni (on the 
basis of their recruitment to the skin), only tissue resident F4/80+MHC-
IIhighCD11cmid macrophages produce IL-10 in response to the infection, 
alongside CD4+ T cells. 
Two kinds of CD4+ T cells were found in the skin as a source of IL-10.  Initially, 
a tolerance-maintaining group of cells that produced IL-10 were observed, and 
were most likely to be in response to skin microbiota. Subsequently, a parasite -
antigen specific group, developed and expanded to take over most of the 
production of this cytokine. Furthermore, IL-10 producing T cells in the skin can 
have a profound impact on the outcome of other infections (e.g. Leishmaniasis) 
(Belkaid et al, 2001). 
The increase in numbers of IL-10 producing F4/80+MHC-IIhighCD11cmid tissue 
resident macrophages as the infection proceeded over the first few days 
indicates that progressively more of these cells participate in the response to 
invading larvae by limiting inflammation. Macrophage derived IL-10 is known to 
confer susceptibility to other helminth infections (Specht et al, 2012), which 
adds weight to the potential role of this early IL-10 production in the course of S. 
mansoni infection. As S. mansoni larvae release the contents of their acetabular 
glands during that invasion process providing the most potent source of 
parasite antigen in the skin, it is probable that these E/S products are the target 
for tissue resident macrophages. 
A natural following step from these findings would be to ablate IL-10 production 
specifically in these F4/80+ cells and evaluate the consequences to the 
infection. Additionally, transgenic animals lacking components of the proposed 
signaling pathway (Diagram 7.1) would be useful, both by validating my results 
and investigating the role of tissue resident macrophage derived IL-10. 
Nonetheless, initial studies performed during my Ph.D. on TLR2 deficient mice 
showed little to no difference in the induction of IL-10 in infected skin compared 
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to naïve controls (data not shown). The redundancy in the TLR system, 
particularly in the proposed signaling pathway that is used by both TLR2 and 
TLR4, coupled with the potential role of commensal microbiota in the induction 
of IL-10, severely compromises the usefulness of single full TLR deficient 
animals. In vivo chemical inhibition of kinases would have similar impairments, 
plus significant off target effects, by affecting not only macrophages but all cells 
in the mouse. 
In that context IL-10+/gfp animals lacking both TLR2 and TLR4 only on F4/80+ 
cells are likely to be a more reliable tool to investigate the contribution of these 
receptors in the induction of IL-10. Only inducible cell type specific deficient 
animals would be appropriate for intracellular components of the pathway (i.e. 
full CREB or Erk deficiency would be lethal at birth). Another exciting avenue to 
explore would be to use Förster resonance energy transfer (FRET) based 
technologies on transgenic mice expressing specific biosensors (such as Erk) to 
investigate signaling events in real time in the skin using multi-photon 
microscopy (as developed by others (Mizuno et al, 2014)). Consequently, my 
findings could be validated and expanded upon in vivo. 
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Concluding remarks  
In conclusion, this work has exhaustively investigated the signaling pathways 
linked to the production of IL-10 by macrophages exposed to S. mansoni 
cercarial E/S products. Key findings from this work include: 
1. A detailed description of global changes to the membrane proteome of 0-
3hRP stimulated macrophages, which highlights the role of metabolism 
in immune responses. 
2. A comprehensive mechanism that links TLR2 and TLR4 mediated, 
MyD88 dependent, MAPK phosphorylation in response to S. mansoni 
cercarial E/S products. The phosphorylation of these MAPKs leads to the 
activation CREB, which is recruited to the promoter of IL-10 to enhance 
the production of this cytokine,  
3. A role for the engagement of TLR2 and/or TLR4 in the endosomes of 
macrophages, leading to the activation of the proposed signaling 
mechanism that links S. mansoni cercarial E/S products to the production 
of IL-10 highlighting in particular the importance of PI3K. 
4. Confirmation that tissue resident macrophages produce IL-10 in vivo in 
response to S. mansoni cercarial E/S products, validating the in vitro 
studies and highlighting the different roles of tissue resident 
macrophages compared to recruited monocytes. 
Overall, these findings enhance current knowledge of macrophage biology. My 
studies provide a possible mechanism, supported by others in the literature, 
that is integral to macrophages in the production of IL-10. As the synthesis of 
this cytokine, and control, is very context specific, this added knowledge might 
enable us to predict instances when therapeutic intervention to boost or limit the 
production of IL-10 by macrophages would be appropriate.  
These findings also highlight the strategies that may be employed by helminth 
parasites to evade the immune system. For example, exploiting commensal 
skin micro-flora to generate a tolerant environment where larvae can penetrate 
our skin, is indeed an elegant mechanism that prevent excessive damage to S. 
mansoni cercariae. As these early events have the potential to impact the 
overall progression of the disease, targeting macrophage IL-10 production (with 
selective inhibitors of the pathway I proposed) could provide a post-exposure 
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prophylactic approach, in case of known accidental contact with cercariae 
contaminated water. However, this approach would be limited by the difficulty in 
targeting macrophages specifically, plus limiting IL-10 production could cause 
undesirable excessive tissue damage to the host. 
Finally, my Ph.D. studies confirm the role of innate immune signaling in 
response to schistosoma larvae in the skin and emphasizes that, even in the 
absence of cues from the adaptive immune system, macrophages are versatile 
cells. 
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8 Appendices
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8.1 Membrane protein analysis using label free proteomics 
Table 8.1 LC-MS/MS pre-run of membrane protein enriched samples sorted based on Mascot score for hits in 0-3hRP treatment 
  0-3hRP LPS Media 
Accession Description Mascot Score 
Peptide 
Matches 
Mascot 
Score 
Peptide 
Matches 
Mascot 
Score 
Peptide 
Matches 
MGI:87904 Actb Actin, cytoplasmic 1 1561 424 1609 506 1529 446 
MGI:107801 Atp5b ATP synthase subunit beta 1271 93 1235 122 1256 179 
MGI:96794 Lmna Isoform A of Lamin-A/C 1134 44 1162 38 1514 75 
MGI:88115 Atp5a1 ATP synthase subunit alpha 966 58 945 61 1052 79 
MGI:104808 Lcp1 Plastin-2 904 44 617 41 664 35 
MGI:95835 Hspa5 78 kDa glucose-regulated protein precursor 861 29 580 33 714 42 
MGI:99600 Aldh2 Aldehyde dehydrogenase 785 42 585 31 854 68 
MGI:97167 Msn Moesin 704 34 802 54 715 46 
MGI:96611 Itgb2 Integrin beta-2 precursor 681 21 773 24 678 28 
MGI:105384 Hspa8 Heat shock cognate 71 kDa protein 630 20 446 21 344 19 
MGI:87902 Acta1 Actin, alpha skeletal muscle 619 138 750 227 652 198 
MGI:1352757 Iqgap1 Ras GTPase-activating-like protein IQGAP1 615 21 509 24 824 43 
MGI:95834 Pdia3 Protein disulfide-isomerase A3 precursor 591 22 589 23 415 14 
MGI:95772 Gnai2 Guanine nucleotide-binding protein G(i), alpha-2 subunit 590 18 413 17 649 30 
MGI:1099832 Tln1 Talin-1 538 13 439 9 274 8 
MGI:96242 Hspd1 Isoform 1 of 60 kDa heat shock protein 538 17 284 11 401 20 
MGI:106504 Efhd2 SWIPROSIN 1 525 25 539 29 591 31 
MGI:106915 Vdac2 Voltage-dependent anion-selective channel protein 2 503 15 377 16 430 24 
MGI:5000466 Anpep Aminopeptidase N 495 20 624 26 589 27 
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MGI:97050 Mdh2 Malate dehydrogenase 492 19 637 28 697 47 
MGI:96607 Itgam integrin alpha M 475 14 277 16 481 27 
MGI:98932 Vim Vimentin 469 16 687 38 752 46 
MGI:1353496 Slc25a5 ADP/ATP translocase 2 463 27 495 42 502 46 
MGI:101757 Cfl1 Cofilin-1 452 21 0 0 351 17 
MGI:88246 Anxa2 Annexin A2 435 18 325 16 383 24 
MGI:2388633 Cltc Clathrin heavy chain 1 431 14 374 13 474 21 
MGI:1350931 Tcirg1 T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 425 13 297 11 359 15 
MGI:95556 Flna filamin, alpha 421 11 0 0 0 0 
MGI:107341 Ctss cathepsin S 417 21 391 27 459 29 
MGI:88318 Cd14 Monocyte differentiation antigen CD14 precursor 415 14 278 18 180 8 
MGI:105068 Rab7 Ras-related protein Rab-7a 391 13 289 26 355 27 
  - 11 kDa protein 386 65 361 105 362 103 
MGI:88562 Ctsd Cathepsin D precursor 383 30 329 42 490 60 
MGI:107717 Myh9 Myosin-9 370 11 482 16 335 12 
MGI:106222 Capza2 F-actin-capping protein subunit alpha-2 368 15 344 13 284 11 
MGI:1316648 Ahnak AHNAK nucleoprotein isoform 1 367 13 551 22 1040 46 
MGI:96778 Lgals3 Galectin-3 359 37 351 56 468 62 
MGI:103206 Irg1 Immune-responsive gene 1 protein 354 9 391 13 0 0 
MGI:2448383 Hist1h2bl;Hist1h2bf;Hist1h2bn;Hist1h2bj;LOC100046213 Histone H2B type 1-F/J/L 340 81 353 61 352 86 
MGI:1891190 Ctsz Cathepsin Z 329 8 194 6 316 11 
MGI:99523 Prdx1 Peroxiredoxin-1 322 20 411 24 426 23 
MGI:97591 Pkm2 Isoform M2 of Pyruvate kinase isozymes M1/M2 316 11 171 6 154 5 
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MGI:88561 Ctsb Cathepsin B precursor 315 20 294 21 408 46 
MGI:97783 Psap Sulfated glycoprotein 1 precursor 311 15 306 14 347 19 
MGI:97572 Phb Prohibitin 307 10 420 12 309 15 
MGI:95784 Gnb2 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 291 10 407 15 482 18 
MGI:88105 Atp1a1 Sodium/potassium-transporting ATPase subunit alpha-1 precursor 291 8 405 10 610 20 
MGI:1353495 Slc25a4 ADP/ATP translocase 1 291 19 250 24 324 26 
MGI:96897 Lyz2 Lysozyme C 289 14 311 21 230 23 
MGI:1917600 Basp1 Brain acid soluble protein 1 276 8 537 13 665 21 
MGI:96832 Lsp1 Isoform 1 of Lymphocyte-specific protein 1 274 7 177 4 222 7 
MGI:1353498 Slc25a3 Phosphate carrier protein 264 10 172 11 230 19 
MGI:88261 Canx Calnexin precursor 261 5 196 12 128 8 
MGI:106919 Vdac1 Isoform Pl-VDAC1 of Voltage-dependent anion-selective channel protein 1 259 15 281 17 334 19 
MGI:1345961 Coro1a Coronin-1A 257 12 329 12 329 11 
MGI:96245 Hspa9 Stress-70 protein 256 8 271 11 425 19 
MGI:106227 Capza1 F-actin-capping protein subunit alpha-1 247 7 191 6 86 4 
MGI:95872 Gusb beta-glucuronidase 247 6 190 4 234 7 
MGI:1918929 Atp5h ATP synthase subunit d, mitochondrial 239 10 130 6 139 6 
MGI:109618 Atp6v1b2 Vacuolar ATP synthase subunit B, brain isoform 231 6 183 5 88 3 
MGI:1931526 Hist1h1c Histone H1.2 231 12 224 14 0 0 
MGI:1915835 Rtn4 RTN4 228 10 164 5 159 8 
MGI:102520 Phb2 Prohibitin-2 223 7 219 9 236 11 
MGI:2135593 Hadha Trifunctional enzyme subunit alpha 222 6 179 4 302 7 
MGI:97464 P4hb prolyl 4-hydroxylase, beta polypeptide 219 5 179 5 117 4 
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MGI:106341 Atp5o ATP synthase subunit O 217 6 188 9 261 16 
MGI:1928370 Rhog Rho-related GTP-binding protein RhoG precursor 217 7 87 3 100 4 
MGI:1261437 Atp5c1 ATP synthase subunit gamma 216 10 161 6 261 14 
MGI:102503 mt-Co2 Cytochrome c oxidase subunit 2 216 18 184 16 202 24 
MGI:1915113 Slc25a11 Mitochondrial 2-oxoglutarate/malate carrier protein 209 6 51 3 257 8 
MGI:2442982 Rab8b Ras-related protein Rab-8B 207 14 0 0 143 10 
MGI:1096881 Eef1a1 Elongation factor 1-alpha 1 203 10 173 7 248 9 
MGI:1861461 Hist1h1b Histone H1.5 201 9 150 8 226 11 
MGI:96745 Lamp1 lysosomal membrane glycoprotein 1 200 13 303 24 282 28 
MGI:97842 Rab1 Ras-related protein Rab-1A 200 10 231 16 205 19 
MGI:106922 Vdac3 Voltage-dependent anion channel 3 199 10 132 9 157 11 
MGI:108563 Sirpa 56 kDa protein 199 5 141 3 194 6 
MGI:108109 Ywhag 14-3-3 protein gamma 198 6 0 0 158 8 
MGI:88252 Calr Calreticulin precursor 198 8 181 8 238 9 
MGI:105066 Rab10 Ras-related protein Rab-10 197 8 0 0 0 0 
MGI:107899 Cd36 Platelet glycoprotein 4 192 8 194 10 327 24 
MGI:1201778 Atp6v0d1 Vacuolar proton pump subunit d 1 191 7 200 11 187 9 
MGI:109484 Ywhaz 14-3-3 protein zeta/delta 191 9 78 3 228 10 
MGI:98084 Rpn1 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 precursor 190 5 225 7 227 7 
MGI:1890773 Actn4 Alpha-actinin-4 187 8 34 1 64 3 
MGI:894689 Ywhae 14-3-3 protein epsilon 184 7 0 0 82 7 
MGI:88574 Cybb Cytochrome b-245 heavy chain 183 5 89 3 128 3 
MGI:3606192 H2afj;LOC632401 H2A histone family, member J 182 20 135 14 158 28 
MGI:1931527 Hist1h1e Histone H1.4 181 10 199 11 225 18 
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MGI:1923558 Rab1b Ras-related protein Rab-1B 179 10 0 0 254 15 
MGI:2443191 Aadacl1 Arylacetamide deacetylase-like 1 173 4 82 2 84 3 
MGI:98817 Hsp90b1 Endoplasmin precursor 170 6 216 7 211 8 
MGI:97846 Rac2 Ras-related C3 botulinum toxin substrate 2 precursor 169 7 0 0 0 0 
MGI:1345964 Coro1c Coronin-1C 169 7 118 3 195 6 
MGI:1927636 Rplp0 60S acidic ribosomal protein P0 167 4 132 4 147 6 
MGI:94893 - Cytochrome b5 reductase 3 166 4 116 4 138 3 
MGI:107876 Uqcrc1 Cytochrome b-c1 complex subunit 1 166 5 0 0 123 5 
MGI:894315 Rap1b; Ras-related protein Rap-1b precursor 165 6 128 7 238 7 
MGI:95781 Gnb1 Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 165 5 266 11 299 12 
MGI:98352 Sod2 Superoxide dismutase [Mn] 164 8 109 6 67 2 
MGI:96073 Hexa Beta-hexosaminidase subunit alpha precursor 163 6 54 2 168 9 
MGI:1929693 Slc37a2 Isoform 2 of Sugar phosphate exchanger 2 159 8 57 3 137 18 
MGI:109318 Myl6 Isoform Smooth muscle of Myosin light polypeptide 6 158 6 171 6 200 9 
MGI:88529 Cs Citrate synthase 157 3 85 3 196 9 
MGI:98887 Ubc;Gm1821;Uba52;Ubb hypothetical protein LOC666586 157 10 171 17 212 15 
MGI:2144765 Pld4 Isoform 1 of Phospholipase D4 155 4 173 3 157 8 
MGI:104652 Capzb Isoform 2 of F-actin-capping protein subunit beta 154 4 193 9 241 7 
MGI:96163 Hmox1 Heme oxygenase 1 152 6 48 1 0 0 
MGI:1935159 EG628438;Hspe1-rs1 CPN10-like protein 151 5 109 6 0 0 
MGI:1915213 Npc2 Epididymal secretory protein E1 precursor 150 4 114 5 108 3 
MGI:87880 Aco2 Aconitate hydratase, mitochondrial precursor 149 4 0 0 184 7 
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MGI:2448320 Hist1h3c;Hist1h3b;Hist1h3f;Hist2h3c2;Hist2h3b;Hist1h3d;Hist1h3e;Hist2h3c1 Histone H3.2 149 15 164 20 136 25 
MGI:1923686 Tufm Isoform 1 of Elongation factor Tu 149 4 0 0 78 3 
MGI:98869 Tuba1a Tubulin alpha-1A chain 148 7 90 5 89 3 
MGI:109194 Ywhah 14-3-3 protein eta 147 5 116 4 214 12 
MGI:105306 Rab5c Ras-related protein Rab-5C 146 4 184 7 167 6 
MGI:96074 Hexb Beta-hexosaminidase subunit beta precursor 143 4 203 6 253 8 
MGI:1934765 Gpnmb Transmembrane glycoprotein NMB precursor 139 34 157 35 190 56 
MGI:97845 Rac1 RAS-related C3 botulinum substrate 1 138 6 141 6 154 13 
MGI:107460 Cox6b1 Cytochrome c oxidase subunit VIb isoform 1 136 5 106 8 126 14 
MGI:97748 Ctsa Lysosomal protective protein precursor 134 5 30 2 32 2 
MGI:109553 Ctsc Dipeptidyl-peptidase 1 precursor 128 4 70 2 66 3 
MGI:1312985 Tagln2 Transgelin-2 127 3 27 1 37 1 
MGI:106211 Cdc42 Isoform 2 of Cell division control protein 42 homolog precursor 126 5 28 1 59 3 
MGI:3647311 EG623365 hypothetical protein isoform 1 126 9 139 10 0 0 
MGI:1349450 Vat1 Synaptic vesicle membrane protein VAT-1 homolog 126 3 136 6 186 8 
MGI:1921367 Actr3 Actin-related protein 3 125 3 191 6 129 6 
MGI:2136381 Hadhb Trifunctional enzyme subunit beta 123 4 108 4 174 7 
MGI:95403 Stom Erythrocyte band 7 integral membrane protein 121 6 190 4 252 13 
MGI:1344426 Mbc2 Isoform 1 of Extended-synaptotagmin-1 120 3 101 2 90 2 
MGI:96819 Anxa1 Annexin A1 119 4 90 2 152 5 
MGI:97750 Ppib peptidylprolyl isomerase B 118 5 146 6 101 3 
MGI:1919020 Ap2b1 Isoform 1 of AP-2 complex subunit beta-1 116 1 48 2 80 2 
MGI:88473 Cox4i1 Cytochrome c oxidase subunit 4 isoform 1 116 6 113 5 141 9 
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MGI:2442910 9130404D14Rik Niban-like protein 1 113 6 36 1 76 2 
MGI:96247 Hsp90ab1 Heat shock protein 84b 113 5 54 3 78 3 
MGI:88342 Cd68 Macrosialin 109 7 105 5 125 8 
MGI:1914436 Rplp2 60S acidic ribosomal protein P2 105 2 99 3 126 5 
MGI:1931523 Hist1h1a Histone H1.1 103 4 70 5 112 9 
MGI:95753 Glud1 Glutamate dehydrogenase 1 101 2 35 1 470 12 
MGI:99554 Lgals3bp Mama protein 100 2 0 0 0 0 
MGI:95904 H2-K1 42 kDa protein 100 4 0 0 0 0 
MGI:88251 Calm3;Calm2;Calm1 calmodulin 1 99 3 79 3 26 1 
MGI:1891435 Usmg5 Up-regulated during skeletal muscle growth protein 5 98 3 83 2 109 4 
MGI:96907 Marcks Myristoylated alanine-rich C-kinase substrate 96 5 82 3 0 0 
MGI:106912 Emr1 EGF-like module-containing mucin-like hormone receptor-like 1 precursor 95 3 143 3 0 0 
MGI:1888388 H2afz Histone H2A.Z 95 8 0 0 131 13 
MGI:1919619 Ehd4 EH-domain containing 4-KJR (Fragment) 94 3 138 3 86 2 
MGI:88474 Cox5a Cytochrome c oxidase subunit 5A 93 3 140 7 158 12 
MGI:1920973 Sh3bgrl3 SH3 domain-binding glutamic acid-rich-like protein 3 91 5 51 2 63 4 
MGI:96392 Icam1 Isoform 1 of Intercellular adhesion molecule 1 precursor 91 3 116 4 0 0 
MGI:99431 Arf1 ADP-ribosylation factor 1 91 2 0 0 65 2 
MGI:1338859 P2rx4 purinergic receptor P2X, ligand-gated ion channel 4 90 3 0 0 0 0 
MGI:1347344 Gla alpha-galactosidase A 90 2 0 0 29 1 
MGI:96748 Lamp2 Isoform LAMP-2A of Lysosome-associated membrane glycoprotein 2 precursor 89 5 170 9 167 13 
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MGI:1915339 Arpc4 Actin-related protein 2/3 complex subunit 4 89 4 39 2 46 2 
MGI:1194924 Cd180 CD180 antigen precursor 87 3 105 1 159 2 
MGI:2138133 Lrrc59 Leucine-rich repeat-containing protein 59 87 3 68 1 69 2 
MGI:1921262 Rap2b Ras-related protein Rap-2b precursor 84 3 91 7 68 3 
MGI:109175 Dab2 Isoform p93 of Disabled homolog 2 84 2 0 0 87 4 
MGI:1201780 Atp6v1a Isoform 1 of Vacuolar ATP synthase catalytic subunit A 83 2 79 4 101 4 
MGI:97810 Ptprc Isoform 2 of Leukocyte common antigen precursor 83 3 107 2 229 8 
MGI:95912 H2-Q2;H2-L;H2-Q1 H-2 class I histocompatibility antigen, L-D alpha chain precursor 81 4 0 0 52 2 
MGI:88338 Cd44 CD44 antigen isoform c 78 1 81 4 72 3 
MGI:1194505 C1qbp complement component 1, q subcomponent binding protein 77 3 28 3 68 8 
MGI:95498 Fcgr1 High affinity immunoglobulin gamma Fc receptor I precursor 75 4 94 6 105 3 
MGI:1914253 Uqcrc2 Cytochrome b-c1 complex subunit 2 74 2 219 4 117 4 
MGI:95832 Grn granulin 74 6 110 6 92 8 
MGI:1890149 Tpm3 Isoform 2 of Tropomyosin alpha-3 chain 73 3 0 0 161 6 
MGI:97143 Marcksl1 MARCKS-related protein 71 2 116 3 0 0 
MGI:1919103 Pdia6 thioredoxin domain containing 7 71 3 48 2 42 1 
MGI:1316715 Cox7a2 Cytochrome c oxidase polypeptide VIIa-liver/heart 71 3 57 2 63 3 
MGI:1923959 Arpc2 Actin-related protein 2/3 complex subunit 2 65 2 26 1 45 3 
MGI:1913325 Chchd3 Coiled-coil-helix-coiled-coil-helix domain-containing protein 3 65 1 54 1 110 4 
MGI:88339 Cd48 CD48 antigen precursor 64 1 0 0 0 0 
MGI:1858210 Stx7 Syntaxin-7 64 1 55 1 100 4 
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MGI:1923864 Immt Isoform 1 of Mitochondrial inner membrane protein 63 1 50 1 119 5 
MGI:1914195 Sdha Succinate dehydrogenase [ubiquinone] flavoprotein subunit 62 2 42 1 63 1 
MGI:1913697 Mgst3 Microsomal glutathione S-transferase 3 61 1 50 1 49 1 
MGI:107777 Atp5j;LOC674583 ATP synthase-coupling factor 6 61 4 164 5 173 11 
MGI:894326 Atp6v1e1 Vacuolar proton pump subunit E 1 61 4 27 1 0 0 
MGI:1344382 Creg1 Protein CREG1 precursor 60 2 0 0 0 0 
MGI:1201689 Tapbp Isoform Short of Tapasin precursor 59 1 91 3 0 0 
MGI:2148924 Clic1 Chloride intracellular channel protein 1 59 1 0 0 31 1 
MGI:1333768 Krt6b Keratin, type II cytoskeletal 6B 59 2 25 1 54 10 
MGI:98073 Rpl7 60S ribosomal protein L7 58 1 68 2 38 1 
MGI:95496 Fcer1g High affinity immunoglobulin epsilon receptor subunit gamma precursor 58 4 75 5 75 3 
MGI:3607712 Krt73 Keratin, type II cytoskeletal 73 57 1 65 1 77 3 
MGI:87866 Acadl Long-chain specific acyl-CoA dehydrogenase 55 1 46 1 97 3 
MGI:106092 Etfa Electron transfer flavoprotein subunit alpha 53 3 0 0 119 3 
MGI:97552 Pgam1 Phosphoglycerate mutase 1 53 1 0 0 0 0 
MGI:96160 Hmga1 Isoform HMG-I of High mobility group protein HMG-I/HMG-Y 52 2 37 1 42 3 
MGI:1926952 Cyb5 Cytochrome b5 51 1 179 2 25 1 
MGI:98257 Msr1 macrophage scavenger receptor 1 isoform a 49 1 99 3 0 0 
MGI:1328323 Syngr1 Isoform 1A of Synaptogyrin-1 49 1 25 1 43 2 
MGI:1915009 5033414D02Rik Uncharacterized protein C9orf46 homolog 49 1 0 0 0 0 
MGI:1913358 Ndufa9 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 9 49 2 48 1 55 1 
MGI:1354721 Slc25a13 Calcium-binding mitochondrial carrier 48 1 0 0 152 7 
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protein Aralar2 
MGI:1196297 Hgsnat Heparan-alpha-glucosaminide N-acetyltransferase 48 1 0 0 42 1 
MGI:96610 Itgb1 Integrin beta-1 precursor 48 2 24 1 0 0 
MGI:2443807 Osbpl8 oxysterol-binding protein-like protein 8 isoform b 48 1 0 0 0 0 
MGI:1316658 Cyba Isoform 1 of Cytochrome b-245 light chain 48 2 62 3 62 3 
MGI:1914647 Erp29 5 kDa protein 47 1 26 1 25 1 
MGI:3040672 Rpl23a 60S ribosomal protein L23a 47 1 47 1 0 0 
MGI:1913758 2400001E08Rik UPF0404 protein C11orf59 homolog 46 2 49 2 40 2 
MGI:1333782 Pld3 Phospholipase D3 46 1 0 0 43 1 
MGI:99435 Arf6 ADP-ribosylation factor 6 46 2 0 0 27 1 
MGI:88271 Cat Catalase 45 1 0 0 32 1 
MGI:88262 Cap1 Adenylyl cyclase-associated protein 1 45 1 58 3 69 3 
MGI:1932697 Mapbpip Mitogen-activated protein-binding protein-interacting protein 45 1 50 2 78 2 
MGI:106028 Rhoc Rho-related GTP-binding protein RhoC precursor 45 1 26 1 0 0 
MGI:1855697 Atp5e ATP synthase subunit epsilon, mitochondrial 45 1 0 0 45 1 
MGI:1914930 Sdhb Succinate dehydrogenase [ubiquinone] iron-sulfur subunit 44 1 0 0 0 0 
MGI:1913293 Atp5d ATP synthase subunit delta 44 2 97 3 49 1 
MGI:1927558 Atp5j2 ATP synthase subunit f 44 2 45 2 48 2 
MGI:107788 Atp1b3 Sodium/potassium-transporting ATPase subunit beta-3 43 2 0 0 0 0 
MGI:1914291 Oxct1 Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 43 2 32 1 92 3 
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MGI:88475 Cox5b cytochrome c oxidase, subunit Vb 42 2 47 3 78 7 
MGI:2443241 Ndufs1 NADH-ubiquinone oxidoreductase 75 kDa subunit 42 1 0 0 104 3 
MGI:1926967 Hsd17b12 Isoform 1 of Estradiol 17-beta-dehydrogenase 12 41 1 0 0 0 0 
MGI:104819 Hnrnpa2b1 Isoform 3 of Heterogeneous nuclear ribonucleoproteins A2/B1 41 1 0 0 60 2 
MGI:1915021 Arpc5 Actin-related protein 2/3 complex subunit 5 41 1 26 1 0 0 
MGI:2442032 Daglb Sn1-specific diacylglycerol lipase beta 40 1 0 0 0 0 
MGI:1346330 Banf1 Barrier-to-autointegration factor 40 1 0 0 25 1 
MGI:1923442 Abhd12 Abhydrolase domain-containing protein 12 40 1 0 0 0 0 
MGI:97555 Pgk1 Phosphoglycerate kinase 1 39 2 0 0 0 0 
MGI:2148491 Acaa1b;Acaa1a 3-ketoacyl-CoA thiolase A 39 1 0 0 0 0 
MGI:95393 EG433182;Eno1;LOC100044223 Alpha-enolase 38 1 0 0 0 0 
MGI:96693 Krt19 Keratin, type I cytoskeletal 19 38 2 82 4 33 2 
MGI:105941 Mpp1 55 kDa erythrocyte membrane protein 38 1 31 1 41 1 
MGI:106636 Atp5k ATP synthase subunit e 38 2 0 0 71 3 
MGI:1098259 Capg Macrophage-capping protein 38 2 78 3 53 2 
MGI:1932395 Rrbp1 Isoform 3 of Ribosome-binding protein 1 38 1 35 1 82 2 
MGI:97356 Nme2 Nucleoside diphosphate kinase B 37 2 36 1 139 4 
MGI:106612 Myo1c Isoform B of Myosin-Ic 37 1 113 3 57 3 
MGI:102705 Gng2 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-2 precursor 37 2 69 3 38 3 
MGI:99778 Gpd2 Glycerol phosphate dehydrogenase 2 37 1 0 0 0 0 
MGI:3582693 Tor1aip1 Torsin-1A-interacting protein 1 37 1 0 0 0 0 
MGI:1921867 Scpep1 serine caroboxypeptidase 1 37 1 25 1 0 0 
MGI:95665 Gba Glucosylceramidase precursor 37 1 0 0 0 0 
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MGI:2178103 Arhgdia Rho GDP-dissociation inhibitor 1 36 1 0 0 0 0 
MGI:99702 Bax Apoptosis regulator BAX 36 1 0 0 0 0 
MGI:1194508 Ddost Dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kDa subunit precursor 36 1 68 2 86 5 
MGI:1355332 Myadm Myeloid-associated differentiation marker 36 1 86 1 37 1 
MGI:3032636 
Ugt1a6b;Ugt1a7c;Ugt1a10;Ugt1a5;Ugt1a2;Ugt1a9;L
OC632297;Ugt1a1 UDP-glucuronosyltransferase 1-
7C precursor 
36 1 47 1 40 2 
MGI:1913391 Ifitm3 INTERFERON-INDUCIBLE PROTEIN 36 2 45 1 25 1 
MGI:1890889 Ndufs5;BC002163 NADH dehydrogenase [ubiquinone] iron-sulfur protein 5 36 1 0 0 33 1 
MGI:3045213 Tlr13 Toll-like receptor 13 precursor 36 1 0 0 0 0 
MGI:1913826 Uqcrh Cytochrome b-c1 complex subunit 6 36 1 52 1 27 1 
MGI:1913540 Atp6v1g1 Vacuolar proton pump subunit G 1 35 1 46 2 38 2 
MGI:1913394 Atp6v1f Vacuolar proton pump subunit F 35 1 0 0 0 0 
MGI:1333743 Mpeg1 macrophage expressed gene 1 35 2 90 3 0 0 
MGI:1270152 Reep5 receptor accessory protein 5 35 1 25 1 0 0 
MGI:2143132 Plekho2 46 kDa protein 35 1 0 0 63 2 
MGI:107812 Tubb5 Tubulin beta-5 chain 34 3 0 0 139 3 
MGI:103016 Ppp1ca Serine/threonine-protein phosphatase PP1-alpha catalytic subunit 33 1 0 0 0 0 
MGI:1919292 Cotl1 Coactosin-like protein 33 1 38 1 51 1 
MGI:96685 Krt10 keratin complex 1, acidic, gene 10 32 1 0 0 55 2 
MGI:1337100 Wdr1 WD repeat-containing protein 1 32 1 32 1 0 0 
MGI:1345283 Slc25a1 solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1 32 1 69 3 65 3 
MGI:104560 Nsf Vesicle-fusing ATPase 31 1 0 0 95 2 
MGI:104568 Hcls1 Hematopoietic lineage cell-specific protein 30 1 58 2 55 2 
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MGI:3643413 EG268795 hypothetical protein isoform 2 30 1 66 1 64 2 
MGI:3644100 EG619883 similar to ribosomal protein L30 30 1 43 1 0 0 
MGI:1333871 Hsd17b10 3-hydroxyacyl-CoA dehydrogenase type-2 30 1 0 0 0 0 
MGI:101847 Mnda;Ifi205 Interferon-activable protein 205-A 30 1 0 0 0 0 
MGI:1298382 Plp2 Proteolipid protein 2 30 1 38 2 0 0 
MGI:1919022 1300012G16Rik Isoform 1 of Putative phospholipase B-like 2 precursor 29 1 0 0 0 0 
MGI:104614 Cox6c Cytochrome c oxidase polypeptide VIc 29 1 0 0 0 0 
MGI:99529 Cd63 Cd63 antigen, full insert sequence 28 1 25 2 44 3 
MGI:97298 Sept2 Septin-2 28 1 0 0 0 0 
MGI:2443286 Slc2a6 solute carrier family 2 (facilitated glucose transporter), member 6 28 1 32 2 0 0 
MGI:103226 LOC100048613;Cox7c Cytochrome c oxidase subunit 7C 27 1 0 0 31 1 
MGI:1351597 Atp5l ATP SYNTHASE, H+ TRANSPORTING, MITOCHONDRIAL F0 COMPLEX, SUBUNIT G 27 2 0 0 0 0 
MGI:1336171 Gng12 Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-12 precursor 27 1 0 0 0 0 
MGI:107686 Ndufa4 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 4 27 1 0 0 131 8 
MGI:1277124 Asah1 Acid ceramidase precursor 27 1 0 0 48 2 
MGI:1913963 Actr2 Actin-related protein 2 27 1 28 1 0 0 
MGI:1350927 Rpl8 60S ribosomal protein L8 26 1 38 1 0 0 
MGI:97286 Ncl Nucleolin 26 1 0 0 29 1 
MGI:1890156 Stx8 Syntaxin-8 26 1 0 0 0 0 
MGI:3646088 EG622339 predicted gene, EG622339 26 2 0 0 25 2 
MGI:98445 Surf4 Surfeit locus protein 4 26 1 0 0 64 1 
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MGI:2136742 Pcdhb8 Protocadherin beta 8 26 1 0 0 0 0 
MGI:2385030 Krt79 Keratin, type II cytoskeletal 79 25 2 0 0 0 0 
MGI:1261415 Sgpl1 Sphingosine-1-phosphate lyase 1 25 1 90 4 25 1 
MGI:1914745 Tmem167b UPF0373 protein C1orf119 homolog precursor 25 1 0 0 0 0 
MGI:98003 Rpl18 60S ribosomal protein L18 25 1 54 3 58 2 
MGI:1931052 Aldoart2 Fructose-bisphosphate aldolase 24 1 71 1 76 2 
MGI:96429 Ifi204 72 kDa protein 24 1 0 0 0 0 
MGI:88348 Cd9 CD9 antigen 24 1 58 1 41 1 
MGI:101757 LOC100048522 similar to Cofilin-1 0 0 296 16 0 0 
MGI:95556 Flna Isoform 1 of Filamin-A 0 0 643 15 775 18 
MGI:95896 H2-Q2;H2-L; H-2D cell surface glycoprotein (Fragment) 0 0 193 11 0 0 
MGI:95896 H2-D1 MRNA, . precursor 0 0 156 7 0 0 
MGI:1913677 Cyb5b Cytochrome b5 type B precursor 0 0 73 5 81 5 
MGI:1915615 Rab14 Ras-related protein Rab-14 0 0 80 5 74 4 
MGI:3648759  Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) isoform 1 0 0 151 5 0 0 
MGI:96103 Hk1 Isoform HK1-SA of Hexokinase-1 0 0 114 4 149 5 
MGI:1915974 Arl8a ADP-ribosylation factor-like protein 8A 0 0 127 4 41 3 
MGI:1338859 P2rx4 P2X purinoceptor 0 0 58 3 0 0 
MGI:1343142 Arpc1b Arpc1b protein 0 0 59 3 57 1 
MGI:1913695 Cyc1 Isoform 1 of Cytochrome c1, heme protein 0 0 67 3 0 0 
MGI:96759 Ldha L-lactate dehydrogenase A chain 0 0 77 3 68 2 
MGI:95499 Fcgr2b Fc receptor, IgG, low affinity IIb isoform 1 0 0 78 3 0 0 
MGI:1920960 Tubb2b Tubulin beta-2B chain 0 0 100 3 0 0 
MGI:95792 Got2 Aspartate aminotransferase 0 0 102 3 192 11 
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MGI:1196457 Atpif1 ATPase inhibitor 0 0 32 2 31 2 
MGI:1855694 Isg15; Ubiquitin cross-reactive protein precursor 0 0 39 2 0 0 
MGI:98809 Tpm1 Isoform 1 of Tropomyosin alpha-1 chain 0 0 44 2 0 0 
MGI:1917160 Slc25a24 Calcium-binding mitochondrial carrier protein SCaMC-1 0 0 45 2 82 3 
MGI:1859821 Prdx5 Isoform Mitochondrial of Peroxiredoxin-5 0 0 47 2 54 3 
MGI:108057 Rpl6 60S ribosomal protein L6 0 0 49 2 0 0 
MGI:96904 M6pr Cation-dependent mannose-6-phosphate receptor precursor 0 0 49 2 0 0 
MGI:1915831 Tmed10 Isoform 1 of Transmembrane emp24 domain-containing protein 10 precursor 0 0 52 2 40 2 
MGI:1915599 Ndufs3 NADH dehydrogenase [ubiquinone] iron-sulfur protein 3 0 0 52 2 111 3 
MGI:2137679 Sfxn3 Isoform 1 of Sideroflexin-3 0 0 52 2 34 1 
MGI:103286 Atp6v0a1 Isoform A1-II of Vacuolar proton translocating ATPase 116 kDa subunit a isoform 1 0 0 53 2 45 2 
MGI:96955 Slc3a2 CD98 heavy chain 0 0 56 2 35 1 
MGI:1100495 Atp5f1 ATP synthase subunit b 0 0 57 2 57 3 
MGI:1926080 Slc25a12 Calcium-binding mitochondrial carrier protein Aralar1 0 0 68 2 0 0 
MGI:2143132 Plekho2 Pleckstrin homology domain-containing family O member 2 0 0 68 2 0 0 
MGI:106008 Anxa5 Annexin A5 0 0 75 2 0 0 
MGI:104563 Napa Alpha-soluble NSF attachment protein 0 0 75 2 78 3 
MGI:106920 Tmpo Isoform Beta of Lamina-associated polypeptide 2 isoforms beta/delta/epsilon/gamma 0 0 98 2 128 4 
MGI:2445284 Lrrc25 Leucine-rich repeat-containing protein 25 precursor 0 0 108 2 0 0 
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MGI:1194884 Evl Isoform 2 of Ena/VASP-like protein 0 0 25 1 0 0 
MGI:106098 Etfb Electron transfer flavoprotein subunit beta 0 0 25 1 27 2 
MGI:1916800 Bst2 Bone marrow stromal antigen 2 precursor 0 0 26 1 0 0 
MGI:1099464 Ssr4 signal sequence receptor, delta 0 0 26 1 0 0 
MGI:107567 Irgm Isoform 1 of Immunity-related GTPase family M protein 0 0 27 1 0 0 
MGI:1928375 Arpc3 Actin-related protein 2/3 complex subunit 3 0 0 28 1 0 0 
MGI:1859307 Unc93b1 Isoform 1 of Protein unc-93 homolog B1 0 0 29 1 0 0 
MGI:99262 Rpl22;mCG_130059 60S ribosomal protein L22 0 0 30 1 0 0 
MGI:1298405 Ap2m1 AP-2 complex subunit mu-1 0 0 30 1 77 2 
MGI:1277214 Sept11 Isoform 3 of Septin-11 0 0 31 1 0 0 
MGI:1351455 Rpl13a 60S ribosomal protein L13a 0 0 31 1 25 1 
MGI:1328317 Trex1 Three prime repair exonuclease 1 0 0 32 1 0 0 
MGI:1353561 Vapa Vesicle-associated membrane protein-associated protein A 0 0 32 1 0 0 
MGI:101912 Dad1 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit DAD1 0 0 32 1 0 0 
MGI:1931071 Sec61a2 Sec61, alpha subunit 2 0 0 33 1 30 2 
MGI:3646682 LOC675192;EG668182 hypothetical protein 0 0 34 1 0 0 
MGI:98085 Rpn2 Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 precursor 0 0 34 1 51 1 
MGI:1276534 Bcat2 Branched-chain-amino-acid aminotransferase 0 0 35 1 0 0 
MGI:1929899 Sqrdl Sulfide:quinone oxidoreductase 0 0 35 1 0 0 
MGI:88578 Cycs Cytochrome c, somatic 0 0 36 1 57 2 
MGI:2149821 Hsd17b11 Isoform 1 of Estradiol 17-beta-dehydrogenase 11 precursor 0 0 36 1 0 0 
MGI:1914518 2900073G15Rik myosin light chain, regulatory B-like 0 0 37 1 0 0 
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MGI:88336 Cd40 Isoform I of Tumor necrosis factor receptor superfamily member 5 precursor 0 0 37 1 0 0 
MGI:107505 Alox5ap Arachidonate 5-lipoxygenase-activating protein 0 0 38 1 57 1 
MGI:894311 Lilrb3 paired-Ig-like receptor B 0 0 38 1 0 0 
MGI:1913404 Tmem14c Transmembrane protein 14C 0 0 41 1 0 0 
MGI:1915903 Samm50 Sorting and assembly machinery component 50 homolog 0 0 41 1 25 1 
MGI:96795 Lmnb1 Lamin-B1 0 0 42 1 52 2 
MGI:95762 Gm2a Ganglioside GM2 activator precursor 0 0 46 1 27 1 
MGI:1098623 Acaa2 3-ketoacyl-CoA thiolase, mitochondrial 0 0 48 1 131 3 
MGI:1913775 Timm50 Import inner membrane translocase subunit TIM50 0 0 48 1 33 1 
MGI:1914761 Tmed9 1 Glycoprotein 25L2 homolog 0 0 50 1 43 1 
MGI:1913462 Sec61b Protein transport protein Sec61 subunit beta 0 0 50 1 0 0 
MGI:3648523 EG432798 similar to ribosomal protein L27A 0 0 51 1 51 1 
MGI:3646154 EG241053 similar to ribosomal protein L12 0 0 51 1 39 1 
MGI:1349419 Aifm1 Apoptosis-inducing factor 1 0 0 51 1 37 1 
MGI:1913296 Ndufb5 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 5 0 0 61 1 41 1 
MGI:95394 Eno2 Enolase 0 0 63 1 25 1 
MGI:107502 Hist1h1d Histone H1.3 0 0 0 0 292 22 
MGI:104680 Hspe1 10 kDa heat shock protein, mitochondrial 0 0 0 0 268 21 
MGI:95773 Gnai3 Guanine nucleotide-binding protein G 0 0 0 0 207 12 
MGI:107450 Dld Dihydrolipoyl dehydrogenase 0 0 0 0 138 3 
MGI:1097712 Npc1 Niemann-Pick C1 protein precursor 0 0 0 0 101 2 
MGI:1915084 Idh3a Isoform 1 of Isocitrate dehydrogenase [NAD] subunit alpha 0 0 0 0 91 1 
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MGI:1313266 Alcam CD166 antigen precursor 0 0 0 0 89 3 
MGI:1913944 Uqcrfs1 Cytochrome b-c1 complex subunit Rieske 0 0 0 0 88 3 
MGI:88232 C5ar1 complement component 5, receptor 1 0 0 0 0 82 4 
MGI:1315197 Hk2 Hexokinase-2 0 0 0 0 74 3 
MGI:1096342 Rhoa Transforming protein RhoA precursor 0 0 0 0 73 3 
MGI:96414 Idh2 Isocitrate dehydrogenase [NADP] 0 0 0 0 72 3 
MGI:1927091 Myo1g Myosin-Ig 0 0 0 0 70 2 
MGI:1929260 Mtch2 Mitochondrial carrier homolog 2 0 0 0 0 70 1 
MGI:96113 Hmgb1; High mobility group protein B1 0 0 0 0 70 2 
MGI:1927234 Suclg1 Succinyl-CoA ligase [GDP-forming] subunit alpha 0 0 0 0 62 1 
MGI:99926 mt-Atp8 ATP synthase protein 8 0 0 0 0 56 2 
MGI:2137677 Sfxn1 Sideroflexin-1 0 0 0 0 52 2 
MGI:99425 Rab11b Ras-related protein Rab-11B 0 0 0 0 52 2 
MGI:1926170 
Dlst Isoform 1 of Dihydrolipoyllysine-residue 
succinyltransferase component of 2- oxoglutarate 
dehydrogenase complex 
0 0 0 0 51 2 
MGI:894297 Clta Clathrin light chain A 0 0 0 0 50 4 
MGI:1933395 Lactb;LOC677144 Serine beta-lactamase-like protein LACTB 0 0 0 0 49 1 
MGI:1921372 Tmem43 Transmembrane protein 43 0 0 0 0 49 1 
MGI:1917529 Krt78 keratin Kb40 0 0 0 0 49 1 
MGI:87870 Acat1 Acetyl-CoA acetyltransferase 0 0 0 0 48 1 
MGI:1890682 Evi2b EVI2B protein precursor 0 0 0 0 47 2 
MGI:103294 Prg2 Bone marrow proteoglycan precursor 0 0 0 0 45 1 
MGI:1913739 Rpl35; 60S ribosomal protein L35 0 0 0 0 45 1 
MGI:3026965 Ccdc109a Isoform 1 of Coiled-coil domain- 0 0 0 0 44 1 
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containing protein 109A 
MGI:2136460 Echs1 Enoyl-CoA hydratase, mitochondrial precursor 0 0 0 0 43 1 
MGI:105368 Atp2b2 Plasma membrane calcium-transporting ATPase 2 0 0 0 0 42 1 
MGI:1929464 Sec11a Signal peptidase complex catalytic subunit SEC11A 0 0 0 0 40 1 
MGI:1914434 Ndufa13 NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 0 0 0 0 40 2 
MGI:1890463 Ear6 Eosinophil-associated ribonuclease 6 0 0 0 0 40 1 
MGI:2385311 Dlat Dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex 0 0 0 0 40 1 
MGI:1922169 4930471M23Rik Uncharacterized protein C2orf18 homolog precursor 0 0 0 0 39 1 
MGI:97532 Pdha1 Pyruvate dehydrogenase E1 component subunit alpha 0 0 0 0 34 1 
MGI:1913745 Ndufb3 NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 3 0 0 0 0 32 1 
MGI:97394 Oat Ornithine aminotransferase 0 0 0 0 31 1 
MGI:1888994 Fmnl1 Isoform 1 of Formin-like protein 1 0 0 0 0 31 1 
MGI:1277989 Shmt2 Serine hydroxymethyltransferase 0 0 0 0 28 1 
MGI:109356 Snap23  synaptosomal-associated protein 0 0 0 0 28 1 
MGI:1346518 Scamp2 Secretory carrier-associated membrane protein 2 0 0 0 0 28 1 
MGI:3616088 Ogdhl oxoglutarate dehydrogenase-like 0 0 0 0 28 1 
MGI:1321389 Vamp3 Vesicle-associated membrane protein 3 0 0 0 0 28 1 
MGI:1915513 Pdhb Pyruvate dehydrogenase E1 component subunit beta 0 0 0 0 28 2 
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MGI:101761 Hmga2 High mobility group protein HMGI-C 0 0 0 0 27 1 
MGI:1914864 Atp6v1h Vacuolar proton pump subunit H 0 0 0 0 27 1 
MGI:108403 Rpo1-3; RNA polymerase 1-3 0 0 0 0 26 1 
MGI:2679150 Oog1 protein isoform 2 0 0 0 0 25 1 
MGI:1916931 Cdk3 Isoform 1 of Cell division protein kinase 3 0 0 0 0 25 1 
MGI:3037658 H2afy3 H2A histone family, member Y3, full insert sequence 0 0 0 0 24 1 
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Table 8.2 Biological process GO terms for regulated proteins 
Biological Process 
0-3hRP LPS 
Term Genes Term Genes 
Up-regulated 
GO:0065007: biological 
regulation 
Capza2, Capzb, 
Cd14, Ctss, Cybb, 
H2-D1, Hsp90b1, 
Hspa8, Ifitm3, 
Lcp1, Msn, Msr1, 
Pdia3, Prdx1, 
Psap, Rap1b, 
Sod2, Tln1, Vdac2 
GO:0065007: biological 
regulation 
Cd14, H2-D1, 
Ifitm3, Msr1, Prdx1 
GO:0050896: response to 
stimulus 
Cd14, Cybb, H2-
D1, Hsp90b1, 
Hspa8, Ifitm3, 
Lcp1, Lyz2, Pdia3, 
Pkm, Prdx1, Psap, 
Rap1b, Sod2 
GO:0050896: response to 
stimulus 
Cd14, H2-D1, 
Ifitm3, Prdx1 
GO:0008152: metabolic process 
Atp6v1b2, Ctss, 
Cybb, Hsp90b1, 
Hspa8, Lap1, 
Lyz2, Pdia3, Pkm, 
Prdx1, Psap, 
Rap1b, Sod2 
GO:0002376: immune system 
process 
Cd14, H2-D1, 
Ifitm3, Prdx1 
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GO:0044237: cellular metabolic 
process 
Atp6v1b2, Ctss, 
Cybb, Hsp90b1, 
Hspa8, Lyz2, 
Pdia3, Pkm, 
Prdx1, Psap, 
Rap1b, Sod2 
GO:0006950: response to stress Cd14, Ifitm3, Prdx1 
GO:0071704: organic substance 
metabolic process 
Atp6v1b2, Ctss, 
Hsp90b1, Hspa8, 
Lap1, Lyz2, Pdia3, 
Pkm, Psap, 
Rap1b, Sod2 
GO:0044763: single-organism 
cellular process 
Atp6v1b2, Ifitm3, 
Prdx1 
GO:0006950: response to stress 
Cd14, Cybb, 
Hsp90b1, Hspa8, 
Ifitm3, Lcp1, Lyz2, 
Pdia3, Pkm, 
Prdx1, Sod2 
GO:0045087: innate immune 
response 
Cd14, Ifitm3, 
Prdx1 
GO:0023051: regulation of 
signaling 
Capzb, Pdia3, 
Prdx1, Psap, 
Rap1b, Sod2, 
Vdac2 
GO:0008152: metabolic process Atp6v1b2, Prdx1 
GO:0002376: immune system 
process 
Cd14, Cybb, H2-
D1, Ifitm3, Lcp1, 
Prdx1, Sod2 
GO:0002252: immune effector 
process Ifitm3, Prdx1 
GO:0045087: innate immune 
response 
Cd14, Cybb, 
Ifitm3, Prdx1 
GO:0009605: response to 
external stimulus Cd14, Ifitm3 
GO:0009605: response to 
external stimulus 
Cd14, Ifitm3, Lyz2, 
Sod2   
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GO:0043408: regulation of 
MAPK cascade 
Prdx1, Psap, 
Rap1b 
GO:0002252: immune effector 
process Ifitm3, Lcp1, Prdx1 
Down-regulated 
GO:0050896: response to 
stimulus Cd36, Idh2, Lmna GO:0008150: biological_process 
Aldh2, Atp5b, 
Glud1, Gpnmb, 
Lmna, Mdh2 
GO:0006950: response to stress Cd36, Idh2, Lmna GO:0008152: metabolic process Aldh2, Atp5b, Glud1, Mdh2 
GO:0023052: signaling Cd36, Lmna GO:0071704: organic substance metabolic process 
Atp5b, Glud1, 
Mdh2 
GO:0007165: signal transduction Cd36, Lmna GO:0044237: cellular metabolic process 
Atp5b, Glud1, 
Mdh2 
GO:0006357: regulation of 
transcription from RNA 
polymerase II promoter 
Cd36, Lmna GO:0050896: response to stimulus Glud1, Lmna 
GO:0051716: cellular response 
to stimulus Cd36, Lmna 
GO:0023051: regulation of 
signaling Glud1, Lmna 
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Table 8.3 Cellular localization GO terms for regulated proteins 
Cellular localization 
0-3hRP LPS 
Term Genes Term Genes 
Up-regulated 
GO:0016020: membrane 
Atp6v1b2, Capza2, 
Capzb, Cd14, 
Cox6b1, Ctss, 
Cybb, Efhd2, H2-
D1, Hsp90b1, 
Ifitm3, Lcp1, 
Lrrc25, Lrrc59, 
Mpeg1, Msn, 
Msr1, Pkm, 
Rap1b, Sod2, 
Tcirg1, Tln1, 
Vdac2 
GO:0016020: membrane 
Atp6v1b2, Cd14, 
H2-D1, Ifitm3, 
Lrrc25, Msr1 
GO:0031982: vesicle 
Actg1, Atp6v1b2, 
Capza2, Capzb, 
Cd14, H2-D1, 
Hsp90b1, Hspa8, 
Ifitm3, Lcp1, Lyz2, 
Msn, Msr1, Pdia3, 
Pkm, Prdx1, Psap, 
Rap1b, Tagln2, 
Tln1 
GO:0031982: vesicle 
Atp6v1b2, Cd14, 
H2-D1, Ifitm3, 
Msr1, Prdx1 
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GO:0005886: plasma membrane 
Atp6v1b2, Cd14, 
Cybb, H2-D1, 
Hsp90b1, Ifitm3, 
Lcp1, Msn, Msr1, 
Pkm, Rap1b, 
Tcirg1, Tln1 
GO:0005886: plasma membrane 
Atp6v1b2, Cd14, 
H2-D1, Ifitm3, 
Msr1 
GO:0005739: mitochondrion 
Cox6b1, Cybb, 
Lrrc59, Pkm, 
Prdx1, Psap, 
Sod2, Tcirg1, 
Vdac2 
GO:0005829: cytosol Atp6v1b2, Msr1, Prdx1 
GO:0042995: cell projection 
Atp6v1b2, Capzb, 
Cybb, Hspa8, 
Lcp1, Lyz2, Msn, 
Pkm, Tln1 
GO:0009986: cell surface Cd14, H2-D1, Ifitm3 
GO:0005829: cytosol 
Atp6v1b2, 
Hsp90b1, Hspa8, 
Lcp1, Msr1, Prdx1 
GO:0005634: nucleus Ifitm3, Prdx1 
GO:0009986: cell surface 
Cd14, Ctss, H2-
D1, Ifitm3, Msn, 
Pdia3 
GO:0005764: lysosome Atp6v1b2, Ifitm3 
GO:0005783: endoplasmic 
reticulum 
Cybb, Hsp90b1, 
Ifitm3, Lrrc59, 
Lyz2, Pdia3   
GO:0005634: nucleus 
Hspa8, Ifitm3, 
Lrrc59, Pkm, 
Prdx1 
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GO:0005764: lysosome 
Atp6v1b2, Ctss, 
Ifitm3, Psap, 
Tcirg1 
GO:0005794: Golgi apparatus Cybb, Lyz2 
Down-regulated 
GO:0044444: cytoplasmic part Cd36, Idh2, Lmna GO:0043226: organelle 
Aldh2, Atp5b, 
Glud1, Gpnmb, 
Lmna, Mdh2 
GO:0016020: membrane Cd36, Lmna GO:0016020: membrane Atp5b, Glud1, Gpnmb, Mdh2 
GO:0005739: mitochondrion Cd36, Idh2 GO:0005739: mitochondrion Aldh2, Atp5b, Glud1, Mdh2 
  
GO:0031982: vesicle Aldh2, Atp5b, Gpnmb, Mdh2 
GO:0005886: plasma membrane Atp5b, Gpnmb, Mdh2 
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8.2 Kinase proteome profiler 
Table 8.4 Kinase proteome profiler coordinates and phosphorylation sites 
Coordinate  Target/Control  Alternate Nomenclature  
Phosphorylation 
Site Detected  
A1, A2  Positive Control  Control (+)  ___  
A21, A22  Positive Control  Control (+)  ___  
B3, B4  Akt1  PKBα, RACα  S473  
B5, B6  Akt2  PKBβ, RACβ  S474  
B7, B8  Akt3  PKBγ, RACγ S472  
B9, B10  Akt pan  ___  S473, S474, S472  
B11, B12  CREB  ___  S133  
B13, B14  ERK1  MAPK3, p44 MAPK  T202/Y204  
B15, B16  ERK2  MAPK1, p42 MAPK  T185/Y187  
B17, B18  GSK-3α/β GSK3α/GSK3β  S21/S9  
B19, B20  GSK-3β  GSK3Bβ S9  
C3, C4  HSP27  HSPB1, SRP27  S78/S82  
C5, C6  JNK1  MAPK8, SAPK1γ T183/Y185  
C7, C8  JNK2  MAPK9, SAPK1α T183/Y185  
C9, C10  JNK3  MAPK10, SAPK1β T221/Y223  
C11, C12  JNK pan  ___  T183/Y185, T221/Y223  
C13, C14  MKK3  MEK3, MAP2K3  S218/T222  
C15, C16  MKK6  MEK6, MAP2K6  S207/T211  
C17, C18  MSK2  RSKb, RPS6KA4  S360  
D3, D4  p38α 
MAPK14, 
SAPK2A, 
CSBP1  
T180/Y182  
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D5, D6  p38β MAPK11, SAPK2B, p38-2  T221/Y223  
D7, D8  p38δ MAPK13, SAPK4  S360  
D9, D10  p38γ MAPK13, SAPK3, ERK6  T183/Y185  
D11, D12  p53  ___  S46  
D13, D14  p70 S6 Kinase  S6K1, p70a, RPS6KB1  T421/S424  
D15, D16  RSK1  MAPKAPK1a, RPS6KA1  S380  
D17, D18  RSK2  ISPK-1, RPS6KA3  S386  
D19, D20  TOR  ___  S2448  
E19, E20  PBS  Control (-)  ___  
F1, F2  Positive Control  Control (+)  ___  
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8.3 Fractionation of S. mansoni cercarial E/S products 
To investigate the role of different components of S. mansoni cercarial E/S 
products in the responses observed in BMMϕs, 0-3hRP was fractionated into a 
soluble preparation (0-3hRPS) and a pellet (0-3hRPP) by using 
ultracentrifugation.  
8.3.1 Fractionation of 0-3hRP 
0-3hRP was fractionated by centrifugation at 100,000g for 1 hour at 4°C into a 
soluble preparation and a pellet. The soluble 0-3hRP preparation was denoted 
as 0-3hRPS, whilst the pellet was re-suspended in PBS and denoted as 0-
3hRPP. The protein content of both preparations was quantified as specified 
before (2.2.1). 
8.3.2 SDS polyacrylamide gel electrophoresis (PAGE) of fractions 
0-3hRP and its fractions were prepared for gel electrophoresis by taking 20µg 
of protein from each preparation, mixing it with 1X LDS sample buffer® (Life 
Technologies) plus 1X NuPAGE® Sample Reducing Agent (Life Technologies) 
and boiling it for 5min at 95°C. Prepared samples and Novex® Sharp Pre-
stained Protein Standard (Life Technologies) were loaded onto 4-12% 
NuPAGE® Bis-Tris Precast Gels (Life Technologies) and run for 2h at 200V in 
1X NuPAGE® MOPS SDS Running Buffer (Life Technologies).  
Gels were directly imaged in a Personal Molecular Imager (BioRad) using a 
638nm excitation laser and images acquired with QuantityOne® software 
(Biorad). 
Alternatively, gels were stained over night using Brilliant Blue G concentrate 
(SIGMA) and then de-stained washing several times in a 25% Methanol 10% 
Acetic acid solution. Stained gels were imaged using a GelDoc® and 
ImageLab® by Biorad. 
8.3.3 Differential effects of soluble and pellet fractions of S. mansoni E/S 
products on cytokine production 
BMMϕs were exposed overnight to 50µg/ml 0-3hRP, 50µg/ml 0-3hRPS, 25µg/ml 
0-3hRPP or left un-stimulated (Media), and culture supernatants tested for 
production of IL-10 and IL-12p40. 0-3hRPP was used at a lower dose (25µg/ml) 
due to limited availability of the material. IL-10 production was strikingly different 
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in BMMϕs exposed to the different preparations (Figure 8.1A). 0-3hRPP induced 
10-fold more IL-10 than either 0-3hRP, or 0-3hRPS, which were not significantly 
different compared to each other (p>0.05). Conversely, IL-12p40 production 
was significantly reduced in BMMϕs exposed to 0-3hRPP compared to 0-3hRP 
stimulated cells (Figure 8.1B, p<0.01), whilst the effect of 0-3hRPS on BMMϕs 
was comparable to that of 0-3hRP.  
Therefore, it appears that the IL-10 inducing feature of 0-3hRP is significantly 
enriched in 0-3hRPP. 
8.3.4 0-3hRPp inhibits TLR4 mediated IL-12p40 production in BMMϕ 
exposed to LPS 
As described in previous chapters (4.3.5.3), MAPK activation in response to 0-
3hRP in BMMϕs is able to limit the induction of IL-12p40 and this ability is linked 
to the signaling events that lead to the production of IL-10. As IL-10 induction is 
significantly increased in response to 0-3hRPP, the capacity of this preparation 
to inhibit IL-12p40 was tested. 
BMMϕs exposed overnight to LPS (1ng/ml) and increasing doses of 0-3hRPP 
were tested for the production of IL-12p40 and IL-10 by ELISA. PMB (2µg/ml) 
was used as a positive control for inhibition. 0-3hRPP was able to significantly 
reduce the amount of IL-12p40 produced by BMMϕs exposed to LPS (Figure 
8.2A, p<0.0001). At the highest dose of 0-3hRPP (50µg/ml), IL-12p40 production 
was still higher than the PMB control, which was expected, as 0-3hRPP alone is 
able to induce IL-12p40 (Figure 8.1B). Likewise, IL-10 production was 
significantly enhanced in response to greater concentrations of 0-3hRPP (Figure 
8.2B, p<0.0001).  
Notably, IL-12p40 production was already significantly impaired compared to 
LPS only at 2µg/ml of 0-3hRPP (p<0.0001), whilst IL-10 levels at that dose were 
not significantly different compared to LPS only BMMϕs. This further supports 
the notion that IL-12p40 inhibition occurs as a result of 0-3hRP driven MAPK 
activation in BMMϕs, and not as an IL-10 feedback loop, as demonstrated 
before (4.3.5.3). 
Unlike 0-3hRPP, 0-3hRP was not able to inhibit IL-12p40 production in response 
to LPS by BMMϕs (Figure 8.3). 
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8.3.5 Protein profile of different fractions S. mansoni E/S products  
As the ability to induce IL-10 in BMMϕs was not equally distributed between the 
fractions obtained from 0-3hRP, the distribution of proteins was qualitatively 
assessed by SDS PAGE. 
Each fraction contained a different quantity of protein (Figure 8.4A), with 0-
3hRPS retaining close to 75% of the protein available in the original 0-3hRP 
preparation. After fractionating, 20µg of 0-3hRP and the same amount from 
each fraction were analyzed by electrophoresis as described before (8.3.2) and 
stained with Brilliant Blue G (Figure 8.4B). In agreement with the estimated 
protein content of unfractionated 0-3hRP, most bands were also present in 0-
3hRPS, whereas only two of the most dominant bands were clearly visible in 0-
3hRPP (marked with arrows). Both bands were identified using MS/MS. The 
higher molecular weight band (a) was Invadolysin (M08) (Sm_90100) with a 
Mascot score of 826 and 7 peptides identified. The lower molecular weight band 
(b) contained two hits: cercarial elastase 2a (mascot score 405, 3 peptides) and 
Sm16 (mascot score 70, 2 peptides). 
8.3.6 0-3hRPp fluoresces naturally 
In the course of experimental work with 0-3hRPP, it became apparent that this 
preparation was emitting light when it was excited with different lasers. 
Consequently, this feature of the secretions was analysed using a fluorimeter.  
Equal volumes of 0-3hRP (Figure 8.5A), 0-3hRPS (Figure 8.5B) and 0-3hRPP 
(Figure 8.5C) were analyzed using a Fluoromax 4 (Horiba). Emission data was 
collected between 420nm and 750nm with excitations at 415nm (top), 488nm 
(middle) and 633nm (bottom). A limited amount of fluorescence was detectable 
in 0-3hRP and 0-3hRPS around 500nm, with no discernible peaks. However, 
both 0-3hRP and 0-3hRPP had a clear emission peak at 675nm that was absent 
from 0-3hRPS. This emission was excited by all three lasers, and was greatest 
when excited with the 633nm laser. In all cases, 0-3hRPP exhibited greater 
levels of fluorescence than 0-3hRP. 
This fluorescence was not restricted to the antigenic preparation in solution, but 
was also clear when BMMϕs internalized the secretions. BMMϕs exposed 
overnight to 0-3hRP, 0-3hRPP or left un-stimulated (Media), were analyzed with 
flow cytometry as described before (2.4), leaving the 633nm/680nm 
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(Excitation/Emission) channel free. As expected, 0-3hRP and 0-3hRPP 
stimulated BMMϕs were positive in the 633nm/680nm channel, with 0-3hRPP 
exposure resulting in higher levels of fluorescence (Figure 8.6A). Consequently, 
0-3hRPP stimulated BMMϕs were sorted based on the brightness of the 
fluorescence (Figure 8.6B) and imaged using confocal microscopy (Figure 
8.6C). 
In line with the results obtained with flow cytometry, 0-3hRPP exposed BMMϕs 
contained differing levels of the fluorescent material, with the brightest cells as 
judged by flow cytometry (right) containing the most material as observed with 
confocal microscopy (Figure 8.6C, right panel). Flow cytometric analysis of the 
middle group (Figure 8.6C, middle panel) and the low group (Figure 8.6C, left 
panel) also correlated to the results obtained by confocal microscopy. Closer 
examination of bight cells (Figure 8.6D) revealed that 0-3hRPP could be 
localized in discrete bright spots, or diffused thought the cytoplasm. 
Finally, all fractions were loaded onto a protein gel and imaged without staining 
in a Personal Molecular Imager (Biorad) (see 8.3.2) with an excitation of 635nm 
and emission of 685nm. Two bands between 10 and 20kDa were strongly 
positive in both 0-3hRP and 0-3hRPP, but not in 0-3hRPS (Figure 8.7, red 
arrows). These bands are in the same region as the band identified earlier 
(8.3.5) so they could be Sm16 or cercarial elastase. 
In short, the component of 0-3hRP that is responsible for the induction of IL-10 
is enriched in the pellet fraction of this preparation. The ability to induce IL-10 
production is linked with the potential to block IL-12p40, which is indeed also an 
effect of 0-3hRPP. Additionally, this material naturally fluoresces, and its uptake 
by BMMϕs can be measured using flow cytometry. Furthermore, increased 
uptake of naturally fluorescent 0-3hRP coincided with an increase in MAPK 
activation (data not shown). 
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Figure 8.1 BMMϕs exposed to 0-3hRP fractions secrete differing 
quantities of IL-10 and IL-12p40 
Supernatants from BMMϕs exposed to 0-3hRP (50µg/ml), 0-3hRPS (50µg/ml), 
0-3hRPP (25µg/ml) or left un-stimulated (Media) were tested for the production 
of (A) IL-10 and (B) IL-12p40. Means +SEM of 6 technical replicates are 
presented. ANOVA and then Dunnett’s multiple comparisons test were 
performed to examine differences between the means of cells stimulated with 
fractions compared to cells stimulated with whole preparation (** = p<0.01; **** 
= p<0.0001; ns = p>0.05). Results are representative of three independent 
experiments. 
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Figure 8.2 0-3hRPP blocks IL-12p40 production by BMMϕs exposed to LPS 
Supernatants from BMMϕs exposed to LPS (1ng/ml) and increasing doses of 0-
3hRPP, or PMB (2µg/ml) (open circles), were tested for the production of (A) IL-
12p40 and (B) IL-10. Means ±SEM of 6 technical replicates are presented. 
ANOVA and then Tukey’s multiple comparisons test were performed to examine 
differences between selected means (**** = p<0.0001; ns = p>0.05). Results 
are representative of two independent experiments. 
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Figure 8.3 0-3hRP does not impair IL-12p40 production in BMMϕs 
exposed to LPS 
Supernatants from BMMϕs exposed to LPS (1ng/ml) and increasing doses of 0-
3hRP, or PMB (2µg/ml) (open circles), were tested the production of IL-12p40. 
Means ±SEM of 6 technical replicates are presented. ANOVA and then Tukey’s 
multiple comparisons test were performed to examine differences between 
selected means (ns = p>0.05). Results are representative of two independent 
experiments. 
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Figure 8.4 0-3hRP fractions retain different levels of proteins 
Three preparations of 0-3hRP were fractionated using ultracentrifugation and 
fractions restored to the original volume of each preparation. (A) The protein 
content of each resulting fraction was determined using a BCA assay and 
expressed as a percentage of the total protein present in the original 
preparation. Unpaired t-test was performed to find statistically significant 
differences between the means (*** = p<0.001). (B) 20µg of 0-3hRP and each 
fraction were analyzed in a protein gel stained with Brilliant Blue G. 
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Figure 8.5 0-3hRP naturally emits red fluorescence 
(A) 0-3hRP, (B) 0-3hRPS and (C) 0-3hRPP were analyzed using a fluorimeter to determine their absorption/emission profile after 
excitation at (top) 415nm, (middle) 488nm or (bottom) 633nm. 
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Figure 8.6 0-3hRP fluorescence is detectable inside BMMϕs 
(A) BMMϕs exposed overnight to 0-3hRP (50µg/ml), 0-3hRPP (25µg/ml) or left 
un-stimulated (Media) were analyzed using flow cytometry. (B) BMMϕs 
exposed overnight to 0-3hRPP (25µg/ml) sorted using fluorescence activated 
cell sorting into three groups were based on levels of 0-3hRPP-associated 
fluorescence. (C & D) Each group was analyzed using confocal microscopy to 
confirm internalization of fluorescent material. (D) Higher resolution image of 
bright cells reveals diffuse fluorescence in the cytoplasm and concentrated 
fluorescence in punctae. 
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Figure 8.7 0-3hRP naturally emits red fluorescence which can be detected 
on a protein gel as discrete bands 
10µg/ml of 0-3hRP, 0-3hRPS and 0-3hRPP were analyzed on a protein gel and 
imaged without staining on a Personal Molecular Imager (Biorad) using a 
635nm excitation laser and detecting at 680nm. Result is representative of 
three individual experiments. 
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8.4 Sm16, a protein in 0-3hRPp, inhibits BMMϕ activation by 
TLR ligands 
As explained above, fractions of 0-3hRP revealed differential abilities to 
modulate cytokine responses by stimulated BMMϕs (8.3). In particular, 0-3hRPP 
was able to prevent LPS induced production of IL-12p40. This fraction 
contained at least two enriched proteins: Invadolysin and Sm16. The latter 
protein has been studied in most detail previously and was found to have a 
profound effect on human macrophages, predominantly by inhibiting TLR 
induced cytokine production (Brännström et al, 2009; Holmfeldt et al, 2007). 
Therefore, it was decided to perform a direct comparison between 0-3hRP and 
recombinant Sm16 (rSm16). 
8.4.1 Western blot analysis of fractions 
0-3hRP and its fractions were resolved using protein electrophoresis as 
described before (8.3.2) and transferred onto a nitrocellulose membrane using 
an iBlot® Transfer Stack (Life Technologies) as specified by the manufacturer. 
Membranes were then analyzed by western blot by using the SnapID® system 
(Millipore). Initially membranes are blocked in vacuum with a 1% BSA solution 
in PBS, then rabbit anti-rSm16 antibody (1:5000) (donated by Dr Martin 
Gullberg, Umeå University, Sweden) was added in vacuum for 10min followed 
by 4 washes in 0.05% Tween in PBS. Membranes were incubated in vacuum 
with goat anti rabbit antibody (1:30000) conjugated to horseradish peroxidase 
for 10min followed by 4 washes in 0.05% Tween in PBS. 
SuperSignal® West Pico (Thermo Scientific) chemiluminescence reagent was 
used to reveal the antibody labelling of proteins on the membranes using X-ray 
film imaging (GE Healthcare). Equal volumes of Luminol/Enhancer Solution and 
Stable Peroxidase solution were mixed and incubated with labelled/probed 
membranes for 5min. Chemiluminescence reagent was removed by washing 
and X-ray film finally exposed for different lengths of time prior to development.  
8.4.2 Sm16 is present in 0-3hRPp 
Increasing amounts of 0-3hRP fractions were analyzed on a protein gel, as 
described before (8.3.2), alongside increasing amounts of rSm16 (kindly 
donated by Dr Martin Gullberg) (Figure 8.8A). rSm16 had a molecular weight 
between 15kDa and 20kDa judged by comparison with the protein standard 
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(expected molecular weight of 16kDa). This was higher than the band identified 
in section 8.3.5, which was between 10kDa and 15kDa (Figure 8.4B, arrow b). 
Nonetheless, both 0-3hRPS and 0-3hRPP contained a band of a similar 
molecular weight as rSm16 (Figure 8.8A, red arrows), therefore it was 
presumed likely that the fractions of 0—3hRP contained Sm16. Densitometry 
analysis performed of the selected bands, allowed the construction of a 
standard curve based on the amount of rSm16 loaded onto the gel and the 
resulting pixel intensity (Figure 8.8B). A linear regression, with an adequate fit 
(R2=0.999), produced an equation to estimate the amount of Sm16 in the 0-
3hRP fractions based on pixel intensities, which showed that the putative Sm16 
band was significantly enriched in 0-3hRPP as a fraction of the total protein, 
compared to 0-3hRPS (Figure 8.8C, p<0.05). The putative band for Sm16 in the 
15µg lane of 0-3hRPP was excluded from the analysis as it appeared elongated. 
However, it is likely that more than one protein is contained in the 
aforementioned band. Consequently, western blot analysis was performed 
(8.4.1), on a gel where equivalent amounts of both fractions were loaded (i.e. 
fractions were diluted to the volume of the original preparation). Indeed, using 
an anti-rSm16 antibody, the native form of this protein was detected in both 0-
3hRPS and 0-3hRPP (Figure 8.9A). Moreover, densitometry analysis of the blot, 
using rSm16 pixel intensity as a normalizer, suggested that Sm16 was 
significantly enriched as a proportion (greater than 5 fold) in 0-3hRPP compared 
to 0-3hRPS (Figure 8.9B, p<0.0001). 
8.4.3 Sm16 blocks cytokine production in response to TLR4 and TLR3, 
but not TLR2 ligands in BMMϕs 
0-3hRPP’s ability to block LPS induced IL-12p40 production could be a result of 
the enrichment of Sm16 in that fraction. Consequently, the capacity of Sm16 to 
prevent TLR signaling in murine macrophages was tested. 
BMMϕs were exposed overnight to LPS (1ng/ml) and increasing doses of 
rSm16 and culture supernatants tested for IL-12p40 and IL-10 by ELISA. rSm16 
was able to reduce the amount of IL-12p40 produced by BMMϕs exposed to 
LPS to media levels at all doses used (Figure 8.10A). Likewise, IL-10 
production was ablated in response to all concentrations of rSm16 (Figure 
8.10A).  
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An intermediate dose of rSm16 (10µg/ml) was taken forward for all other 
experiments, where the ability of this protein to block TLR driven cytokine 
production in response to other ligands was tested. rSm16 was dissolved in a 
phosphate buffer (pH 7.5) containing 0.45M NaCl to prevent aggregation. To 
rule out any effects of this buffer, BMMϕs exposed to all TLR ligands were given 
an equivalent amount of this buffer as a negative control (Buffer control).  As 
before, BMMϕs exposed to LPS were unable to produce IL-12p40 and IL-10 
when rSm16 was present in the culture, whereas Buffer control had no effect 
(Figure 8.11A & B). rSm16 had no effect on cytokine production of BMMϕs 
exposed to Pam3CSK4 (Figure 8.11C & D). However, Poly I:C treated BMMϕs 
were unable to produce IL-12p40 and IL-10 when rSm16 was given at the same 
time, whilst no impairment was observed with Buffer control (Figure 8.11E & F). 
8.4.4 Sm16 is able to prevent BMMϕ activation in the context of IFN-γ 
stimulation 
Macrophage function is modulated in vivo by several cytokines, specially IL-4 
and IFN-γ (see 1.3.1). IFN-γ boosts the pro-inflammatory phenotype of 
macrophages and works in tandem with innate stimuli, such as LPS, to provide 
a necessary second signal for complete oxidative burst (see 1.3.1). 
Consequently, the effects of rSm16 on BMMϕ-activation in the context of IFN-γ 
stimulation were investigated.  
Culture supernatants from BMMϕs exposed overnight to LPS or Media, +/- IFN-
γ (25U/ml), +/- rSm16 were tested for IL-12p40 by ELISA and Nitric oxide (NO2-) 
production by commercially available Greiss reaction (Life Technologies). As 
before, IL-12p40 production was ablated by rSm16 in LPS stimulated BMMϕs 
(Figure 8.12A). IFN-γ activation resulted in a marked increase in the production 
of IL-12p40 by macrophages stimulated with LPS, but not Media alone. 
Nevertheless, rSm16 was able to significantly reduce IL-12p40 production in 
LPS treated IFN-γ stimulated BMMϕs (Figure 8.12A, p<0.0001). 
A small amount of NO2- was produced in response to LPS, that could be 
significantly reduced by rSm16 in BMMϕs (Figure 8.12B, p<0.01). IFN-γ 
activation greatly enhanced the detected levels of NO2- in LPS stimulated 
BMMϕs; however, rSm16 was able to significantly reduce that response (Figure 
8.12B, p<0.0001). 
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In short, rSm16 was able to significantly reduce the activation of BMMϕs in 
response to innate stimuli even in the context of potent IFN-γ stimulation. 
8.4.5 TLR2 is not required for rSm16 effect on cytokine production in 
BMMϕs 
rSm16 was able to prevent TLR4 and TLR3 mediated cytokine production in 
BMMϕs, but no defect was observed when a TLR2 ligand was used. Earlier, 0-
3hRP was shown to be recognized both by TLR2 and TLR4 (see 4.3.2), 
therefore the effect of exogenous rSm16 on 0-3hRP cytokine induction was 
tested.  
BMMϕs exposed overnight to 0-3hRP and rSm16 produced significantly less IL-
12p40 than BMMϕs exposed to 0-3hRP alone (Figure 8.13A, p<0.01). However, 
IL-10 production in response to 0-3hRP was significantly increased when 
rSm16 was added to the culture (Figure 8.13B, p<0.001). Buffer control had no 
effect on either cytokine. Unlike Pam3CSK4, which is only recognized by TLR2, 
0-3hRP uses both TLR2 and TLR4. TLR4 deficiency had a greater impact in IL-
12p40 production than TLR2 in BMMϕs stimulated with 0-3hRP. Whereas TLR2 
deficiency had a greater effect on IL-10 production than TLR4 in BMMϕs 
exposed to 0-3hRP. As cytokine production was not ablated by rSm16 in 
BMMϕs exposed to 0-3hRP, and Sm16 blocks TLR4 stimulation, these results 
confirm TLR2 is involved in the recognition of 0-3hRP. The observed increase 
in IL-10 induced by co-stimulation with rSm16 and 0-3hRP indicates that TLR4 
signaling could be antagonizing the production of IL-10 in BMMϕs. The 
reduction in IL-12p40 in these co-stimulated cells also implies that TLR4 is 
responsible partly for the induction of this cytokine in response to 0-3hRP. 
As 0-3hRP is recognized by TLR2 (see 4.3.2), and rSm16 is unable to block 
signaling from that receptor, the role of TLR2 in the effects of the recombinant 
protein were tested. TLR2-/- BMMϕs, obtained as described before (2.3), were 
exposed overnight to LPS and Poly I:C and culture supernatants tested for IL-
12p40. Both ligands induced a robust IL-12p40 production in TLR2-/- BMMϕs, 
however, rSm16 was able to completely ablate the production of this cytokine 
(Figure 8.14). Therefore, rSm16 acts on BMMϕs independently of TLR2. rSm16 
inhibition of Poly I:C induced cytokines was also evident in TLR4-/- BMMϕs (data 
not shown). 
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8.4.6 Sm16 is taken up by BMMϕs into a distinct processing pathway 
0-3hRP uptake has been shown to be important for triggering of downstream 
signals (see chapter V) and others have described its delayed processing in 
BMMϕs, marked by a prolonged stay in early endosomes (Paveley et al, 2009). 
Other inhibitory helminth products sequester TLR signaling machinery through 
endocytosis (Pineda et al, 2014). Consequently, the uptake and processing of 
rSm16 was investigated. 
BMMϕs were exposed for 10 and 100min to rSm16 labeled with AF594 and 
analyzed with confocal microscopy as described before (5.2.3), with antibodies 
for EEA-1 (Figure 8.15B) and relevant no primary antibody controls (Figure 
8.15A). rSm16 was closely associated with EEA-1 at 10 and 100min after 
stimulation. Closer analysis of confocal images revealed that EEA-1 could be 
seen surrounding rSm16 (Figure 8.16, white arrows on inserts), indicative of the 
latter protein being present in early endosomes positive for EEA-1. EEA-1 is not 
a membrane protein, but rather it associates with the outside of the endosome 
Typical staining with EEA-1 is for this protein to surround the cargo (Beas et al, 
2012). This prolonged retention of rSm16 in these compartments, was 
reminiscent of previous similar observations for 0-3hRP (Paveley et al, 2009).  
To further study the cellular fate of rSm16, BMMϕs were exposed to this labeled 
protein and FITC conjugated DEXTRAN (DEXTRANFITC) (SIGMA) as a control 
for readily processed cargo. Both stimuli were removed after 100min, and the 
cells imaged at frequent intervals (Figure 8.17). At 10 and 60min after removal, 
both rSm16 and DEXTRANFITC were found in different compartments of 
BMMϕs. rSm16 was more abundant in the periphery of the cell, whereas 
DEXTRANFITC was closer to the nucleus, although by 100min after stimuli 
removal, only a faint signal was detected from DEXTRANFITC. rSm16 was also 
greatly reduced, yet foci were still visible in the perinuclear region (Figure 8.17). 
In summary, 0-3hRPP contains a significantly higher proportion of Sm16, which 
has potent inhibitory activity on TLR4 and TLR3 induced signaling. This activity 
is not mediated by direct interaction with TLR2 or TLR4 and is able to enhance 
0-3hRP driven IL-10 production, strongly suggesting that Sm16 works in 
tandem with the signaling events triggered by 0-3hRP to induce that cytokine. 
Furthermore, rSm16 is quickly internalized by BMMϕs and placed in early 
endosomes, leading to a delayed processing pathway compared to other cargo.  
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Figure 8.8 0-3hRP fractions protein profile comparison to rSm16 
(A) 0-3hRP was fractionated using ultracentrifugation and resulting 0-3hRPS 
and 0-3hRPP analyzed in a protein SDS PAGE gel stained with Brilliant Blue G 
alongside rSm16. (B) A standard curve was constructed based on densitometry 
analysis of dominant band in rSm16 lanes (red arrow) and a linear regression 
was performed to obtain an equation (displayed on graph) to fit the curve. (C) 
Densitometry analysis of Sm16 equivalent bands in 0-3hRP fractions (red 
arrows) was used to estimate the µg of putative Sm16 per µg of total protein. 
Mean +SEM are presented and an unpaired t-test performed to examine 
statistically significant differences between them (* = p<0.05). 
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Figure 8.9 Sm16 abundance in 0-3hRP fractions  
0-3hRP was fractionated using ultracentrifugation and resulting 0-3hRPS (78µg) 
and 0-3hRPP (10µg) were analyzed in a protein gel alongside rSm16 (1µg). (A) 
Western blot analysis of said gel was performed with rabbit anti-rSm16 antibody 
(1:5000), with the corresponding goat anti rabbit HRP (1:30000) secondary 
antibody. (B) Based on densitometry analysis of rSm16, the relative 
concentration of Sm16 in both fractions was estimated. Mean +SEM are 
presented and an unpaired t-test performed to examine statistically significant 
differences between them (**** = p<0.0001). 
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Figure 8.10 rSm16 blocks cytokine production in BMMϕs exposed to LPS 
Supernatants from BMMϕs exposed to LPS (1ng/ml) or Media (open triangles) 
and increasing doses of rSm16 were tested for the presence of (A) IL-12p40 
and (B) IL-10. Means ±SEM of 3 technical replicates are presented. ANOVA 
and then Tukey’s multiple comparisons test were performed to examine 
differences between the means compared to Media control (**** = p<0.0001; ns 
= p>0.05). Results are representative of three independent experiments. 
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Figure 8.11 rSm16 blocks cytokine production in BMMϕs exposed to TLR4 
and TLR3, but not TLR2 ligands 
Supernatants from BMMϕs exposed to (A-B) LPS (1ng/ml), (C-D) Pam3CSK4 
(5µg/ml), (E-F) Poly I:C (25µg/ml) or Media plus rSm16 (10µg/ml) (hatched 
bars) or an equivalent volume of protein buffer (open bars) were tested for the 
presence of (A, C, E) IL-12p40 and (B, D, F) IL-10 (limit of detection of 
16pg/ml). Means ±SEM of 3 technical replicates are presented. ANOVA and 
then Dunnett’s multiple comparisons test were performed to examine 
differences between selected means (* = p<0.05; ** = p<0.01; *** = p<0.001; 
**** = p<0.0001; ns = p>0.05). Results are representative of three independent 
experiments. 
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Figure 8.12 rSm16 blocks both cytokine production and oxidative burst in 
BMMϕ exposed to LPS and IFN-ϒ  
Supernatants from BMMϕs exposed to LPS (1ng/ml) or left un-stimulated 
(Media) plus recombinant IFN-Υ (25U/ml) and/or rSm16 (10µg/ml) were tested 
for the production of (A) IL-12p40 by ELISA and (B) nitric oxide (NO2-) by 
Greiss reaction. Means ±SEM of 3 technical replicates are presented. ANOVA 
and then Sidak’s multiple comparisons test were performed to examine 
differences between selected means (* = p<0.05; ** = p<0.01; *** = p<0.001; 
**** = p<0.0001; ns = p>0.05). Results are representative of three independent 
experiments. 
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Figure 8.13 rSm16 has differential effect on cytokine production in 
BMMϕs exposed to 0-3hRP 
Supernatants from BMMϕs exposed to 0-3hRP (50µg/ml) with PMB (2µg/ml) or 
left un-stimulated (Media) plus rSm16 (10µg/ml) (hatched bars) or an equivalent 
volume of protein buffer (open bars) were tested for the production of (A) IL-
12p40 and (B) IL-10. Means ±SEM of 3 technical replicates are presented. 
ANOVA and then Dunnett’s multiple comparisons test were performed to 
examine differences between selected means (* = p<0.05; ** = p<0.01; *** = 
p<0.001; **** = p<0.0001; ns = p>0.05). Results are representative of three 
independent experiments. 
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Figure 8.14 rSm16 blocks IL-12p40 production in BMMϕs exposed to TLR4 
and TLR3 ligands in a TLR2 independent manner 
Supernatants from BMMϕs from TLR2-/- mice exposed to LPS (1ng/ml) or Poly 
I:C (25µg/ml) (solid bars), plus rSm16 (10µg/ml) (hatched bars), were tested for 
IL-12p40 by ELISA. Means ±SEM of 3 technical replicates are presented. 
ANOVA and then Dunnett’s multiple comparisons test were performed to 
examine differences between selected means (** = p<0.01; **** = p<0.0001). 
Results are representative of two independent experiments. 
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Figure 8.15 Uptake of fluorescently labelled rSm16 by BMMϕs  
BMMϕs exposed to labeled rSm16AF594  (red) and dyed with nuclear stain DAPI 
(blue) were analyzed by confocal microscopy (63X objective, 38.8µm x 
38.8µm). (A) Representative no primary antibody controls are given for EEA-1 
staining. (B) Representative confocal images of BMMϕs containing labeled 
rSm16 within EEA-1 positive endosomes (green) after 10min and 100min. 
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Figure 8.16 High resolution image of vesicles containing rSm16 in BMMϕs  
BMMϕs exposed for 10min to labeled rSm16 (red) and dyed with nuclear stain 
DAPI (blue) were analyzed by confocal microscopy (63X objective, 38.8µm x 
38.8µm). Intracellular EEA-1 positive structures containing labeled Sm16 are 
highlighted (2µm x 2µm). 
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Figure 8.17 Intracellular trafficking of rSm16 is delayed compared to 
dextran processing  
BMMϕs were exposed for 100min to labeled rSm16 (red) and DEXTRANFITC 
(green). Stimuli were then removed and cells washed and imaged after 10, 60 
and 100min. Representative confocal images of BMMϕs dyed with nuclear stain 
DAPI (blue) at each time point are presented (63X objective, 24µm x 24µm). 
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List of Abbreviations 
-/- Full genetic deficiency 
° Degree 
~ Approximately 
0-3hRP Cercarial E/S Products 
0-3hRPP Insoluble 0-3hRP 
0-3hRPS Soluble 0-3hRP 
2ME 2-mercaptoethanol 
AAMϕs Alternatively activated macrophages 
ANOVA Analysis of Variance 
AP-1 Activator protein 1 
Arg-1 Arginase 1 
BgMϕs BioGel elicited macrophages 
BMMϕs Bone marrow derived macrophages 
BreA Brefeldin A 
BSA Bovine serum albumin 
C/EBPβ CCAAT/enhancer binding protein β 
CAMϕs Classically activated macrophages 
CD Cluster of Differentiation 
ChIP Chromatin Immunoprecipitation 
CLR C-type lectin receptors 
CREB cAMP response element binding 
CSF-1 Macrophage colony stimulating factor 
CytD Cytochalasin D 
DC SIGN Dendritic Cell-Specific Intercellular adhesion molecule-3-
Grabbing Non-integrin 
DCs Dendritic cells 
DEC Dermal Exudate Cells 
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DETC Dendritic epidermal T cells 
DEXTRANFITC FITC conjugated dextran 
DNA Deoxyribonucleic Acid 
EEA-1 Early endosome antigen 1 
Egr1 Early growth response protein 1 
Erk Extracellular signal-regulated kinase 
FACS buffer 1% FCS in PBS 
FASP Filtered assisted samples preparation 
FCS Foetal calf serum 
Fix/Perm Fixation/Permeabilization 
FSC Forward Scatter 
g Gravities 
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 
GFP Green fluorescent protein 
GO Gene ontology 
HRP Horseradish peroxidase 
i.p. Intra-peritoneal 
IFN-γ Interferon gamma 
Ig Immunoglobulin 
IKKβ Inhibitor of nuclear factor kappa B kinase β 
IL- Interleukin 
IL-10+/gfp IL-10 reporter mice heterozygous for GFP 
IL-4ra IL-4 receptor alpha 
ILCs Innate Lymphoid cells 
inh. Inhibitor 
iNOS Inducible nitric oxide synthase 
IPI International protein index 
IRAK1 Interleukin-1 receptor-associated kinase 1 
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JAK1 Janus kinase 1 
kDa Kilo Daltons 
L-Glut L-Glutamine 
LBP LPS binding protein 
LC-MS/MS Liquid chromatography – mass spectrometry 
LCs Langerhans cells 
LPS Lipopolysaccharide 
mAb Monoclonal antibody 
MAP2K Mitogen associated protein kinase kinase 
MAP3K Mitogen activated protein kinase kinase kinase 
Map3K7 Mitogen activated protein kinase kinase kinase 7 
MAPK Mitogen activated protein kinase 
MAPKAP MAPK activated-protein kinase 
MD2 Lymphocyte antigen 96 
MEK1/2 Mitogen activated protein kinase kinase 1/2 
MFI Median Fluorescence Intensity 
MFI Median fluorescence intensity 
MGI Mouse Genome Informatics 
MHC-II Mayor histocompatibility complex class II 
min Minutes 
ml Milliliter 
MR Macrophage mannose receptor 
MSK Mitogen! and stress!activated protein kinase 
MyD88 Myeloid differentiation protein 88 
NF-κB Nuclear factor κ B 
NLR NOD like receptor 
No Ab No antibody 
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NOD Nucleotide oligomerization domain 
Nrp-1 Neuropilin-1 
ns Not significant 
ON Overnight 
P- Phosphorylated 
P-Akt Phosphorylated Akt 
P-CREB Phosphorylated CREB 
P-Erk Phosphorylated Erk1/2 
P-p105 Phosphorylated p105 
P-p38 Phosphorylated p38 
P-p65 Phosphorylated p65 
pAb Polyclonal antibody 
PAMP Pathogen associated molecular pattern 
PBS Phosphate buffered saline 
PCR Polymerase chain reaction 
Perm Permeabilization 
PFA Paraformaldehyde 
PI3K Phosphatidylinositol-4,5-bisphosphate 3-kinase 
PMB Polymixin B 
Poly I:C Polyinosinic:polycytidylic acid 
PRR Pattern recognition receptor 
qPCR Quantitative real time PCR 
RAF Proto-oncogene serine/threonine-protein kinase 
Rag Recombination-activation gene 
Relmα Resistin like molecule α 
RNA Ribonucleic Acid 
RSK Ribosomal s6 kinase 
rSm16 Recombinant Sm16 
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SEA S. mansoni egg antigen 
SEM Standard error of the mean 
SHP1 Src homology region 2 domain-containing phosphatase-1 
SR-AI/MSR1 Macrophage scavenger receptor 1 
SSAP Soluble schistosomula antigen preparation 
SSC Side Scatter 
STAT3 Signal transducer and activator of transcription 3 
Th T helper 
TIRAP Toll-interleukin 1 receptor (TIR) domain containing adaptor 
protein 
TLR Toll-like receptor 
TNF-α Tumor necrosis factor alpha 
Tpl2 Tumor progression locus 2 
Tr1 Type 1 regulatory 
TRAF 6 TNF receptor associated factor 6 
TRAM TRIF related adaptor molecule 
TRIF TIR-domain-containing adapter-inducing interferon β 
TSLP Thymic stromal lymphopoietin 
TYK2 Tyrosine kinase 2 
VLAD Visual Annotation Display 
Ym1 Chitinase like 3 
Zym Zymosan A 
α-CD36 Antibody against CD36 
α-CREB Antibody against CREB 
α-P-CREB Antibody against phosphorylated CREB 
α-Pol II Antibody against RNA Polymerase II 
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